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Abstract 
The DNA binding interactions of five novel bis(2,2: 6'2"- 
terpyridine)ruthenium(II) complexes functionalised with an aryl tail group (i) 
biphenylene (biphen), (ii) P-napthyl (napth), (iii) phenanthrene (phen), (iv) anthracene 
(anth) and (v) pyrene (pyr) in the 4' position on each terpyridine ligand were 
investigated with calf thymus DNA (ct-DNA), poly [d(A-T)12 and poly [d(G-C)12 DNA 
using the spectroscopic techniques of absorbance, circular dichroism (CD) and linear 
dichroism (LD). All five complexes bind non-covalently to DNA. At low complex 
concentrations, the anth, phen and pyr complexes were found to intercalate their aryl tail 
groups between DNA bases. The napth complex exhibits both an intercalative and a 
non-intercalative mode. The biphen complex exhibits groove binding with no 
significant tail intercalation. At high metal complex concentrations, aggregation of the 
complexes on the DNA is observed, resonance light scattering indicate aggregates of 
low nuclearity along the groove. 
The DNA binding interactions of a novel series of structurally similar eighteen 
platinum(H) square planar complexes with subtle ligand variations of the formula 
[Pt(L)CI(DMSO)] where L denotes an acylthiourea ligand system were investigated 
with ct-DNA, poly [d(A-T)12 and poly [d(G-C)12 DNA, 5'-mononucleotides and 9- 
methylguanine. Absorbance, CD and LD studies indicate ligand variation affects DNA 
binding interaction. Mass spectrometric studies suggest these complexes bind covalently 
to DNA via the loss of the chloride or possibly the DMSO groups on the platinum. 
Supramolecular copper(l) and silver(l) metal lo-cyclophanes and their 
interactions with the isomers of di- and tri-methoxybenzenes and chiral anionic 
compounds were investigated. The metal] o-cyclophan es can adopt two conformations, a 
helical and a bridging non-helical structure. CD, NMR and X-ray crystallography show 
the dianion sodium antimQnyl-L-tartrate can resolve this mixture. Absorbance and 
fluorescence studies suggest the metallo-cyclophanes bind methoxybenzenes. The 
design and synthesis of novel longer asymmetric ligands capable of assembly into a 
larger suprarnolecular metallo-cyclophanes is included. 
vii 
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1 Introduction and spectroscopic 
techniques 
1.1 Background 
The work presented in this thesis describes novel inorganic metal complexes and 
their interactions with bio-molecules. The main aim has been to develop methods to 
study metallo-complexes spectroscopically. A variety of systems have been studied, the 
common features of which are the spectral techniques used and the need to solubilise 
the systems in organic solvents. In chapter 2, the interaction of a series of octahedral 
ruthenium(II) bis-terpyridine complexes with DNA is described and discussed. Similar 
studies on some smaller platinum(II) square planar complexes form the subject matter 
for chapter 3 with mass spectroscopic data contributing to the overall picture of the 
interactions. Chapter 4 reports the investigation of the molecular sensor potential of the 
simplest class of system studied, that of novel self-assembling copper(l) supramolecular 
metal lo-cycloph anes, 1 with small aromatic compounds and concludes with the 
description of the synthesis of a novel larger ligand capable of self-assembly into a box 
structure. Chapter 5 contains the overall conclusions of this thesis. 
1.2 Introduction 
In this introductory chapter, the background to each aspect of the work is 
discussed. In Section 1.3 the spectroscopic techniques used to the conduct bio-physical 
studies are explained. Section 1.4 contains a basic explanation of the use of inorganic 
metal complexes in biology. Section 1.5 covers the different ways in which molecules 
interact. Section 1.6 provides an overview of DNA and its binding modes. Finally 
I 
Section 1.7 reports on the preliminary studies conducted on the potential use of organic 
solvents with DNA for the work in chapters 2,3 and 4. 
1.3 Spectroscopic techniques 
1.3.1 Introduction 
The sun is a burning mass of energy that errýits electromagnetic radiation, more 
commonly known as light. Visible light, which is the electromagnetic radiation our 
eyes detect, represents only a very small -portion of the electromagnetic spectrum. 
Electromagnetic radiation waves of different frequencies and wavelengths can also be 
produced by different sources. For example, light is emitted by very hot objects such as 
the filament of a light bulb. 
The characteristics of the electromagnetic radiation depend on its wavelength 
and can be grouped accordingly: from the long wavelength, low frequency radiowaves 
to microwaves, infrared waves, light waves (sub-divided into the visible and invisible 
(the ultra-violet (UV))), x-rays and cosmic rays (short wavelength, high frequency). 
Electromagnetic radiation i. s described as having dual wave and particle properties. It is 
the energy resulting from the acceleration of electric charge and the associated electric 
fields and magnetic fields (found everywhere in the universe). It can be considered as 
made up of two components, electric and magnetic waves that both oscillate at right 
angles to each other and to the direction of motion, with wavelength, 4 and frequency, 
v. It can also be described in terms of a photon (a particle of light with no mass) of a 
particular wavelength with an energy AE. 2-6 
hc AE=- = hv A 
2 
where h= Planck's constant (6.626 x 10-34 j s), v= frequency of the radiation, X= 
wavelength of the radiation and c= speed of light (3.0 x 108 M s-1). No two wavelengths 
have the same photon energy. 2,5 
Spectroscopy is the study of the interactions between radiation and matter - 
specifically in this instance the interaction between light and matter. Different molecular 
processes occur when light in each region is absorbed by matter. The internal energy of 
a molecule can be due to energy associated with electrons (electronic), energy 
associated with vibrations between atoms (vibrational), and energy associated with 
rotation of various groups of atoms within the molecule relative to other groups 
(rotational). Microwave radiation stimulates the rotational motion of molecules when is 
is absorbed, infrared (IR) stimulates vibrations of molecules, ultra violet radiation and 
visible light cause electrons to be promoted to higher energy electronic levels and X- 
rays and short wavelength UV break chemical bonds and ionize molecules (bond 
2,5 breaking and ionisation). 
The emphasis of the work in this thesis is on the interpretation of optical 
(electronic) spectra in terms of the macroscopic electronic properties of molecules and 
the changes in these properties that occur upon interaction with other molecules e. g. 
DNA 
The spectroscopic techniques used to probe interactions, i. e. the changes in the 
electronic properties of molecules, are described in the following sections. 
1.3.2 Normal absorption spectroscopy 
The interaction of radiation with matter involves the transfer of energy 5 from 
the light beam to the molecule. The simplest form of spectroscopy is that of absorption. 
Normal absorption spectroscopy, more commonly ten-ned UV-Visible absorbance 
3 
spectroscopy, probes the electronic transitions of a molecule when it absorbs the energy 
(AE) of one photon at certain wavelengths. If the energy of the incident photon 
corresponds to the energy required to move (promote) an electron in a molecule from its 
ground state (low energy) to an excited state (higher energy) the photon may be 
absorbed and a redistribution of electron density between those states induced. The 
movement of the electron is termed an electronic transition. 4 
The rearrangement of electron density during an electronic transition can be 
characterised in terins of a net linear displacement of charge. The magnitude and 
direction of a given transition is described by the (electric dipole) transition moment, p, 
a vector of defined length and direction within the framework of the molecule. 4 The 
length of the vector squared is proportional to the intensity of the transition, whereas its 
direction is the transition polarisation. The probability that absorption will occur 
depends on the relative alignment of the transition moment and the electric field of the 
incident light. The probability is maximised when the transition moment and electric 
field are aligned in parallel. 
In the visible region of the spectrum, when white light is shone onto coloured 
material, it is either absorbed or reflected. What is actually seen by the eyes are the 
colours that are not absorbed, the coinplementary colours. These therefore fonn the flat 
part of the spectra with no signal, as they are not absorbed. The absorbance bands 
correspond to the wavelengths at which the complex absorbs energy. The smaller the 
difference in energy between the ground and excited states, the longer the wavelength. 
Absorption also depends on the environment (see Section 1.7). Absorption spectroscopy 
can be used to probe the interactions of a molecule if the interaction perturbs the 
transitions. 
The transmittance, T, of a sample of molecules is related to the absorbance by 
4 
loglo(-I)=Ioglo(Lo =A TI 
where A is the sample absorbance at each wavelength, 10 is the intensity of light incident 
on the sample and I is the intensity of light emergent from the sample. The Beer 
Lambert law 2-4 states that absorbance is linearly related to the concentration of the 
absorbing species c (mol dM-3 ) and the path length I (cm) of the cell in which the 
solution is placed, 
Aecl (1.3) 
where e is the molar absorptivity also known as the extinction coefficient (mol-1 dM3 
cm-1) of the species. There are limitations to this linear relationship. s is characteristic of 
the sample, its environment and the wavelength! If a solution is too concentrated then 
the absorbance is no longer linear with concentration. This may be due to very few 
photons being transmitted or to chemical features (usually intermolecular interactions) 
of the system. 
1.3.2.1 Spectroscopic transitions 3,5-8 
Molecules can undergo a number of different electronic transitions (see Figure 
1.1). Intense absorbance bands are produced by a-cy* and Tc-n* transitions, (typically 
conjugated molecules can exhibit em,,, > 10,000) and weak bands by n-cF* and n-TO: 
transitions (these require less energy and can exhibit F,, n,,, < 100). The strongest cy-cy* 
transitions can be found below 200 nm in the UV region of the spectrum. 
5 
I 
Antibonding a (cF*) 
Antibonding Tc (7t*) 
Nonbonding n 
Bonding 7r 
Bonding a 
Figure 1.1 Summary of electronic energy levels. The n-iE* and Tr-n* (heavy arrow) transitions are indicated! 
All ligands possess a number of molecular orbitals which may be a, cy*, TE, Tc* or 
n (non bonding) in character. Those ligands containing ir bonds e. g. conjugated 
aromatic n system molecules or unsaturated groups (chromophores) can exhibit 
electronic spectra of n-7u*, ir-n* transitions (promotion of electrons from non-bonding 
levels (n) or filled molecular orbitals (Tc) to anti-bonding (Tc*) orbitals). In the context of 
this thesis, the promotion of an electron from a iz ligand to antibonding n* orbital 
i. e. is referred to as a ligand centred/in ligand (11L) transition. 
Transition metal complexes can also exhibit small metal-metal or d-d transitions 
(due to the re-distribution of electrons in the partially filled d-orbitals), metal centred 
(MC) transitions, (i. e. Tim-cFm* through the promotion of an electron from a Ti metal 
orbital to an antibonding (Y* metal orbital) and metal-to-ligand charge transfer (MLCT) 
transitions (i. e. TIM-TEL* where an electron is promoted from metal centred it bonding 
(Tim) orbital to an unfilled ligand centred antibonding (irL*) orbital). Charge transfer 
(CT) bands are due to a change in electron distribution e. g. between delocalised orbitals 
as in aromatic groups of the ligand or conversely empty orbitals of the metal. 
6 
1.3.2.2 DNA transitions 
DNA is composed of planar aromatic bases attached to a sugar phosphate 
backbone. Its spectroscopy, that can be readily measured in a laboratory, is due to 
transitions from Tc bonding orbitals to Ti antibonding (7E*) orbitals of these bases. Duplex 
DNA concentrations can be determined spectroscopically using established c values and 
utilising the Beer-Lambert law. At known wavelengths for ct-DNA (calf thymus) F, 25g = 
6600 mol-'dM3CM-1 ; for poly[d(G-C)12 referred to as GC DNA, F-254 = 8400 mol-1 
drn 3 cm-1; for poly[d(A-T)12 referred to as AT DNA 6262 = 6600 mol-1 dM3CM-1. 
The absorption spectrum of DNA is sensitive to changes in structure (heating, 
for example, produces a hyperchromic effect - an increase in absorbance) or 
interactions with other molecules. The changes can aide characterisation of the type of 
binding. A decrease in absorbance intensity (hypochromic effect) is thought to be 
attributable to Tc-TE* stacking interactions, with wavelength shifts to longer wavelengths 
(red shifts) being characteristic of intercalation of a planar molecule between DNA base 
pairs. The effect on the absorption spectroscopy of groove binders is usually less 
dramatic upon binding to DNA. Figure 1.2(a) illustrates the spectroscopy of ct-DNA. 
Ct-DNA is colourless in water, and therefore transparent above 300 nm, its transitions 
are below 300 nm in the UV region of the spectra. These 7E-7c* transitions are due to the 
planar purine and pyrimidine bases (see Section 1.6). 
7 
2 
1.6 
1.2 
0.8 
0.4 
0 
C) 0 
-0.0035 
-0.007 
-0.011 
10 
cm ei -v E 
0 
10 
(a) Absorbance 
ct-DNA 
(b) LD 
ct-DNA 
CD 
ct-DNA 
200 250 wavelength /nm 300 350 
Figure 1.2 4 The spectroscopy of ct-DNA (125 pM) in water, (a) the absorbance spectrum of ct-ONA, (b) the LO 
spectrum, the negative LD signal is due to the transitions of the bases perpendicular (1) to the long axis of DNA and 
(c) CD spectrum of ct-DNA, the positive and negative signals seen are due to transitions of the planar achiral bases 
that are attached to the chiral sugar phosphate backbone of the DNA. 
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1.3.3 Linear dichroism spectroscopy 
Linear dichroism (LD) is defined as the difference in anisotropic absorption of 
light linearly polarized parallel (All) and perpendicular (Aj to the direction of 
oiýentatiori. 
LD = ý, - A_L (1.4) 
An isotropic collection of molecules will have no LD, whilst a group of 
molecules whose transition moments are macroscopically oriented will absorb differing 
amounts of parallel and perpendicular plane polarised light, producing a non-zero LD 
spectrum. For a perfectly oriented molecule when uniaxially oriented i. e. for a transition 
polarised exactly parallel to the orientation direction, the measured LD would equal All 
0) or for a transition polarised exactly perpendicular to the orientation direction, the 
measured LD would equal - 
Aj_ 
(< 0) (the factor of 2 being due to cylindrical 2 
symmetry of t4e orientation system). Thus qualitative information about the orientation 
of molecules in space can be extracted from the sign of the LD. A more quantitative 
picture of molecular alignment can be obtained from the reduced LD (LD"). 
r LD -Aj_ LD 
AA 
(1.5) 
where A is the normal isotropic absorption and constitutes an average over all possible 
orientations. 
Molecules can be macroscopically oriented in a number of ways. Small 
molecules can be oriented in stretched polymer films, whereas longer molecules like 
DNA may be oriented by viscous drag (flow orientation) or an electric field. 4 In this 
9 
thesis, stretched polymer films and flow orientation are used to orient and determine 
geometry of complexes using LD. 
1.3.3.1 Stretched film linear dichroism 
Stretched film LD can provide information about the polarisation directions of 
transition moments of a particular molecule. The symmetry of the molecule is often 
helpful is assigning the orientation of the molecules within the film. In addition, it 
governs the polarisations of transition moments. Once polarisations for complexes have 
been assigned, they can be used to determine binding orientations of the complexes on a 
flow-oriented macromolecule (DNA). 
Stretched film preparation 4 
Blank and complex saturated films were prepared using Polyvinyl alcohol (PVA 
Type III low molecular weight) purchased from Sigma Chemical Co. Low molecular 
weight PVA was dissolved in water (10 % w/v). The solution was then heated with 
stirring to near boiling until a clear viscous solution was formed. To half of this PVA 
I 
solution, a saturated solution of the complex to be oriented (200 gL) was added with 
slow mixing. The mixture was cast onto a glass plate, covered and allowed to dry over 3 
days. A second film containing no complex, the blank film, was also prepared using the 
remaining half of the solution. Film UV and LD spectra of both films were collected 
both before and after each film was mechanically stretched (in a mechanical stretching 
device using heat) to twice its length in order to determine complex transition 
polarisations. The blank spectra were then subtracted from those of the complex. 
The LD' spectra of unstretched and stretched film were calculated by dividing 
the LD by the Absorbance, A 
10 
LDr - 
LD 
A 
The LD'is an absorbance independent measure of LD, the magnitude of which reflects 
the average orientation of an electronic transition relative to the axis of orientation. 
The long and short axis of a molecule can usually be intuitively assigned. The 
long and short axes of the molecule (and the one perpendicular to them) are usually 
coincident with its spectroscopic axes if these are defined by symmetry. When the 
molecule is inserted into a stretched film, the long axis of the molecule will 
preferentially onent/lie along direction of orientation (stretch) whilst the short axis 
would resist the stretch and therefore lie at right angles to the stretch direction. 
Molecular orientation can be achieved by stretching the film, however, the 
degree of orientation attained is imperfect and an orientation distribution results. The 
distribution can be discussed in terms of an axis framework which relates the 
macroscopic (laboratory) axis, such as the stretch of the film, to the molecular axes of 
the system (Figure 1.3). 
4 
da, z 
y 
propogation 
dimcdon of 
IgK X 
Figure 1.3 Macroscopic (X, Y, Z) and molecular {x, y, z) axis systems, where 0 is the angle between Z and z 
In order to analyse film LD data, we make the assumption that the molecule 
behaves as an uniaxial rod 4 in the stretched film. The degree of orientation can be 
described in terms of the average orientation parameter, S, for a uniaxially oriented rod 
within a stretched film. To determine S from the LD' in ideal situations, one identifies a 
long axis polarized transition and assumes that the angle between its transition moment, 
II 
orkwitedon 
dmcbon, Z niokmxdar 
A and the orientation axis, a, is 0. The reduced linear dichroism for that whole 
absorption band is then: LD(z) = +3S, where S is the orientation parameter defining the 
efficiency of the macroscopic orientation (S =I perfect orientation, S=0 for no 
orientation). Alternatively, short axis polarisation transitions (that would be 
perpendicular to z) therefore here a= 90" and LD'(x, y) = -1.5S. If the molecular axes do 
not coincide with molecular long and short axes, the situation is more complicated. 
Thus transition polarizations can be assigned according to the signs of the stretched film 
LD'. Generally, positive LD' features are assumed to correspond to long axis polarised 
transitions and negative LD' signals to short axis polarisation transitions, though if the 
degree of orientation is too low, the short axis polarised transitions may appear as less 
positive rather than negative. 4 
1.3.3.2 Flow linear dichroism 
Flow LD can be applied to systems that are intrinsically otientable in solution or 
become oriented on interaction with a molecule that has intrinsic orientability e. g. long 
molecules suchý as polymers, specifically DNA. Flow LD can be used to probe the 
conformation and structural geometry of DNA or to probe the orientation of molecules 
bound to DNA relative to that of the nuclcobases. 
Experimentally the DNA solution is flow oriented using a quartz couette flow 
Cell. 4 The couette cell is made of two concentric quartz cylinders, the inner of which is 
solid and rotates (Figure 1.4). The sample (1.8 -3 mL volume) can be contained in a 
narrow gap between the two cylinders with aI mm (0.5 mm on each side) path length. 
Rotation of the inner cell at constant speed exposes the solution to a hydrodynamic 
shear force that macroscopically orients the solution by the resulting viscous drag, thus 
providing a constant flow of solution. The flow must be larninar to avoid light scattering 
and loss of orientation. 
12 
IwA43 
J"'A3 "'61 
Figure 1.4 A schematic of a Couette flow LD cell. 4 Light is propagated in the X direction (perpendicular to the flow 
direction). All is the absorbance of Z polarised light and A. L is the absorbance of Y polarised light 
Long strands of DNA will orientate in the direction of flow of the solution 
(DNA of at least 500 base pairs is necessary in order to facilitate orientation)4 and 
exhibit a LD signal at their absorption wavelengths. The flow oriented LD spectrum, 
(Figure 1.2(b)) of B-DNA above 190 nm exhibits a negative signal due to the plane 
it-n* transitions of the bases attached at -90' to the DNA long helix axis. Linearly 
polarised light is passed through the cell, if a molecule binds to DNA, an induced LD in 
the bound molecules' transitions or a change in magnitude of the DNA LD signal may 
be noted. A non-zero LD signal outside the DNA region when DNA is present is 
generally indicative of interaction between a metal complex and DNA. An increase in 
negative LD magnitude may be indicative of DNA stiffening or lengthening, conversely 
a decrease in LD magnitude may suggest that the DNA is shortening or bending. 
Flow LD of effectively rod-like DNA, e. g. B-form ct-DNA duplexes, is assumed 
to exhibit uniaxial orientation about the helix axis for which the LD' may be expressed 
as 
7,9 
LD' =S3 
(3(COS2 
a) - 1) 2 
(1.7) 
where o: refers to the angle between a transition moment and the DNA helix axis and () 
denotes an ensemble average over the orientation distribution function. In flow 
orientation, S for DNA is usually determined by assuming that the DNA bases are all 
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polarised at cc - 86' from the helix axis. A value for cc of 86' has been calculated for 
the predominantly TE-n* in-plane polarised transitions of the DNA bases found 
perpendicular to the DNA helix .4 Using this value, a value of S for the in plane 'n - n* 
transitions of the DNA bases can be determined from the magnitude of its LD' at 260 
nm using equation 1.7. Once S for DNA has been determined, cc may be computed for 
the transition moments of DNA bound complexes with known polarisations. The value 
of (x for a bound complex can then be used to help identify the mode of binding. The in- 
plane transitions of a bound intercalator, for example, would be expected to have 
negative LD' of similar magnitude to that of the DNA bases since the complex and 
bases would be co-planar. In practice, intercalators locally stiffen the DNA and so 
usually have LD' values slightly higher than the average DNA base. A bound complex 
in the minor groove of B-DNA, by way of contrast, would have positive LD and ot = 
45' for a long axis polarised transition that followed the pitch of the groove. 
If the DNA absorbance and flow LD at 260 nm is overlaid by transitions of 
bound molecules, then S, for the orientation of the DNA bases, will not be able to be 
I 
determined. An independent check of the DNA orientation can be made at varying 
ligand concentrations by measuring the LD of a probe, such as methylene blue (MB), a 
known intercalater. 10 Methylene blue can be added to solutions when ligand transitions 
overlap the DNA transitions, as it exhibits a long axis polarised transition at 675 nm 
outside the spectroscopic range of most DNA binding ligands. 10 It has a strong binding 
constant and large extinction coefficient so only low concentrations of it (-1 pM) are 
required (see Chapter 2) and the DNA signal remains relatively unperturbed. 
When working with organic solvents in flow LD studies, the concentration of 
DNA, evaporation, viscosity and turbulence effects all need to be taken into account and 
the experimental set up adjusted accordingly (see Section 1.7). 
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1.3.4 Circular dichroism spectroscopy 4 
Circular Dichroism (CD) is defined as the difference in absorption A of left (A, ) 
and right (A, ) circularly polarised light. 4 CD probes the spectroscopy and structure of 
chiral or asymmetric molecules. 
CD =A, -A, (1.8) 
In technical terms, CD measures the difference in helical redistribution of 
electron density that occurs in chiral chromophores upon excitation with left or right 
circularly polarised light. The origin of the helical electron motion lies in the non- 
perpendicular and non-coplanar polarisations of li, the electric transition moment and in, 
the magnetic dipole transition moment that is unique to chiral chromophores. Helical 
transitions are then a consequence of the linear charge displacement induced by the 
electric field vector of the exciting light, combined with the circular displacement of 
charge induced by the magnetic field vector of the exciting light. 4 
In simple terms, left and right circularly polarised light is passed through a 
solution, if the molecules are achiral. there is no difference between the interaction with 
the two polarisations and there will be no signal on the spectra. If the molecule is chiral, 
a difference in the absorbance of the left and right light is seen and a CD signal results. 
CD has been used to prove a chiral molecule has been synthesised, or resolved 
into pure enantiorners, or to probe the structures of biological marcromolecules e. g. 
protein conformational changes and the interaction of ligands with biornolecules. CD 
provides information about the spectroscopically active chiral species in solution. Thus 
achiral compounds will give a zero signal unless they are bound to a chiral molecule 
e. g. DNA, in this case an induced CD (ICD) signal is observed. 
The CD spectrum of B-forrn ct-DNA (Figure 1.2(c)) above 190 nm is due 
almost exclusivelY to the 7r-7L* transitions of the nucleobases. The bases themselves are 
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achiral in isolation, however, due to a combination of their helical arrangement in space 
in duplex DNA (pemiitting electronic coupling between the transitions of adjacent 
bases) and their attachment to the intrinsically chiral deoxyribose sugar they produce a 
CD spectrum that is due to the convolution of all the transitions of the bases. 4 The form 
of the spectrum is dependent on both the base composition and conformation of the 
DNA being probed. Other DNA conformations also have characteristic CD signatures 
as variations in the precise relative orientations of the bases between the different 
polymorphs are reflected in the CD spectrum 4 (see Section 1.6 and Chapters 2 and 3). 
Although in principle CD can be used to give geometric information about the 
observed species through a knowledge of transition moments, 4 in practice this is often 
very difficult and DNA-ligand spectra are non-nally interpreted empirically. CD is, 
however, usually the most sensitive spectroscopic technique for probing changes in 
binding mode as a function of concentrations and/or mixing ratios. 4 Any change in the 
behaviour of the system is reflected in the CD spectrum. A change in the intensity of the 
ligand ICD usually mirrors a change in the amount of bound ligand, whereas a variation 
in shape of the ligand ICD reflects a change in binding mode. 
Although many DNA binding ligands are achiral, investigation of DNA-ligand 
interactions is still possible by CD. The bound ligand may perturb the structure of the 
host DNA resulting in a change in the CD signature of that DNA, and the ligand itself 
will acquire ICD enabling its transitions to be probed directly. The ICD originates from 
the coupling of the ligand transitions with those of the DNA bases or the imposition of a 
4 
chiral conformation on the ligand by the DNA binding site. The presence of ICD at the 
wavelength of an achiral ligand transition therefore implies DNA binding. 
Stacking interactions between DNA bound ligands can also be detected in the 
CD spectrum. The occurrence of stacking interactions results in electronic coupling 
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between the ligand transition momentS. 
4 This coupling is apparent in the CD spectrum 
as anomalously large signals usually changing between positive and negative with the 
zero point at the absorption wavelength of the ligand transitions. This is commonly 
referred to as exciton CD. The strength of the coupling depends on the individual 
oscillator strengths of the coupled transition moments and their relative orientation and 
energies. 
1.3.5 Fluorescence spectroscopy" 
The emission (fluorescence or luminescence) of a compound results from the re- 
emission of radiation that was absorbed by a molecule. Atoms and molecules are 
excited by the absorption of electromagentic radiation. The excited species then relax to 
the ground state, giving up their excess energy as photons. The lifetime of an excited 
species is brief because there are several ways in which an excited molecule or atom can 
give up its excess energy and relax to its ground state, e. g. by non-radiative relaxation" 
(vibrational relaxation and internal conversion) and fluorescent relaxation (radiationless 
decay and fluorescence). 
Fluorescence is one'of several mechanisms by which a molecule returns to the 
ground state after it has been excited by the absorption of radiation. Thus all absorbing 
molecules have the potential to fluoresce, but most do not because their structure or 
environment provides radiationless pathways by which relaxation can occur at a greater 
rate than fluorescent emission. If an excited molecule can find no other way to lose 
energy it will fluoresce to its ground state. The extent to which a molecule is fluorescent 
is also determined by the environment to which the molecule is exposed. Fluorescence 
spectroscopy is useful as an interaction can lead to a change in the fluorescence 
properties of a ligand, e. g. octahedral [Ru(,, )(biPY)2(dppZ)]2+ (where bipy is 2,2'- 
17 
bipyridine and dppz is dipyridophenazine) is termed a 'molecular light switch': the 
complex shows no luminescence in aqueous solution, but when bound to DNA it 
luminesces strongly. It is thought that this is because the hydrophobic environment of 
the intercalation site of dppz prevents fluorescence quenching by the solvent. 
13, Chapter 2 
Wavelengths shifts and quenching may also be observed in the ligand fluorescence 
spectrum if ligand-ligand interactions are occurring. 
At low concentrations the fluorescence intensity is linearly proportional to the 
concentration of the fluorescent solute according to: 
F=2.3Iooecl (1.9) 
where F is the fluorescence intensity, 10 is the intensity of the excitation source, e is its 
molar absorptivity at the excitation wavelength (mol-lcm-'dM3), I is the path length 
(cm), c its concentration (mol dM-3 ) and 0 is fluorescence quantum yield, (the number of 
molecules that fluoresce divided by the total number of excited molecules or 
equivalently, the ratio of photons emitted to photons absorbed; for highly fluorescent 
I 
molecule, 0 tends toward unity). The fluorescence signal is directly proportional to the 
concentration of the fluorophore, so K, a binding constant can be determined. Because of 
this direct proportionality, the quantitative treatment of fluorescent binding data can be 
carried out in the same manner as that for absorption spectroscopy. However, the direct 
proportionality between F and c is lost when the latter becomes high enough that more 
than a few percent of the incident radiation is absorbed. This is the result of self- 
quenching in which the analyte molecules absorb the fluorescence produces by other 
analyte molecules. 
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1.3.6 Mass spectrometry 
Mass spectrometry is a powerful tool for the rapid identification and 
quantification of small amounts of unknown compounds. 5 Mass spectrometry requires 
that the complex of interest is charged. This can be achieved by a number of 
methods. 14,15 It can provide information about the molecular mass of a compound. A 
range of mass spectrometric (MS) techniques have been used in this work. It is usual 
under the conditions of many MS experiments for fragmentation of the molecule to 
occur, resulting in the formation of fragment ions. Thus it is possible to determine 
which ligands or groups of atoms are bonded together from the way the compound 
breaks up or fragments. 
Mass spectrometry (MS) has recently extended to the analysis of large 
molecules, e. g. proteins, enlarging its application in the biochemical field with the 
development of soft ionisation techniques 5,14 including electrospray ionisation. 15 
Electrospray ionisation (ESI) is not a real ionisation process (i. e. conversion of neutral 
molecules to ions). It is the transfer of species, ionised in the condensed phase into the 
gas phase as isolated entities. 15 This method does not destroy compounds and can often 
retain non-covalently bound complexes 15 as the principle function of the electrospray 
interface is the disruption of the non-covalent interactions between compound and 
solvent molecules. Ions attributable to non-covalently bound species have been 
observed in electrospray mass spectra suggesting the presence of associations much 
stronger than between compound and solvent. 15 
The few ESI-MS experiments reported in this thesis were run on a Bruker 
BioTOF mass spectrometer. The di-sodium salts of the 5'-nucleotides and methyl 
guanine were used and investigated in positive mode. 
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1.4 Inorganic metal complexes 
1.4.1 Inorganic chemistry in biological systems 16-18 
There are approximately thirty essential elements that are indispensable to some 
form of life. Carbon, hydrogen, nitrogen and oxygen make up 99% of the human body. 
Other essential elements play a vital role in the human body, e. g. calcium, fluorine and 
phosphorus are important in the construction of healthy teeth and bones, iron is 
necessary for the transport and storage of oxygen, respiration and cell division. An 
imbalance of elements can lead to numerous illnesses and diseases, e. g. an excess of 
manganese can lead to psychiatric disorders, a deficiency of magnesium can lead to 
convulsions. 
Other non-essential elements have been found to be important and are used in 
medicine. 'Metallodrugs' 17 containing gold have been used for years to treat arthritis, 
copper is used in the treatment of rheumatism and as an anti-inflammatory agent and 
lithium is used in psychotropic drugs as an anti -depressive. 
18 Newer drugs containing 
elements such as bismuth and antimony have been found to have anti-ulcer and anti- 
parasitic properties respectively. Perhaps the most well known coordination complex 
used in therapeutic applications is cisplatin, an anticancer agent. Metal complexes made 
up of manganese(II) and batium. and also some lanthanides especially gadolinium(III) 
are also being used as diagnostic agents in MRI (magnetic resonance imaging) in the 
detection of diseases. 1 
6-19 
Undeniably, inorganic chentistry plays a large role in biological and bio-medical 
processes, with applications in medicine in the treatment, management and diagnosis of 
disease. Advances in and understanding coordination chemistry can and are leading to 
the design of new complexes with potential applications in the treatment of a variety of 
illnesses and diseases. 
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1.4.2 Coordination chemistry as a tool for supramolecular chemistry 
Nature uses self-assembly processes in a variety of ingenious ways to construct 
large and ordered molecular arrays such as proteins and other biomolecular structures 
which exhibit an exquisite specificity in their molecular recognition properties. Most 
self-assembly processes in nature use the many weak, non-covalent interactions found 
between pre-formed sub-units or well defined assemblies to guide the formation of a 
structure. The assembly of the tobacco mosaic virus (TMV) is an excellent example of 
molecular recognition and self assembly in nature (Figure 1.5). 19 
RNA 
tsin cost 
Figure. 1.5 A schematic diagram of a tobacco mosaic virus particle. It is 300 nm in length, 18 nm in diameter and is 
composed of approximately 2130 identical subunits that self assemble to form a helical sheath around a single strand of 
RNA, 6390 base pairs in length, through non-covalent interactions. (Diagram taken from reference 19) 
The last few years have seen the emergence of self-assembly as a promising 
approach to the generation of synthetic compounds with large, rigid, molecular-sized 
cavities. 19-22 This approach, combined with an understanding of the coordination 
chemistry of metal ions and their structural role in the spatial arrangement of a wide 
range of ligand complexes have been incorporated into a new type of chemistry 
supramolecular inorganic chemistry. 
Supramolecular chemistry 23-25 can be defined as a highly interdisciplinary field 
of science covering the chemical, physical, and biological features of self-assembling 
chemical species held together by organised non-covalent binding interactions. 
Supramolecular (intermolecular) interactions are at the foundation of highly specific 
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biological processes, and together with molecular recognition processes play roles of 
vital importance. Examples of this include the fact that resistance to disease relies on the 
presence of antibody molecules which recognize and combine with specific molecules 
on the surface of an invading organism; the substrate binding by enzymes or receptors; 
the intercalation complexes of nucleic acids; and cellular recognition (immunology). 26 
Coordinate metal-ligand bonds possess partial covalent character, but like many 
supramolecular interactions are frequently labile (especially first row transition metals) 
and are distinct in nature from traditional covalent bonds (e. g. C-C or C-H). 
An increase in awareness of the coordination chemistry of specific metals, 
together with (i) the ease with which structures can be designed and synthesised to self 
assemble (i. e. the number of ligands added, or potential binding sites can be carefully 
controlled), (ii) the fact that cavity size, shape and properties can be altered by using 
different ligands and metals with different oxidation states, and (iii) the development of 
new innovative, inexpensive approaches' has led to metals now being a key feature in 
the fonnation of supramolecular structures. Chapter 4 reports the investigation of the 
molecular sensor potential of novel self-assembling copper(l) supramolecular 
cyclophanes with small aromatic compounds, and includes the synthesis of a new ligand 
capable of self assembling into a box structure. Chapter 2 reports on the DNA binding 
properties of novel octahedral bis-terpyridine ruthenium(H) complexes with potential 
intercalating functionalities. Chapter 3 investigates the DNA binding properties of a 
number of novel square planar platinum(H) complexes with subtly different electron 
withdrawing/donating functionalities with possible anti-cancer therapeutic potential. 
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1.5 Molecular interactions 
Molecules can interact covalently (bond forming) or non-covalently. 27-30 
Covalent interactions are short range chemical interactions arising from electron 
sharing. Non-covalent interactions are generally weaker. An understanding of the nature 
of non-covalent interactions is useful, especially since these interactions are 
fundamental to many of the biomolecular processes involving recognition, binding and 
self-assembly found in nature . 
28,31 Examples of non-covalent interactions are the 
fon-nation of duplex DNA and the assembly of supramolecular systems. The five main 
types of non-covalent interactions are: electrostatic interactions, hydrogen bonding, 7r- 
ir interactions, hydrophobic/hydrophillic and van der Waals forces. Electrostatic 
interactions can be defined to include charge-charge, dipole-dipole, dipole-induced 
dipole etc. The strongest of these is charge-charge. It dominates the binding when 
cationic molecules bind to DNA though the other kinds of interactions may be more 
important for determining the binding mode and the relative binding strengths within 
classes of molecules. 
Hydrogen bonding is an example of predominantly electrostatic interaction 
between molecules. A hydrogen bond involves the sharing of a hydrogen atom between 
one atom that has aH atom (donor) and another atom that has a lone pair of electrons 
(acceptor). The hydrogen can be bonded formally (covalently) to one atom (the donor, 
D) and still interact favourably with another (the acceptor, A) due to strong dipole- 
dipole attraction caused by the electron withdrawing properties of the more 
electronegative atom (e. g. F, N, 0) attracting electrons from the hydrogen. 
Schematically it may be illustrated as: 
a- 6+ 5- 
D-H 
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H-bonding interactions are directional, in other words they are strongest when 
linear, and the distance between acceptor and donor atoms is typically - 2.8 A. 28 A 
hydrogen bond has approximately a tenth of the strength of the covalent bond, with the 
strongest (and shortest) hydrogen bonds produced from electronegative or charged 
acceptors or donors. Hydrogen bonds in DNA-ligand systems typically occur between a 
hydrogen that is covalently attached to aN or 0 (hydrogen donor) and aN or 0 donor 
with a partial negative charge (H acceptor). 
Aromatic rings can interact favourably in either face-to-face or face-to-edge 
orientations (Figure 1.6). This is because the 7t electrons of an aromatic system are 
localised above and below the plane of the ring giving the aromatic ring face a small net 
negative charge (electron rich region) and the ring hydrogens a small positive charge 
(electron deficient region). In the face-to-face interaction (Figure 1.6(a)), referred to as 
Tc stacking, the rings sit on top of each other but due to the electrostatic interaction, in a 
slightly offset arrangement. The face-to-edge interaction (Figure 1.6(b)) is also 
sometimes described as a C-H --- ninteraction. Electron rich atoms (high electron 
density) interact with the ring edges whereas electron deficient groups (e. g. protonated 
amino groups) interact favourably with the ring face. 28,30 
V 
(a) (I, ) 
Figure 1.6 (a) Offset face-to-face stacking and (b) face-to-edge stacking, taken from reference 30. 
London dispersion interactions, or van der Waals interactions, are long range 
interactions that occur between atoms. Weak attractive London dispersive forces arise 
as a result of induced charge separation, polarization of the electron clouds as two 
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molecules approach each other, leading to temporary dipole-induced dipole interactions. 
This weak attractive force increases as the distance between atoms is decreased up to a 
particular point, the van der Waals contact distance (- 3.75 - 2.5 
A). Closer contact 
between atoms results in repulsion (electrostatic charge-charge repulsions between the 
adjacent electron clouds) between the two atoms becoming dominant. This force is 
important as it can be considered as the force that stops matter collapsing in on itself. 28 
As with all non-covalent interactions the medium (solvent, solutes etc. ) exerts a 
considerable influence on interactions. 
Hydrophobic interactions are due to the very low solubility of non polar 
molecules in polar media e. g. water. A polar compound is able to organise favourable H 
bonding interactions with the polar water molecules but non-polar molecules are unable 
to this - disruPting the hydrogen-bonding network resulting in an unfavourable re- 
ordering of the hydrogen bonding network. This interaction between water and a non- 
polar molecule/fragment is termed a hydrophobic interaction. In general, polar 
molecules (e. g. water) interact poorly with hydrophobic (i. e. non polar) molecules or 
molecular regions. Hydrophobic molecules therefore tend to aggregate and 'squeeze 
out' water from the interacting faces of the hydrophobic molecules, so that overall less 
surface is exposed to aqueous solution. This minimal surface requires less reordering of 
hydrogen bonding interactions in water and is more favourable, thus the hydrophobic 
interactions describe the tendency of non-polar groups to associate when in polar 
environments. Hydrophobic guests are thus more likely to interact with hydrophobic 
hosts, thus this hydrophobic interaction may be major driving force for molecular 
association. This is an important non-covalent interaction in biological terms. 32 
Non-covalent interactions can occur over the whole structure unlike limited 
covalent localised bonds. A large number of these interactions are necessary for 
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stability. Many weak interactions are needed to provide the strength of one covalent 
bond - therefore any recognition events will be highly specific and any biomolecular 
interactions are readily disrupted by changes in environment, such as pH, temperature 
and concentration. 28 
1.6 DNA 
DNA- deoxyribonucleic acid - is present in all living things, large and small. 
It is arguably the. most complex structure and we are only just beginning to understand 
it. An indication of the complexity of the molecule is the fact that the DNA in the 
human haploid genome (the total genetic message) is made up of 3x1O9 base pairs. 33 
DNA is responsible for the maintenance of the species, it passes from one 
generation to the next in germ cells. It also carries the information to enable all proteins 
required for the operation of biological systems to be synthesised. The genetic message 
is encoded by the sequence of purine and pyrimidine bases in the nucleotide chains. 
Three nuelcotides specify a single amino acid in the ultimate protein product. The text 
of the message is the orqer in which the amino acids are lined up in the proteins 
manufactured by the cell. 
IOH 
OH H 
Nucleoside 
HO- 5- Base, 
4' 
00 
OH H 
Base, 
Figure 1.7 The general structure of deoxyribose, a nucleoside and a nucleotide 
DNA consists of two complementary polymer strands that intertwine to give a 
double helix running in anti-parallel directions. 31,34-36 Each strand is made up of a series 
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of units called nucleotides. A nucleotide is made up of a sugar (deoxyribose for DNA), 
a phosphate and base (Figure 1.7). There are four different types of nucleotides in 
DNA, these share the same sugars and phosphates but have different bases attached to 
them. These bases are planar aromatic nitrogen-containing heterocyclic molecules. 
They are the purines, adenine (A) and guanine (G), and the pyrimidines, thymine (T) 
and cytosine (C) (Figure 1.8). 
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Figure 1.8 The purines adenine(A) and guanine (G) and pyrimidines thymine (T) and cytosine (C) 
A base attached to a sugar (a nucleoside) is formed by connecting the N9 of the 
purine or the NI of the pyrimidine bases to the CY position of the deoxyribose. These 
nucleosides are linked to one another with a certain directionality i. e. through phosphate 
groups attached to the 5'hydroxyl group and the Yhydroxy group of adjacent sugars 34 
to fonn nucleotides as shown in Figure 1.9. 
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Figure 1.9 Directionality of the nucleotides 5' to Ton a flexible phosphate chain 
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Using the Watson Crick rules for base pairing, 34--36 the four different bases fonn 
specific pairwise interactions: A with T forming two hydrogen bonds and G with C 
forming three hydrogen bonds (see Figure 1.10). The bases are attached to a flexible 
sugar phosphate chain. The DNA strands associate by the hydrogen bonding between 
these planar base pairs. The base pairs are not necessarily planar: they can twist and roll, 
or in a base pair they can propeller twist or buckle. 
4,34,35 
H 
N N-H ---O CH3 IN 
--- H-Ný-J\N 
ce N---/ N ý- 
C 
ce 
adenine thymine 
N 0---H-N 
N- N-H / 
cl, N =-/\ 
--- N 
/ý-N 
jq-H --- 
dIr 
guanine 
H 
cytosine 
Figure 1.10 The four different bases of DNA showing Watson-Crick hydrogen bonding between the pairs that join the 
two strands of DNA together. Cl' denotes connection to the sugar 
As the base pairs are hydrophobic they tend to tuck themselves away from water 
by stacking on top of each other creating a non-polar interior in the double helix. This 
leads to the DNA forming a helix with a given number of bases per turn. The DNA 
double helix is therefore stabilised by this hydrophobic action. 
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Figure 1.11 A portion of the structure of double stranded DNA showing the hydrogen bonding interactions. Diagram 
reproduced from reference 4 
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guanine 
The hydrogen bonds also contribute to the overall stability of the double helix 
but their main function is the specificity for forming the correct base pairs . 
35 The 
phosphate backbone is negatively charged, and as such the phosphates tend to repel 
each other. This repulsion can destabilise the DNA double helix. Fligh ionic strength 
(high salt concentration) shields the negatively charged phosphates from each other, 
thus decreasing the repulsion and stabilising the double helix, similarly, cationic 
molecules can stabilise DNA. 
Figure 1.12 Double helical structures of B, A and Z DNA. Note the major and minor grooves are indicated. Picture 
reproduced from reference 4. See Tables 1.1 and 1.2 
A number of different conformations of double helical DNA can be fon-ned by 
rotating various bonds. 34,35 The structures of A-DNA, B-DNA and Z-DNA are shown in 
Figure 1.12. DNA under physiological conditions is generally assumed to be in a B- 
type conformation. 34 The B-fonn ct-DNA used in this work- is made up of 42% AT and 
58% GC. 
B-DNA and A-DNA = right handed with 10 and 11 bases per tum 
respectively, Z-DNA is left handed with 12 bases per turn. A and B confon-nations 
differ in pitch (how much the helix rises per turn). Z-DNA is a left handed helical form 
of DNA in which the phosphate backbones of the two antiparallel DNA strands are still 
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Z-DNA 
arranged in a helix but with a more irregular appearance (see Table 1.1). The 
conformation of DNA (A, B and Z) depends on temperature, salt concentration, as well 
as base composition of the DNA. Structural changes from A to B forms in mixed 
sequence DNA are induced by changes in the relative humidity of the surroundings. 31,34, 
35 
Table 1.1 Groove dimensions in DNA double heliCeS 4,34 
Parameters B-DNA A-DNA Z-DNA 
Bases / turn of helix 10 11 12 
Major groove wide and deep narrow, deep f [at 
Minor groove narrow, deep broad, shallow narrow, deep 
Table 1.2 Groove dimensions in DNA double helices 4.34 
Major groove Minor groove 
DNA Width (A) Depth(A) Width (A) Depth(A) 
A 2.2 13.0 11.1 2.6 
B 11.6 8.5 6.0 8.2 
z 8.8 3.7 2.0 13.8 
The arrangement of the double helix is such that there are two distinguishable 
grooves running the length of the DNA: the major and the minor groove. For B-DNA, 
the major groove has a width of -12A and a depth of -8 A; the minor groove 6A and 8 
0 
0 34 A respectively (see Table L-2). This means that only thin molecules, that can twist can 
interact with the minor groove whereas much larger molecules can interact with the 
major groove. The grooves are of different sizes because the two strands come together 
through the bases that attach to the phosphate backbone at an angle that is not 180' 
apart around the axis of the helix. Many sequence specific interactions of the proteins 
with DNA normally occur along the major groove, because the bases (which contain the 
sequence information) are more exposed along this groove. 
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1.6.1 Duplex formation determined using melting curve experiments 
When duplex DNA is heated, it can lose its helical structure as the two strands 
separate, this action is termed denaturation and is shown by an increase in absorbance at 
260 nm as the bases unstack - termed a hyperchromic shift. When the same DNA is 
slowly cooled, the two strands should come together again - reanneal - to form the 
duplex through hydrogen bonding and hydrophobic interactions. The decrease in 
absorbance at 260 nm is termed a hypochromic shift. In practice ct-DNA is too 
complicated to reanneal correctly. A typical melting curve takes the fon-n of an S- 
shaped absorbance plot (this is characteristic of the double to single stranded transition). 
If the DNA is not duplex, and does not either denature on heating nor reanneal on 
cooling, its absorbance will change very little with temperature. Melting curve 
experiments can be used to determine whether a given type of DNA is duplex under a 
given set of conditions. They can also be used as an estimate of ligand binding strength, 
since stronger binders stabilise duplex DNA more effectively. 
1.6.2 Binding modes with DNA ligands 
There are a numb6r of ways in which metal complexes, which are usually 
cationic can interact with the polyanionic duplex DNA. 31,34 These include (i) major or 
minor groove binding, (ii) intercalation - where a planar molecule slips between the 
base pairs (into a hydrophobic environment) and leads to unwinding of the DNA, (iii) 
external binding to the phosphate backbone (this is usually non-specific, electrostatic 
binding), (iv) covalent binding inter / intra strand binding i. e. inter between two strands, 
intra on same strand - usually to the guanine N7. 
Molecules bind to DNA by recognising structural features of the DNA. The 
difference between binding in the major and minor groove binding is due to hydrogen 
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bonding characteristics, electrostatic potential, solvation. and steric effects. 34 Hydrogen 
bonding is fundamental in the recognition of target binding sites. 34 The edges of the 
bases have hydrogen bonding potential for ligand binding. Both the major and minor 
grooves of B-DNA and the different bases present numerous H-bonding donor and 
acceptor sites at which specific interactions may occur. 31,34,35 Figure 1.13 indicates the 
directionality of the hydrogen bonds. The minor groove contains hydrogen bond 
acceptors at N3 on adenine and guanine, 02 on thymine and cytosine, with the amino 
group of guanine at C2 acting as a hydrogen bond donor. In the major groove, N7 on 
guanine and adenine, 06 on guanine and 04 on thymine can act as H bond acceptors 
and the amino groups at C6 on adenine and C4 on cytosine as potential H bond donors. 
Hydrogen bonding can be accepted to the N3 of adenine but the C2 amino 
group of guanine presents a steric block to hydrogen bond formation at N3 of guanine 
and at C2 carbonyl of cytosine (Figure 1.13). This is because the hydrogen bond 
between the amino group of guanine and the carbonyl oxygen of cytosine in GC pairs 
lies in the minor groove and sterically inhibits penetration of molecules into this groove 
in GC rich regions. 
major 
7 
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9N5 6) N-H --- 0 CH3 ý4 
9N '4 6 
0 
cl, 3N -2 
3N >/ 
-2 
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qrN 560 
--- H-N ý4 
; N- ý4 N-H --- N6 3\ 
cl, 3 N:: 
ý'-2 
N 
N-H --- 0 cl, 
guanine Ht 
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Figure 1.13 The arrows indicate the directionality of the hydrogen bond donors and acceptors in A-T and G-C base 
pairs; major and minor indicate respective grooves. 3' 
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Metal complexes can interact with DNA 31,34 by (i) covalent or (ii) non-covalent 
binding interactions. Most covalent interactions take place with non-specific binding to 
the phosphodiester backbone or sugar residues, e. g. DNA strand scission. 34 The recent 
main emphasis for covalent binding has been on the recognition of particular sites on 
DNA by nucleophilic reactions. Purines are most susceptible to covalent attack, with 
guanine preferred over adenine. This is because the pyrimidine bases are less aromatic 
than the purines, the latter are more electron rich. Guanine N7 is the most electron rich 
site on DNA and is the most easily oxidised. It is also mainly the N7 on the G and N7 
on A in the major groove that are exposed to the solvent, and are considered to be 
general binding sites, they are electron rich and are surrounded by negative charge of 
the phosphate groups. Particular sites for covalent binding are N7, N6 and 06 in the 
major groove and N2 in the minor groove. Metal complexes, can bind to either one or 
two sites at once forming a crosslink. This crosslinking binding mode can be intra- or 
interstrand (on the same strand, or between two strands) depending on the distance 
between the two functional groups on the drug and on the affected DNA sequence. The 
best known example of this is cisplatin, which binds covalently to guanine, and is 
known to bind intra and intdrstrand depending on the positions of the guanines. 
1.7 Studies on organic solvents with DNA 
In the work reported in this thesis, it has been necessary to use organic solvents 
to get some of the metal complexes into solution. It is essential that the solvent chosen 
provide a good spectroscopic window, does not interact with the complex in an 
unfavourable fashion (spectroscopy is dependent on solvent environment) and most 
importantly does not change the structure of the DNA. The use of non-aqueous solvents 
may also be advantageous in drug delivery terms (see Chapter 3). Organic solvents are 
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not commonly used with DNA, as the presence of organic solvents can lead to a change 
in the conformation of DNA and/or the break up of the DNA duplex. It was therefore 
crucial to determine the extent to which DNA can tolerate organic solvents. 
1.7.1 Organic solvent tolerance of DNA 
Absorbance and CD and melting curve studies were conducted to determine the 
solvent tolerance limits of ct-DNA with acetonitrile (MeCN), N, N-dimethylformamide 
(DNM) and dimethylsulfoxide (Me)2SO (DMSO). Ct-DNA is made up of 42 % AT and 
58 % GC. It is a long DNA that is fairly robust. Therefore, it was expected to be more 
stable than the shorter synthetic DNAs: poly[d(A-T)12 and poly[d(G-C)12 referred to as 
AT and GC DNA respectively. 
Experiments on ct-DNA with and without sodium cacodylate buffer (NaCac) 
were primarily investigated. The absorbance and CD spectra can be found in Appendix 
1. From this study, maximum organic solvent limits of 70% acetonitrile and 10% DMF 
or DMSO were set when working with ct-DNA (see Table 1.3). At or below these 
stated percentages, the CD spectrum of the DNA was found unchanged indicating its 
structure was standard B-form The absorbance spectra of ct-DNA with MeCN remained 
approximately constant up to a 80% MeCN v/v, whereas the spectra of ct-DNA with 
DMSO and DNM did not, showing an immediate increase in absorbance on solvent 
addition. This increase indicates an unwinding of the DNA helix. 
Table 1.3 The percentage organic solvent that can be used with ct-DNA without any significant spectroscopic structural 
change in the DNA 
Without buffer/ %solvent With buffer /% solvent 
CD Absorbance CD Absorbance 
MECN 70% 80% 70% 70% 
DMF 10-20% - 20-30% 10-20% 
DMSO 10-20% 20-30% 10-20% 
34 
AT and GC DNA were also investigated with acetonitfile, the solvent of choice 
for Chapter 3, without salt or buffer. Melting curve experiments showed that the DNA 
was not remaining duplex. An inconsistent change in absorbance as temperature was 
increased and little or no decrease in absorbance on cooling (not shown) was thought to 
be due to the acetonitrile disrupting the hydrophobic and hydrogen bonding interactions 
between the base pairs leading to an increase in the ability of the bases to tilt and slide 
around or the loosening or breaking of base pair hydrogen bonding interactions in 
favour of other hydrogen bonding interactions (e. g. with solvent). This resulted in both 
AT and GC DNA being unable to reanneal. 
Therefore when using MeCN, salt (NaCl) and buffer (a constant 1 mM sodium 
cacodylate buffer) were required to ensure AT and GC DNA duplex conformation. The 
amount of salt and sodium cacodylate buffer required was found to be dependent on the 
percentage organic solvent present and are summarised in Table 1.4. This was 
confirmed under experimental conditions. 
Table 1.4 Salt (NaGI) requirements determined for AT and GC DNA using a1 mM NaCac buffer 
Minimum requirements :5 40% MeCN -: ý: 40% MeCN 
AT-DNA 30 mM NaCl - 30 - 40mM 30 mM, > 60% 40 mM GC DNA 1 OmM NaCl lomm 20 mM 
GC DNA shows more stability with acetonitrile than AT DNA hence the need 
for less salt and buffer. This is attributable to its stronger hydrogen bonding interactions 
(three hydrogen bonds) compared to those for AT DNA (two hydrogen bonds). 
1.7.2 Organic solvents in film LD. 
Film LD of organic soluble complexes proved difficult to measure due to the 
different solvent requirements of the complexes and polyvinyl alcohol (PVA). See 
Section 1.3.3.1. The possibility of using a 50: 50 v/v waterorganic solvent to make up a 
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film for LD experiments proved impossible as the PVA immediately precipitated out of 
solution. 
The alternative and ultimately the method used involved the preparation of a 
water based film and limiting the organic solvent addition to complex sample 
introduction. That is, addition of sample (in this case of a volume of 200 gL of 
complex) in organic solvent mix ratios of up to 50: 50 water: DMSO; 50: 50 water: MeCN 
and 90: 10 water: DM[F to a water based PVA solution could be tolerated. The blank film 
was also prepared using an equal volume of organic solvent. 
1.7.3 Flow LD with organic solvents. 
When working with organic solvents in flow LD studies, the concentration of 
DNA, evaporation, viscosity, turbulence effects all need to be taken into account and 
adjusted accordingly. The use of organic solvents in flow LD studies of DNA can cause 
a reduction in viscosity, an increase in turbulence and DNA signal-scattering, and leads 
to evaporation. The use of MeCN, in this case in combination with water, was found to 
be more prone to evaporation than when working with water alone, leading to signal 
errors. The use of a cell covering (in this case parafilm) to limit evaporation with a 
higher minimum cell volume of 2000 pL was found to be sufficient in order to avoid 
baseline errors, as was a slower couette rotating speed. Additionally, the use of an 
organic solvent (MeCN) leads to a decrease in the overall viscosity of a solution, but 
using too high a rotating speed can lead to turbulence and spillage or evaporation. 
Therefore a lower speed than used for aqueous samples was found necessary. However, 
too low a speed can lead to problems as reduction in speed reduces the LD signal 
especially of shorter DNA sequences (see Table 1.5). Each time the rotating speed was 
changed a baseline LD of solvent mix was measured to avoid baseline errors. 
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The number of scans taken for each titration step (LD measures the average 
signal of bases) also affects the signal quality. Furthermore, shorter DNA are prone to 
having larger noise/scattering effects. A minimum of 8 scans was found to be ideal, a 
larger number of scans led to noticeable solvent evaporation and signal deterioration. It 
was necessary to experiment and compromise on signal size, quality and noise. An 
option would be to work at higher DNA concentrations, but limited sample availability 
precluded this course of action. 
The flow LD signal of ct-DNA is large enough to compensate for the effects of 
using MeCN. The DNA signal of the shorter synthetic GC duplex (-750 base pairs) and 
AT DNA is on average much smaller and here the effects were found to be much more 
noticeable. GC DNA was found to be much less viscous than ct-DNA at similar 
concentrations. This led to greater difficulty in achieving a reasonable signal, as well as 
a decrease in signal-to-noise ratio relative to ct-DNA. More scans or the use of higher 
concentrations were necessary. LD studies of AT DNA were not undertaken, the AT 
DNA does orientate, but the flow LD signal was considered too small even before the 
addition of potential ligand binding agent which may cause an increase or decrease in 
signal size. 
Table 1.5 Flow LD signal size of duplex DNAs ct-, GC and AT DNA 
duplex DNA/ (concentration) Flow LD signal size at 260 nm/ AOD 
Ct-DNA (100 PM) --O. Ol 
GC DNA a (200 gM) - -0.003 30 mM NaCl +1 mM NaCac buffer 
AT DNA b (200 gM) - -0.0005 30 mM NaCl +I mM NaCac buffer 
a= The LD signal of GC-DNA (at the same concentration and conditions) is itself small when compared to the 
signal size of -0.01 for a lower concentration solution of ct-DNA (100 gM) 
b= AT DNA does orientate but its LD signal at 260 nrn has a distinct negative maxima of -0.0005 for a 
-200pM (30mM salt + ImM buffer) solution, this is before the addition of any metallo complex which may 
increase or decrease the size. 
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2 DNA binding of aryl substituted 
ruthenium bis-terpyridine complexes 
2.1 Introduction 
There is an extensive literature on ruthenium(II) transition metal complexes and 
their binding to DNA. In particular there has been a drive to design intercalating metal 
complexes. Sometimes the complexes are designed for their own properties, but often it 
is because the ruthenium analogue of complexes of other metals (such as rhodium) 
binds in the same geometry to DNA but is chemically stable so can be used to identify 
DNA binding modes of more reactive species. In this project, five novel ruthenium(II) 
bis-terpyridine chloride complexes with potentially intercalating aryl tails were 
investigated for their DNA binding interaction. Figure 2.1 shows the general structure of 
the parent complex [Ru(terpyAr)2 ] 2+ and the aryl tail group (Ar) substituted in the 4' 
position on each tfidentate 2,2'; 6'2"-terpyridine (terpy) ligand. Each complex is 
hereafter referenced by its qryl tail group abbreviation. 
i 
Ar 
[Ru(terpyAr), ] 2ý 
a: b 
phenmthmw (phen) (crpy 
fý-Pth3i (-Pth) 
c90 0 , ýpy 
terpy 1. py 
biphenyký (biphen) p>-- (w) 
Figure 2.1. The general structure of the Ru(terpyAr)2CI2 complexes and the aryl tail group of each of the complexes 
investigated where Ar = aryi tail group (i) biphenylene (biphen), (Ii) P-napthyl (napth), (iii) phenanthrene (phen), (iv) 
anthracene (anth) and (v) pyrene (pyr); terpy indicates point of attachment of tail group to 4' position on the terpyridine 
(terpy). 
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Bidentate polypyridyl ligands such 2,2'-bipyridine, (bipy) or 1,10-phenanthroline 
(1,10-phen) (Figure 2.2) complex to six coordinate ruthenium(H) to form tris chelate 
complexes which are well known as effective non-covalent DNA binders. 1-10 Their 
binding interactions are complicated by the chirality of the metal complex resulting in 
different enantiomeric effects, these are covered in section 2.1.1. 
Cýý3, 
Figure 2.2 Bi-dentate ligand structures investigated include (i) 2,2'bipyridine = bipy (ii) 1,10-phenanthroline = 1,10-phen 
Complexes formed when two terpy ligands are attached to six coordinate 
ruthenium(II) have a distinct advantage over their bidentate (tris chelate) counterparts in 
that the ruthenium(II) metal forms achiral [Ru(terpY)2]2+ complexes where no 
stereoisomerism is possible. The terpy ligand also introduces a significant element of 
planarity into the geometry of the complex that might provide steric advantages. In 
addition, controlled substitution in any position on the terpy is possible thus increasing 
the options for metal complex geometry (though asymmetric substitution leads back to 
the complication of stereoisomerism which we wished to avoid). ' 1,12 
Sauvage and co-workers have provided a comprehensive review of the 
spectroscopic properties of [Ru(terpY)2]2+ complexes. 12,13 Many (Ru(terpY)21 2+ 
complexes and other heavy transition metal bis-terpy complexes (e. g. osmium(H)) have 
also been described. 14-16 Research into the spectroscopic properties of these bis-terpy 
complexes has mainly concentrated on symmetrical aromatic ligands 11,13,17 and recently 
branched out to include asymmetric ligand ruthenium(H) terpy complexes, ' 8extended 
conjugated systems19 and bis-ruthenium(][I) complexes. 20,21 There is a literature 
precedent for terpy metal complexes binding to DNA. Terpy substitued platinum 
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complexes have been shown to bind in a range of intercalative and groove binding 
modes. 22-28 Reports on the interactions of ruthenium(II) bis-terpy complexes with DNA 
are, however, limited. Perhaps the reason why not as much work has been carried out on 
the DNA interaction of terpy complexes as has been done with the bidentate ligands is 
that [Ru(terpY)2]2+ exhibits less favourable photophysical properties at room 
temperature than its tris-chelate counterparts. 14 The [Ru(terpY)2]2+ complex, in fact is 
essentially non-emissive in water at room temperature (see section 2.3.4). 29,30 
2.1.1 Tris(chelate)ruthenium(II) complexes 
Chiral tris-chelate complexes of the structural formula [RUP3 ]2+ are formed 
when a six coordinate ruthenium(H) metal is bonded to three bidentate ligands (L) 
where L typically equals bipy or 1,10-phen. 31,32 This is simply due to the bidentate 
nature of the ligands and the geometry of the metal. The structure formed is a three- 
winged propeller in shape. Its stereoisomers, i. e. two enantiorners, are usually annotated 
as A for the right-handed enantiorner and A for left-handed, these are illustrated in 
Figure 2.3. 
, (V ýj 00, , 
U), , 
0, 
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Figure 2.3 The A and A enantiomers of ruthenium(fl) tris 1,10-phenanthroline. Taken from reference 4 
Ruthenium(H) complexes of structural analogues and mixed ligand analogues 
have been extensively investigated mainly because of their potential for enantioselective 
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recognition of DNA as well as their photophysical properties (i. e. excited state lifetimes, 
luminescence intensities, chernical stability and redox properties. 
2'5,31-33 
The most widely studied member of this group of tris-chelate compounds is 
[Ru(1,10-phen)3]2+ tris(1,10-phenanthroline)rutheniUM(], ) 3,34 (Figure 2.3). Its binding 
modes to DNA are still not clear - most likely because there are a range of binding 
modes that all occur. The methods used to determine mode of binding include UV- 
Visible absorbance, circular dichrosim and linear dichroism experiments, viscosity 
studies, NMR, molecular modelling and energy calculations. 
Satyanaryan et al. provide a comprehensive review of the work on the tris(1,10- 
phenanthroline)ruthenium(H) complex. 4 In summary, Barton et A conducted unwinding 
studies with closed circular DNA, absorbance and fluorescence spectroscopy and 
concluded that both enantiomers bind to DNA through two different modes of binding 
one intercalative and the other surface binding. *5,6 Further investigations using 1H NNR 
suggested that A-[Ru(1,10-phen)3 ]2+ preferred intercalation, while the A-[Ru(1,10- 
phen)3]2+ preferred surface binding, possibly in the minor groove .7 Satynaryan and co- 
workers, in the absence of definitive X-ray crystallography data however, concluded 
that their linear dichroisin and viscosity experiments on the enantiomers (when 
comPared with those of classical intercalators e. g. ethidium and actinomycin) suggested 
that there was one mode of binding for each enantiomer which is non-intercalative in 
nature. 38 This was also proposed by Haworth et al. who on the basis of molecular 
modelling studies concluded that partial insertion of one phenanthroline ring was 
feasible between the base pairs but not full insertion, due to steric hindrance from the 
other two external phenanthroline rings. 9 Later, using 2D NMR, Eriksoon et al. 
proposed that both enantiomers bound only in a non-intercalative fashion in the minor 
groove and displayed an AT binding preference. 10 The non-intercalative nature of the 
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binding was re-confirmed by Coury et A using scanning force microscopy, which 
revealed that neither enantiomer caused changes in the length of DNA. 35 
Coggan et at. have suggested that the conflicting data on the binding modes of 
ruthenium(II) tris-phenanthroline complex could be due to a number of factors: the 
different techniques used and therefore timescales, different DNA sequences being 
used, and different behaviours of the enantiomers. 1 They showed that the binding modes 
adopted are concentration and mixing ratio dependent. They also investigated methyl 
substituents of the parent phenanthroline tfis-chelate. Both the A and A enantiomers of 
the metal complex and its [4,7]-dimethyl derivative showed at least two binding 
regimes. They concluded from CD, LD, and molecular modelling studies that for the A 
enantiomer the partially inserted mode is favoured at all mixing ratios whereas the 
A complex, at excess DNA, prefers a minor groove binding mode with the chelates 
spanning the groove. At close packed metal complex loading a slotted minor groove 
mode becomes more favourable for A and some major groove partial insertion also 
occurs. 
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Research in this area has focussed on octahedral ruthenium, rhodium or osmium 
complexes containing mixed ligands of 1,10-phen and bipy derivatives, such as the 
dipyrido(3,2-a: 2', 3'-c)phenazine (dppz) ligand (Figure 2.4(i)). 
(i) dppz 
Figure 2.4 (i)The dipyrido(3,2-a: 2', 3-c)phenazine (dppz) ligand (ii) A-[Ru(1,10-phen)2(dppz)lz* complex, reproduced 
from reference 37 
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Complexes containing the dppz ligand have been shown to bind strongly to 
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DNA by intercalation of the dppz ligand. Osmium(II) and ruthenium(H) complexes 
containing one dppz ligand and two ancillary ligands (bipy or 1,10-phen) e. g. 
[Ru(biPY)2(d PPZ)]2+ or [Ru(1,10-phen)2(dppZ)]2+ (the latter is illustrated in Figure 
2.4(ii)) have been found to function as 'molecular light switches for double helical 
DNA'. These complexes show no luminescence in aqueous buffer but when bound to 
DNA by intercalation of the dppz ligand they luminesce strongly. 37-40 However, the 
specifics of the binding geometry (including the apparent lack of DNA sequence 
specificity) has not been firmly established and has been subject to some debate with the 
following different NMR studies implicating both major and minor groove. 
Using proton NMR and a duplex DNA hexamer d(GTCGAC)2, Dupureur and 
Barton proposed that [Ru(1,10-phen)2(dppz))2+ intercalates from the major groove . 
41,42 
Further investigations using known major and minor groove DNA binding agents in 
competition with the complex for DNA binding sites on double stranded AT-DNA, GC- 
DNA and ct-DNA also resulted in support for the original proposal of intercalation of 
the ruthenium(II) compleX from the major groove. The study additionally indicated an 
AT site preference for intercalation of the dppz ligand . 
43 By way of contrast, Lincoln et 
al. have proposed that both isomers of the same complex, [Ru(1,10-phen)2(dppZ)]2+ 
intercalate from the minor groove of the DNA helix, on the basis of photophysical 
studies and the similarities between the DNA binding geometry of the metal complex 
with that of the intercalator actinomyin D. 
36,44,45 
H3C 
N-, 
2N 
N H3C 
(i) dpq (ii) dmphen 
Figure 2.5 (i) dpq = dipyrido[2,2-d: 2', 3'-flquinoxaline, (ii) dmphen = 2,9-dimethyl-l, l 0-phenanthroline 
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Aldrich-Wright and colleagues conducted a proton NIVM study of the binding of 
the DNA hexamer d(GTCGAC)2 with A-[Ru(1,10-phen)2dpql2+ where dpq denotes 
dipyrido[2,2-d: 2', 3'-fl quinoxaline ligand (Figure 2.5(i)) which is closely related to A- 
2+46,47 [Ru(1,10-phen)2(dppz)] . The complex was found to intercalate from the minor 
groove. Further studies of binding of the A enantiomer of Ru(1,10-phen)2L)2+ where L-- 
1,10-phen or dpq showed that both complexes bound in the minor groove. NMR 
investigations into [Ru(dmphen)2dpq, 2+ (where dmphen denotes 2,9-dimethyl-1,10- 
phenanthroline (Figure 2.5(ii)) binding to the DNA hexamer d(GTCGAC)2 suggest that 
the dpq ligand of the A- enantiorner intercalates deeply into DNA hexamer base stack 
but the A enantiomer only partially intercalates, still from the minor groove. 48 
In contrast to the above minor groove intercalators, octahedral ruthenium(fl), 
rhodium(III) complexes [ML2(phi)]"', (MEL(phi)2]n+, [M(phi)31+, where phi = 9,10- 
phenanthrenequi none diimine (see Figure 2.6(i) and (ii)) and L=1,10-phen or bipy 
have been prepared and found to bind to B-DNA via intercalation of the phi ligand from 
the major groove when M= i-hodium(IH). 
49-53 
IN 
Figure 2.6 The structures of (i) phi = 9,10-phenanthrenequinone dimine, (H) A-[Rh(phen)2phil 3. CoMpleX taken from 
reference 53 
The DNA binding location of these ruthcnium(H) polypyridyl complexes is not 
yet firmly established. These complexes are known to promote direct strand scission via 
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hydrogen abstraction from the deoxyribose, upon photoactivation. 50 The attraction of 
these major groove DNA binding agents is that a mechanism for DNA degradation 
involves the abstraction of a hydrogen atom from the sugar adjacent to the binding site, 
a major groove binder can then access CY and CT hydrogens which are accessible in 
the major groove of DNA. The phi complexes of rhodium(HI) are major groove 
intercalators and their photo induced strand cleavage reactivity has thus been the subject 
of some study in an effort to probe the reaction and optimise it. 
H 
-H 
ll-ý 
Figure 2.7 The 5,6-chrysenequinone ciflmine ligand denoted chrysi 
A derivative of the phi ligand is the broader four ring 5,6-chrysenequinone 
diimine (chrysi) (Figure 2.7). Modelling has suggested that the chrysi ligand unlike the 
phi ligand is too bulky to intercalate between standard B-DNA base pairs but can do so 
near mismatched DNA basp pairs which are destabilised as a result of the disruption of 
the regular B-DNA structure. 54 Thechrysi complex is highly specific for such sites and 
has been shown to recognise and photocleave a single base mismatch in a 2725 base 
pair linearised plasmid heteroduplex. 52,55 Such sterically demanding intercalators have 
been suggested to have applications in mutation detection systems and as mismatch- 
specific chemotherapeutic agents. 
52,56 
2.1.2 Octahedral terpy complexes 
In the design of our ligands we began with the facts that terpy is known to lead 
to intercalation of square planar complexes. 
22,24-26,28,57 Thorp et al. have investigated 
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octahedral terpy mixed ligand complexes that exhibit comparable DNA strand scission 
interactions 58,59 to those for the major groove intercalators [Rh'I'L2(phi)]" (see section 
2.1.1). The binding specificity of [Ru, '(terpy)(L)OH212+ where L= bipy or 1,10-phen 
with ct-DNA was initially investigated . 
60 [Rull(terpy)(bipy)OH2,2+ was found not to 
cleave or lengthen DNA thus seeming to indicate that the intercalation of these and 
similar octahedral complexes containing terpy is not sterically feasible. 58 
2+ 
N 
NN 
fl) 
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Figure 2.8 Structures of (i) [Ru(terpy)(bipy)0]2. (ii) (Ru(terpy)(dppz)0]2+ structures taken from reference 58 
However, the oxidised fonn, (Ru(lv)(terpy)(bipy)0]21 (Figure 2.8(i)) combines a 
reactive oxoruthenium(IV) functionalitiy and has been found to cleave DNA by guanine 
oxidation and sugar oxidation of the Cl' hydrogen deoxyribose bond to cause strand 
scission . 
61 The location of these Cl', C4' and C5' hydrogens of deoxyribose sugar in 
duplex DNA is deep within the minor groove. Complexes of this type exhibit 111inor 
groove binding compared to their major groove binding rhodium(RI) counterparts. 
However, when the bipy ligand is replaced by dppz (see Figure 2.8(ii)), and binding 
specificity investigated, the complex is found to lengthen and unwind DNA indicative 
of classical intercalation. A study by Thorp et al. provides evidence that sugar oxidation 
by [Ru(terpy)(dppz)0]2+ occurs from complexes bound in the minor groove, but as only 
10 % of the complex was found to be consumed by sugar oxidation the study also states 
that there still remained 90 % of the complex (not undergoing the sugar reaction) which 
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may be bound in the major groove . 
58 This is agreement with the NMR studies 
conducted by both Lincoln and Aldrich-Wright (see Section 2.1.1) although it must be 
noted that Thorp et al. worked with a dppz complex containing terpy and oxo groups 
whereas the NMR experiments were carried out using complexes containing dppz and 
either two ancillary bipy or 1,10-phen ligands. 
Studies comparing the bipy complex, [Ru(terpy)(bipy)0]2' and its dppz 
equivalent, [Ru(terpy)(dppz)0]2+ found that two of the interaction sites for dppz were 
59 
not intercalative rather they were shape recognition specific to the dppz ligand. 
--, 2+ 
Figure 2.9 X and Y denote points of substitution on the terpy and bipy ligand respectively of the [Ru(terpy)(bipy)Ol 
complex, reproduced from reference 59 
When the [Ru(terpy)(bi PY)OI 
2+ 
COMPICX was substituted with electron donating 
or withdrawing substituents at the 4' position of the terpy or bipy (Figure 2.9), the 
electronic properties of the complex were found to change whereas the coordination 
environment of the reactive oxo, ligand was not significantly affected. This suggested 
that the selective cleavage in duplex and single stranded DNA was not strongly reliant 
on the substituents on the metal complex. 59 
2.1.3 Planar aromatic DNA binding moieties 
Another type of DNA binding of relevance to this work is the DNA binding 
modes of planar aromatic molecules such as anthracene and pyrene with cationically 
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substituted tails - specifically water soluble piperazinylcarbonyloxyethyl derivatives 
(see Figure 2.10). 
H2C'tH2 
N i'-ýý'ýCH3 
CH3 
(ii) 
cc, 
H2C NCH2 
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iý-ý 
ff-CH3 
CH3 
(iii) 
Figure 2.10 Piperazinyl carbonyloxyethyl derivatives denoted (i) anthracene (ii) pyrene and (M) phenylanthracene (taken 
from reference 62) 
Using CD and LD, Becker and Nord6n found that the anthracene and pyrene 
aromatic portions were found to be capable of intercalation between base pairs in either 
the major or minor groove, but attached ancillary tail ligands were also found to have a 
role in deten-nining the DNA binding mode, (i. e. location in the major or minor groove, 
strength of binding) and have a steric effeCt. 62'63 For example, substitution of anthracene 
(Figure 2.10(i)) with phenylanthracene (Figure 2.10(iii)) prevents intercalation and 
leads instead to the complex externally binding to both AT and GC. 62 
HO 
Figure 2.11 The structure of 9-hydroxyellipticine taken from reference 64 
9-hydroxyellipticine (9-OBE), (Figure 2.11) and its derivatives exhibit 
anticancer activity in cell lines via interaction with DNA, and intercalation is thought to 
be. the therapeutically active binding mode. Spectroscopic studies on the binding of 9- 
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OHE with ct-DNA, AT-DNA and GC-DNA conducted by Ismail et al., have shown 
concentration dependent binding modes that change from intercalation to interaction in 
either major or minor grooves. 64 The complex has been shown to adopt two modes of 
binding, intercalative. and the other a stacked binding mode involving the formation of 
drug oligomers in the DNA major groove dependent on the drug load. 
9-OHE binds intercalatively to AT, GC and ct-DNA at very low drug load with 
the hydroxyl group projecting in the minor groove and the amino group is in the major 
groove. At higher concentrations, a non-intercalative binding mode with the drug 
oriented parallel to the DNA bases becomes operative probably in the major groove. 
The second mode was shown by resonance light scattering (RLS)65 to be a stacked 
binding mode with small oligomer i. e. stacks rather than extended aggregates. Reduced 
LD, LD, studies suggested binding geometry that precluded a minor groove binding 
(where plane of drug is - 45 degree angle from the plane of bases) so it was concluded 
that the drug stacks in the major groove. Strong concentration dependence was observed 
for the two binding modes where intercalation is favoured at very low drug load with 
stacking interactions more prominent as concentration is increased. 
2.2 The complexes of this study 
The design of the molecules studied in this chapter benefits both from the 
extensive ruthenium metal complex DNA binding literature and the extended planar 
aromatic cationic binding. The interactions of these five complexes (Figure 2.1) with 
their bi-functional intercalating tail groups and shape sensitive [Ru(terpy)] core with 
DNA can be probed without danger of any photoactive strand scission taking place. 
Ruthenium(H) usually adopts a six coordinate octahedral geometry. In our 
complexes, each terpy ligand has three nitrogen atom binding sites, the two ter-pys 
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attach either side of the inert ruthenium(II) in the sterically favourable octahedral 
arrangement. The tail groups in the complexes studied in this work (see Figure 2.12) are 
substituted on the 4' position, para to the nitrogen of the terpy and lie opposite each 
other. The Wposition on the terpy lies along its two-fold axis, and the aryl tail either lies 
or approximately lies with this twO-fold axis along an axis of the aryl tail. The 
[Ru(terpyAr)2]2+ core thus has two reflection planes, an S4 axis and three C2 axes so it 
has D2d symmetry. 12 The anthracene and biphenylene complexes have this symmetry 
when the tails are oriented coplanar with the terpy groups. The others have it on average 
if one assumes either free rotation about the link to the tail or no preference for either 
orientation of the planar tail. 
The main techniques used in this chapter are spectroscopic and so the 
spectroscopy of the complexes is very important for the interpretation of the data 
collected. As discussed in Chapter 1, an absorption spectrum is made up of electronic 
transitions arising from molecules absorbing energy at certain wavelengths and their 
electrons are promoted from a ground to an excited state. Absorption spectroscopy can 
be used to probe the interactions of specific transitions of a molecule by changes in its 
environment e. g. by DNA binding perturbations. The individual spectroscopy of the 
tails 
32,6"9 is well established as is that of the [Ru(terPY)21 core of the molecule. ' 
2- 
14,17,29,31,32,66 These are summarised in Figure 2.12 and in Tables 2.1 - 2.3 in section 2.3. 
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Figure 2.12 Molecular axis system for the metal complexes. In each case, the aryl tail groups (Ar = anth, pyr, biphen, 
phen, napth) are attached at the 4' position of the terpy (2,2'; 6,2"-terpyridine) ligand. The x, y, z axis system is the 
symmetry determined axis system of the Ru(terpY)2 core of the molecule, as indicated by the large double arrows. The 
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2,2'; 61,2" terpyridine (terpy) 
anthracene (anth) 
long a)ds of Iýand 
pyrene (pyr) 
2.2.1 Materials 
Ruthenium complexes 
The five novel ruthenium(H) bis-terpyridine chloride complexes's were 
provided by E. Plummer (University of Warwick). For each of the ligands, the solid 
state structure of either the ruthenium or iron complex cation has been determýined by X- 
Ray crystallography. 15 In each case, the geometry at the metal is basically octahedral 
subject to the constraints of the terpy ligands. In solution free rotation about the terpy- 
aryl band is anticipated. These complexes were all water soluble, so the binding studies 
reported in this chapter were carried out in aqueous solution with the exception of the 
pyrene and phenanthrene complexes where a small amount of methanol was used to 
make up the metal complex stock solutions (5% and 1.5% respectively). 
Polynucleotide samples 
Duplex calf-thymus DNA, (deoxyribonucleic acid (DNA) Sodium salt, 'highly 
polymerised' Type 1) purchased from Sigma (referred to as ct-DNA), poly [d(A-T)12 
and poly [d(G-C)12 DNA both for in vitro use only from Amersham. Phannacia-Biotech 
(referred to as AT and GC DNA respectively), were all used without further 
purification. AT and GC DNA were made up in 30 mM NaCl, I mM sodium cacodylate 
buffer, pH 6.92 and 10 mM NaCl, I mM sodium cacodylate buffer, pH 6.92 
respectively. Concentrated stock solutions of ct-DNA were made up in water. Duplex 
formation was confirmed under experimental conditions (i. e. melting curve 
experiments), concentrations were determined spectroscopically using extinction 
coefficients (see Chapter 1). Duplex DNAs of greater than 500 base pairs in length were 
necessary to facilitate orientation in solution for relevant LD (linear dichroism) flow 
expenments. 
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Other materials 
Polyvinyl alcohol (PVA) (Type III) purchased from Sigma Chemical Co. was 
used to make the film for film LD. Methylene blue (MB) was purchased from BDH 
Chemicals Ltd. The solvents used were 18.2 Mn water, and analytical grade methanol. 
Instruments 
Absorbance spectra were measured using a1 cm pathlength quartz cuvette and 
either a Jasco V550 UV-Visible or Cary IE UV-Visible spectropolarimeter. CD and LD 
(film and flow) were measured on a Jasco J-715 spectropolari meter adapted for LD 
measurements. The samples were flow oriented using a quartz couette flow Cell. 70 
Fluorescence spectra were measured using aI cm pathlength, four sided clear quartz 
cuvette on a Perkin Elmer LS 50b. Methylene blue (a known DNA intercalator)l was 
used as an internal reference to help determine binding geometries of the complexes 
under varying complex concentrations in relation to the orientation of DNA. For film 
LD, blank and complex saturated films were prepared using PVA as described in 
Chapter 1. LD spectra were collected both before and after each film was mechanically 
stretched to twice its length in order to determine complex transition polarisations. 
2.2.2 Methods 
Titration methods with ct-DNA 
Metal complex-DNA binding interactions with each of the five ruthenium 
complexes was initially probed using UV-Visible absorbance, fluorescence and circular 
dichroism spectroscopies. For these preliminary studies, the metal complex 
concentration was kept constant as a known concentration of ct-DNA was added. In 
contrast, for the in depth spectral investigations, titration series were set up so that the 
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DNA concentration remained constant as the metal complex concentration was varied, 
this was achieved by adding aliquots of DNA with each addition of metal complex thus 
allowing for any variation in the interaction with DNA to be probed. 
2.2.2.1 Film linear dichroism 
Film LD can provide information about the polarisations of transition moments 
of a Particular molecule. The symmetry of the molecule is often helpful in assigning the 
orientation of the molecules within the film. In addition, it governs the polarisations of 
transition moments. Once the transition polarisations for the ruthenium complexes have 
been assigned, they can be used to determine binding orientations of the complexes on a 
flow-oriented macromolecule (DNA) as outlined in Chapter 1. 
The long and short axis of the molecules can usually be intuitively assigned. The 
long and short axes of the molecule (and the one perpendicular to them) are usually 
coincident with its spectroscopic axes if these are defined by symmetry. This is the case 
for the anth and biphen complexes studied in this chapter. In the case of the other 
complexes, the axes are not defined by symmetry, but the symmetry axes of the terpy 
core of the molecule are close to the long and short axes as illustrated in Figure 2.12. 
When the molecule is inserted into a stretched film, the long axis of the molecule will 
orient/lie along direction of orientation (stretch) whilst the short axis would resist the 
stretch and therefore lie at right angles to the stretch direction. 
In order to analyse the film LD data, we make the assumption that the molecule 
behaves as uniaxial rods 70 in the stretched film and that the orientation axis is the S4 axis 
of the [Ru(terpY)21 core of the molecule (see Figure 2.1). Therefore, for a z-polarized 
transition, the angle between a transition moment and the orientation axis, a, is 0 and 
the reduced linear dichroism (LD r )for the whole absorption band: LDr(z) = +3S, where S 
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is the orientation parameter (see Chapter 1). For x/y polarisation. transitions a= 90' and 
LD'(x, y) = -1.5S. 
Thus transition polarizations can be assigned according to the signs of the 
stretched film LD". Generally, positive LD' features are assumed to correspond to long 
axis polarised transitions and negative LD' signals to short axis polarisation transitions, 
though if the degree of orientation is too low, the short axis polarised transitions may 
appear as less positive rather than negative. Therefore the strongest positive LDr 
indicates a transition of greatest long axis character, whereas a least positive or negative 
LD' that of short axis character. Since the LD' across an absorption band is constant, the 
absence of any flat LD' features indicates that transitions of different polarisations 
overlap in all regions of the spectra. This is frequently the case for transition metal 
complexes of octahedral parentage. Therefore we begin our analysis of the film LD by 
making the assumptions that the most positive LD" corresponds to a long axis (z) 
polarised transition and any negative (or positive minima at places of large absorbance 
intensity) LD' correspond to short axis (x/y) polarised transitions. 
2.2.2.2 Flow linear dichroism 
Long strands of DNA will orientate in the direction of flow of the solution and 
exhibit a LD signal at their absorption wavelengths. If a molecule binds to DNA, an 
induced LD in the bound molecule's transitions or a change in magnitude of the DNA 
LD signal may be noted. As each ruthenium(II) complex is too small to be flow 
oriented, (confirmed experimentally by lack of signal complex on its own), a non-zero 
LD signal in the ruthenium complex transitions when DNA is present indicates 
interaction between the metal complex and DNA. Flow LD probes orientations of 
specific transitions relative to the DNA helix axis for transitions of known polarisation. 
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In flow orientation, S (the orientation parameter) is usually detern-fined by assuming that 
the DNA bases are all polarised at -86' from the helix axis. As ruthenium transitions 
overlay the DNA transitions, an independent probe, i. e. methylene blue (MB) was used 
to determine DNA orientations on mixing. See Chapter 1 for an explanation. The 
methylene blue/DNA absorbance, LD and LD'and complex + DNA + MB experimental 
data are given in Appendix 2.1. 
2.3 Results and discussion 
2.3.1 Electronic absorption spectra of the ruthenium terpy complexes 
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FIgure 2.13 Absorbance spectra of the five ruthenium(II) complexes (10 pM) in water. Spectra are identified in the 
figure inset. 
The complexes are a vivid orange-red colour in solution and absorb strongly in 
both the UV and visible regions of the spectrum. The absorption spectra of the five 
complexes in water are displayed in Figure 2.13. These spectra are in accord with 
expectations for ruthenium terpy complexes, which, as surnmarised in Table 2.1, are 
characterised by a variety of intense bands in the UV and visible region. 
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Particular bands of relevance to our metal complexes are: 
(i) the shoulders at -200 nm and -330 nm and the bands centred about 280 nm and 
3 10 rim which correspond to the terpy ligand 7r-7E* transitions so can be assigned 
as in-ligand or ligand centred (IL) bands 
(ii) the relatively intense and broad absorption bands in the visible region of the 
spectrum corresponding to metal (7rm) to ligand (7rm*) charge transfer transitions 
(MICT), 
(iii) the other bands, mainly in the. UV region of the spectra, that may be attributed to 
the IIL transitions of the tail group, 32 though there may also be some metal 
centred (MC) or MLCT bands in the UV region 
(iv) the long absorption tail found at lower energies (greater than 500 nm) for each 
complex in the visible region of the spectra that has been assigned to spin 
forbidden MLCT transitions by Kalyanasundaram et al. 32 
2.3.2 Film linear dichroism of the ruthenium terpy complexes 
Film LD and film absorbance spectra, of the five metal complexes in stretched 
PVA films were measured to enable transition moment polarisations to be qualitatively 
assigned thus facilitating the use of flow LD in determining DNA binding geometries. 
A number of assumptions have been made using the general figure of the parent 
[Ru(terpyAr)2]2+ complexes from Figures 2.1 and 2.12 as outlined in the Figure 2.12 
caption. In particular, it has been assumed that the long axis of the metal complex lies 
along its z-axis (through the terpy and the tail) so z is preferentially oriented along the 
stretch direction of the film. If this assumption is correct, then the terpy long axis will 
lie perpendicular and the terpy short axis will lie parallel to the z axis of each complex 
as illustrated in Figure 2.12. Thus the long axis terpy transitions centred at 310 and 330 
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nm in solution will be expected to have a negative film LD signal and a maximum LD' 
Yalue. Conversely the 200 nm and 270-290 nm (solution phase) transitions would have 
positive LD' values. 
Figure 2.14 shows the film absorbance, film LD and film LD' spectra for each of 
the five complexes. The absorbance in the film before and after stretching, when 
overlaid (data not shown), shows a small change in the shape of the spectrum and a 
decrease in magnitude upon stretching (due to the decrease in pathlength of the sample). 
Comparison with the water spectra of Figure 2.13 shows the absorbance is better 
resolved in the PVA environment and in general is also slightly red shifted for each 
complex relative to the water spectra. The observed spectra are consistent with the 
above expectations for the terpy transitions in each case, confirming that the assumption 
about the metal complex orientation in the film is indeed correct. The long wavelength 
(550-600 nm) spin forbidden transition has a reasonably large positive LD' signal for 
each complex, suggesting that it is polarised predominantly along the metal complex z- 
axis. The MLCT bands are dominated by z-polarised transitions, particularly at - 500 
nm where each complex has a large positive LD' signal. The tail transitions are all 
consistent with this interpretation with the transitions along (or close to) the z-axis 
having large positive LD' signals (usually not of maximum values as they overlap with 
other transitions of x/y polarisation). The tail group long and short axis polarisation 
transitions are summarised in Table 2.2 and the qualitative polarisation assignments of 
each complex based on the film LD studies are surnmarised in Table 2.3. 
Table 2.2 Summary of long and short axis polarisations of individual tail group transitions 
Tail long axis / nm short axis / nm 
Biphen 200-220,330-400* (355) 230-250 
Napth 225-230,340-400*(350) 200-210 
Phen 200-210 225,275,330-400*(375) 
Anth 250 225,340-400*(390) 
Pyr 200-220,350-400* 240,340 
*= 340-400 mix of terpy(o, metal centred (MC) and tail transitions 
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It is not possible from the LD data to determine anything about the inter-aryl. 
twist of the tail with respect to the terpy group since the non-z axis lies in the x/y plane 
of the uniaxial rod. Regions with significantly sloping LD' signals are indicative of 
overlapping bands of different polarisations. 
2.3.3 Preliminary studies of the interaction of ruthenium terpy complexes with 
ct-DNA 
The visible absorption spectra of the complexes in the absence and presence of 
DNA in a 10: 1 DNA base: complex ratio are illustrated in Figure 2.15. As both ct-DNA 
and the ruthenium complexes have overlapping transitions below 300 nm, metal 
complex spectral changes can be most easily seen above this wavelength where ct-DNA 
has no absorbance. A change in each of the five complexes' absorption spectra is 
observed on addition of ct-DNA. The change is least for the anth and phen complexes. 
The most notable changes are as follows: 
(i) The wavelength shifts to longer wavelength (red shift) for all complexes. The 
effect is particularly noticeable for the biphen and napth complex where the solution 
changes from red-orange to pink. The other complex colour changes are more subtle 
as illustrated by the absorbance spectra. 
(ii) The terpy transitions are in general not perturbed significantly upon binding to 
DNA. The 300-350 nm region of the spectrum shows very little change for anth, 
small changes for napth, phen and larger changes for biphen (wavelength shift) and 
pyr (intensity reduction). In the biphen case, some of the change may be due to 
changes in the biphen EL spectroscopy. 
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Figure 2.15 Absorption spectra of aqueous ruthenium(II) complexes (i) biphen, (ii) napth (iii) phen (iv) anth and (v) pyr 
in the presence and absence of ct-DNA in a [10 pM complex: 100AM ct-DNA] ratio. The dotted line represents the DNA 
alone in solution, the dashed line the metal complex alone in solution, the solid line is complex + ct-DNA. 
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(iii) The MLCT bands of phen and anth show a very small hypochromic effect and 
those of napth and pyr a larger one in addition to a red wavelength shift. Biphen by 
way of contrast shows a hyperchromic effect. This suggests that the biPhen complex 
behaves in a different fashion to the other four complexes. 
(iv) There is significant hypochromism in the DNA region of the spectrum for pyr 
and anth (where the magnitude of the absorbance is lower when the DNA is added 
at -240 nm) 
It is therefore clear that each complex binds to DNA in a binding mode that is 
close enough and strong enough to affects its absorption spectroscopy. An appreciable 
decrease in absorbance and a wavelength shift can be indicative of strong binding. A 
wavelength red-shift and hypochromic effect for n-7r* transitions on addition of DNA is 
often indicative of a Tc-n* stacking interaction, usually due to intercalation between 
DNA base pairs or oligomerisation mediated by the DNA template. 
The [Ru(terpyAr)2 ]2+Complexes alone in solution are achiral and therefore do not 
exhibit a signal in CD. Addition of ct-DNA (-100 gM) to a constant complex 
concentration (10 gM) in a [10: 1] DNA base: metal ratio, induces chirality in the 
complex transitions as illustrated in Figure 2.16. 
10 
C, 
E 
a 
0 
-10 
-20 
5x 
E) pyr + ct-DNA phen + ct-DNA 
I --E3 - napth + ct-DNA ----- biphen + ct-DNA 
......... anth + ct-DNA pyr alone 
200 300 400 500 600 
wavelength / nm 
Figure 2.16 CD spectra of the ruthenium(II) complexes in the presence and absence of DNA (10: 1 DNA base. metal 
complex ratio). The 350 nrn - 650 nm region of the spectra has been magnified 5x 
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All five ruthenium(II) complexes exhibit a chiral signature on interaction with 
ct-DNA but not alone in solution as demonstrated by the flat unbroken line for the pyr 
complex on its own. The MELCT signal is positive above 500 nm and may be small 
positive or negative below this point. The terpy region from 300-350 nm gains a 
negative signal in each case. All the complexes except anth have a larger positive peak 
(which will include the DNA signal) at 275 nm. In the anth case, this positive 
component may be cancelled by the large negative 250 nm induced CD (ICD) of the 
anth itself. 
Preliminary fluorescence studies 
[Ru(terpY)2]2+ does not fluoresce in water at room temperature. 12,14,17,29-32 
However, substitution in the 4'position on the terpy ligand with electron withdrawing or 
donating groups, 11,13,14,17,19,29,31.67,68 has been shown to lead to a fluorescence signal. 
17,71 
All five tail groups of Figure 2.1 are aromatic and conjugated and some of them, 
including anthracene, pyrene, and phenanthrene, are themselves fluorophores. 
Fluorescence studies on these ruthenium(II) complexes were therefore 
undertaken in aqueous solution at room temperature, in the presence and absence of ct- 
DNA. The complexes were excited at IL terpy, aryl tail and MELCT transitions. The 
excitation wavelengths (X,,, ) were as follows: for IL terpy (, %ex = 270-280 nm, 310 nm), 
,,, 
for pyr = 240 nm, anth = 250 nm, biphen = 235 nm, napth = 225 aryl tail transitions (Xc 
nm, phen = 250 nm) and MLCT - 490 nm). 
Excitation of the MILCT band both before and after DNA addition resulted in no 
fluorescence or quenching. On excitation of the IL terpy and aryl tail bands, the 
complexes did exhibit a little fluorescence alone in aqueous solution (of less than 100 
68 
intensity units) in the 350 - 400 nm region assigned predominately to the aryl tails. On 
addition of ct-DNA (100 IAM DNA to a 10 JIM complex in a 10: 1 ratio), the anth, 
biphen and pyr complexes exhibited a small enhancement in fluorescence whilst the 
napth and phen complexes exhibited fluorescence quenching. 
As no significant fluorescence change was seen, we concluded that all 
complexes are generally non-luminescent in aqueous solution at room temperature 
despite the intrinsic fluorescence of the tail groups. Fluorescence studies were therefore 
not pursued further. 
2.3.4 Titration series to investigate the interactions of the metal complexes with 
DNA 
On the basis of the promising preliminary results, further investigations, using 
absorbance and CD and flow LD were undertaken over a wide range of DNA 
basexomplex ratios to probe the interactions with ct-DNA and where appropriate with 
AT and GC DNA. Each complex-DNA interaction was investigated over a mixing ratio, 
R, of [20: 1-1: 1] DNA -base: metal complex. 
At the 20: 1 limit isolated binding may 
occur, whereas at 1: 1 this is not possible. 
2.3.4.1 LTV-Visible absorbance titration spectra 
The absorbance titrations of each complex with constant ct-DNA concentration 
(100 pM) are shown in Figure 2.17. The general trend of all five absorption spectra is, 
as expected, an increase in absorbance intensity as the complex concentration is 
increased with transitions of both the DNA and complex overlapping below 300 nm. 
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Figure 2.17 Absorbance titration spectra for (i) biphen, (H) napth, (iii) phen, (iv) anth, and (v) pyr. Working with a 
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70 
2.3.4.2 Circular dichroism titration spectra 
CD provides information about the spectroscopically active chiral species in 
solution. Thus the metal complexes will give a zero signal unless they are bound to the 
chiral DNA. Although in principle CD can be used to give geometric information about 
the observed species, 70 in practice this is often very difficult. CD is, however, usually 
the most sensitive spectroscopic technique for probing changes in binding mode as a 
function of concentrations and/or mixing ratios. 70 The CD titration series for each metal 
complex with ct-DNA is given in Figure 2.18 
The anth, pyr and phen complexes (Figure 2.18(i) - (iii)) exhibit similar CD 
behaviour. They have positive MLCT signals at all ratios and small signals for the long 
wavelength tail transitions. At the low metal complex loads the 310 nm terpy regions of 
the spectra have negative CD bands and the DNA region is dominated by the DNA CD 
signal. At - 7: 1 (DNA base: metal complex) for anth and - 4: 1 for pyr and phen, the 
terpy region and the DNA region take on a very different form, indicating the switching 
on of a second binding mode. In each case there is an isosbestic point at the 310 nm 
absorbance maximum and the magnitude of the signals in this region and the DNA 
region increases significantl-y, though the increase is proportional to the metal complex 
added. The form and magnitude of the spectra suggest a degenerate exciton interaction 
between terpy groups and perhaps also between tail groups (there is e. g. an approximate 
isosbestic point at the anth maximum at -250 nm). 
The napth complex (Figure 2.18(iv)) by way of contrast has an isosbestic point 
throughout the whole series near the maximum of the 275 nm DNA band even though 
the 310 nm terpy region changes its spectral fonn gradually throughout the series, 
though remaining negative in sign. This is consistent with either a gradual occupation of 
a second mode (as opposed to two sequential modes) or a single binding mode which 
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demonstrates sequence selectivity. Its MILCT band is also significantly smaller than that 
of the other complexes. The signal (and presumably the specific binding) also saturates 
at about R=2: 1 (by 70 pM metal complex it is probably condensing). 
The biphen complex (Figure 2.18(v)) also shows little change in the shape of its 
CD spectrum over the whole range of mixing ratios, though the very low metal complex 
load spectra are different in shape from the medium and high loadings. There is a small 
MLCT signal, the 330-400 nrn biphen signal saturates at a comparatively small signal 
by R=3.3: 1, and the DNA region is largely unaffected by the addition of the metal 
complex. The data is consistent with a single binding mode, though weak signals may 
mask changes. The magnitude of these signals is typical for metal complexes binding to 
DNA. ' 
Figure 2.19 shows the CD spectra of the interactions of biphen with ct-DNA, 
GC DNA and AT DNA, the equivalent GC and AT DNA absorbance spectra are given 
in Appendix 2.2. The biphen complex behaves with GC in a manner similar to its ct- 
DNA behaviour except that the positive 350 nm band is not observed (Figure 2.19(i) - 
(ii)). With AT DNA (Figure 2.19(iii), the 310 nrn terpy band is smaller than with ct- 
DNA and of opposite sign, while the 350 nm band is larger and also of opposite sign. 
The AT MLCT band is very small and negative in sign and the DNA region is perturbed 
by the metal complex. With AT DNA, at high metal complex loadings (above 5: 1) there 
is a significant increase in signal magnitude in the 300 - 400 nm part of the spectrum, 
which corresponds to a negative exciton signal of the tail. At low loadings this mode is 
already dominating the spectra, suggesting a cooperative TE-n self-stacking mode. The 
opposite CD signs for ct-DNA and AT DNA indicate that the twist of the biphen is 
opposite in each case. It is unusual to see such different behaviour with GC, AT and ct- 
DNA: the CD spectra suggest different binding modes with all of them. 10 
72 
40 
20 
CD 0 (1) 
-20 
-40 
-60 
10 
0 
E -10 
a 
0-20 
-30 
-40 
20 
0 
cm 
E -20 
-40 
-60 
on 
(i) anth 
0 -18 
-5 -20 
-6.5 -22 
-8 -25 
10 -35 
13 -40 
15 (a) 
......... 0 -10 
-5 -13 
6.5 -15 
-8 -- 18 
(b) 
--------- 0 -22 
-- 15 -25 
-18 -35 
-20 -40 
(C) 
-ov 
200 300 400 500 600 
wavelength / nm 
Figure 2.18 CD titration series for ruthenium(II) complexes (i) anth, (ii) phen, (iii) pyr, (iv) napth, and (v) biphen. Working 
with a constant ct-DNA concentration (100 pM)(dofted line) over (a) all mixing ratios, (b) at low complex concentrations 
and (c) at higher concentrations. Legend states IM ruthenium(II) complex concentration added. 
73 
100 
50 
73 0 
E 
0 
0 
- 50 
-100 
-150 
16 
8 
cm 
E 
0 
0 
8 
-16 
100 
50 
M0 E 
C 
0 
- 50 
-100 
-1 rn 
(H) ph en 
--------- 0 -13 -25 
-5 -15 -30 
-6.5 -18 -35 
-8 -20 -40 
-10 -22 -50 
(a) 
J- 
-------------- 
--------- 0 13 
- 5 -15 
- 6.5 18 
- 8 20 
- 10 - 25 
(b) 
0 
20 
-25 
-30 
-35 
Ile -40 
- 50 (C) 
200 
Figure 2.18 (H) phen 
300 400 
wavelength / nm 
500 600 
74 
80 
40 
0 
0 
-40 
-80 
-120 
12 
cm 6 
E 
0 
-6 
92 
46 
cý 
a) 
0 
-46 
-qp 
(iii) pyr 
--------- 0- 18 -40 
-5 - 20 -50 
6.5 - 25 -60 
-88 - 30 -70 
- 10 10 - 35 
(a) 
--------- 0 -10 
5 -18 
- 6.5 -- 20 
- 8 
(b) 
I 
--------- 0 -40 
-- 20 -50 
- 25 -60 
- 30 -70 
- 35 
200 300 400 500 600 
wavelength / nm 
Figure 2.18 (M) pyr 
75 
50 
40 
30 
cm Q 
«0 20 
10 
0 
-10 
-20 
33 
C» 
22 
E 
0 
-ii 
48 
40 
32 
c) 24 
E 
16 
8 
0 
-8 
-16 
(iv) napth 
--------- 0 -20 
5 -30 
6.5 40 
-8 -50 
-10 60 
-13 70 
0 
-5 
-6.5 
-8 
10 
-13 
-20 
-- 30 
(b) 
0 
E3 20 
- 30 
40 
-50 
-60 
-- 70 
(C) 
200 
Figure 2.18 (lv) napth 
300 400 
wavelength / nm 
500 600 
76 
10 
5 
Q) 
E 
cl 
0 
.5 
-10 
8 
4 
0 
-4 
-8 
8 
4 
0 
-4 
-A 
(v) biphen 
Ik 
I 
......... 0 20 
-5 -25 
7 30 
10 40 
16 -- 60 
(a) 
--------- 0 -16 
5 - 20 
7 25 
10 30 
(b) 
0 
30 
40 
60 
200 300 400 
wavelength / nm 
500 600 
Figure 2.18 (v) b1phen 
77 
10 
5 
C) 
E 
-0 
0 
-5 
4 
0 
m 0 *0 -4 
-8 
-12 
-16 
5 
0 
m 
- 10 
- 15 
-20 
(i) biphen with ct-DNA 
--------- 0 20 
-5 25 
7 30 
10 40 
16 60 
(ii) biphen with GO-DNA 
--------- 0-- 20 
-5 - -25 
-6.5 -- 40 
-10 -- 50 
(iii) biphen with AT-DNA 
.......... 
Al 
--------- 0-- 25 
5-- 40 
-6 5-- 50 . 
VI -10 9 70 
20 
200 300 400 500 600 
wavelength /nm 
Figure 2.19 CD titration spectra of biphen with (i) ct-DNA, (ii) GC DNA and (iii) AT-DNA. Working with a constant DNA 
solution of 100 fLM (doffed line). Legend indicates pM concentration biphen added. Titration spectra (i) has been 
reproduced from Figure 2.18 (v) for ease of comparison. 
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2.3.4.3 Flow linear dichroism titration spectra 
DNA exhibits a negative flow LD signal between 200 - 300 nm, due to the 
transitions of its bases being approximately perpendicular to the long axis of DNA. All 
five complexes also give rise to LD signals above 300 nm upon addition to DNA. As the 
DNA absorbance is overlaid by metal complex transitions, the orientation of the DNA 
bases is not clearly distinguishable using LD' in the presence of the metal complexes. 
An independent check of the DNA orientation was therefore made at varying metal 
concentrations by measuring the LD of a probe, methylene blue (MB), a known 
intercalater. 8 A small amount of MIB was used such that the DNA signal remained 
relatively unperturbed. Appendix 2.1 contains the flow LD and LD" spectra for the 
complexes with MB. 
For each complex at R= 20: 1, the M13 + DNA + metal complex MB LD signal 
was found to be larger in magnitude than that of the M[B + DNA alone with the ranking 
order being phen > pyr > napth > anth > biphen >metal complex free DNA (i. e. MB 
DNA alone). However, as the metal complex concentration increased, the MB signal 
was found to decrease in -magnitude with 
the exception of anth. This suggests that at R= 
20: 1 the DNA is either unwinding or lengthening or stiffening - all characteristic of 
intercalation. At higher R, bending or kinking of DNA or simply displacement of the 
MB by the metal complexes may be taking place. 
Flow LD titrations were undertaken, in order to deten-nine the orientation of the 
metal complexes on the DNA. Figure 2.20 shows the flow LD titration spectra of four of 
the five (anth, phen, pyr and napth) metal complexes on interaction with ct-DNA. Anth, 
phen and pyr exhibit similar flow LD titration spectra (Figure 2.20(i)-(iii)), with a 
negative MELCT region, negative tail region from 350-400 nm, and positive terpy region 
between 300 and 340 nm. Although the spectra are suggestive of only a single binding 
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orientation for each complex, there is a subtle change in the shapes of the spectra from 
-4: 1 anth and pyr and -2: 1 for phen. As the concentration of each complex is increased, 
from R= (20: 1 - 4: 1) for anth and pyr and (20: 1 - 2.5: 1) for phen, their LD spectra 
show an increase in the negative magnitude of the band centred at 260 nm attributed to 
DNA, with a progressive red shift leading to the sharpening of the transition to -275 nm 
as the terpy transition gradually appears superimposed over the DNA signal. The anth 
spectra also show a sharp positive 250 nm band and phen and pyr have a shoulder in 
this region suggesting the presence of a positive band that is cancelled by the negative 
signal due to the DNA and perhaps other transitions. At higher metal complex 
concentrations, the prominent 275 nm terpy(s) band decreases in magnitude (less 
negative, more positive) for all three complexes, this suggests that the low and high 
loading binding modes are oriented in similar fashions. 
The napth pattern (Figure 2.20(iv)) is similar to the anth, phen and pyr metal 
complexes at lower metal complex loadings except that the positive terpy 300-340 nm 
region is cancelled by the tail of the negative napth band. At higher metal complex 
concentrations the MLCT band first shows cancelling positive and negative signals and 
finally there appears to be-a significant red shift of the band and a net small positive 
peak. The decrease of the negatiVe signals is apparent from about 40 [tM napth 
complex, though the positive signal is not dominant until 85 gM. This suggests that 
there are 2 modes in operation simultaneously with the second binding mode operative 
at higher metal complex loads -2: 1 mixing ratios, as opposed to one binding mode with 
some sequence selectivity. There is significant decrease in all the LD signals (though no 
corresponding decrease in absorbance signal) at these higher concentrations, which 
implies loss of orientation for both complex and DNA, which may be associated with 
DNA bending or coiling. 
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To probe whether it was a sequence variation that gave rise to the high metal 
complex load differences, LD titration experiments with GC DNA were undertaken. For 
the anth, phen and pyr complexes, the LD spectra with GC DNA (Figure 2.21(i --iii)) 
are superficially similar to those with ct-DNA but show significantly greater signals in 
the aryl tail bands (350-400 nm) at medium metal complex loadings. The napth GC 
(Figure 2.21(iv)) results are similar to those of ct-DNA except that the positive 310 nm 
ct-DNA signal is a negative minimum with OC and the 275 nm band is smaller in 
magnitude than the 260 nm. band for GC. 
The biphen LD spectrum on interaction with ct-DNA (Figure 2.22(i)) is different 
to those for anth, phen and pyr and napth, with the MLCT region being positive at all 
mixing ratios and the spin forbidden transition having a clearly identifiable signal 
(rather than just being almost a shoulder under the MLCT band long wavelength tail as 
is the case for the other complexes). The terpy region of the biphen spectrum is positive, 
however the 310 nm region is a minimurnrather than a maximum suggesting its LD is 
actually negative. The DNA region LD is negative, but of lower magnitude than the 
signal due to DNA alone, in contrast to the other metal complexes. 
In order to deterrnine whether there was any sequence dependence of the 
unusual behaviour of the biphen complex, the LD with AT and GC DNA were 
measured (Figure 2.22(ii) and (iii)). The three DNAs show almost identical spectra 
(except for the lower orientation parameter with the shorter synthetic DNAs). 
Importantly, the biphen transitions below 350 nm are all positive compared to the 
negative transitions exhibited by the anth, phen and pyr and to some extent napth 
complexes. This is another indication of a dissimilar binding interaction of biphen 
compared with the other complexes. 
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Figure 2.22 Flow LD titration spectra for biphen with (i) ct-DNA, (ii) AT-DNA and (M) GC-DNA. Working with constant 
DNA concentration (100 pM) (dotted line). The legend states pM biphen complex concentration added. As the biphen 
complex concentration is increased, all three plots show increasingly positive LD signals with plot (a) for ct-DNA 
exhibiting the largest LD signals. At highest biphen concentrations for each plot, (a) ct-DNA, (b) AT-DNA and (c) GC- 
DNA, i. e. 60,100,120 pM respectively the LD signal shows a decrease in size, this is due to b1phen precipitation. 
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The LD' (the LD divided by the absorbance) can be used to deterniine the 
orientation of the complexes on the DNA. The LD' spectra for the Flow LD titrations of 
anth, phen, pyr and napth with ct-DNA (Figure 2.20. ) are shown in Figure 2.23 and 
those for biphen with ct-DNA, AT and GC (Figure 2.22) are shown in Figure 2.24. 
These are an aid to working out the orientation of the complexes on the DNA. Consider 
first the anth data. The largest magnitude (negative in this case) LD' signal is in the 
MLCT region, which the film LD showed to be z-polarised. If we assume that this 
means these transitions are perpendicular to the DNA helix axis (in other words there is 
not significant local kinking of the DNA helix about the metal complex, which is 
supported by the MB data), then by comparison with the low metal complex loading 
DNA region then we must conclude that the z-axis of the metal complex is more 
perpendicular to the helix axis than the average DNA base. Consistent with this all the 
z-polarised transitions (cf. Table 2.3) have a negative LD signal. Thus the z-axis of the 
metal complexes lies approximately parallel to the DNA bases. 
The two terpy groups of necessity lie perpendicular to one another in all 
complexes as well as perpendicular to the z-axis. Thus, regardless of their orientations 
in the x/y plane, the net LD signal from the two perpendicular terpy ligands will be 
positive if the z-axis lies perpendicular to the DNA helix. 
The variations in the anth LD spectra as a function of loading are small so the 
orientation of the different chromophores is essentially independent of load. 
Unfortunately, due to the presence of the two terpy and anth groups, unless the anths are 
skewed there is no way intercalative or groove binding modes can be distinguished from 
the LD: if skewed, at least one would be non-intercalated. The retention of the structure 
of the anth spectroscopy at - 250 nm is also not a reliable guide since at least one 
anthracene per metal complex must be non-intercalated. ' 
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Figure 2.23 LD' plots for ruthenium(li) complexes (i) anth, (N) phen, (iii) pyr and (iv) napth. Legend indicates LDr AM 
ruthenium(li) complex concentration equivalent, ldr 0= LDr for ct-DNA alone in solution, its data above 300 nrn has not 
been plotted due to excessive noise. LD' plots generated using Figure 2.17 and Figure 2.20. All four spectra show 
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The 310 nm terpy band is pure xly polarised (Figure 2.12), long axis polarised 
within the terpy, and its intensity is unaffected by the addition of DNA (Figure 2.20(i)). 
However, its LD' signal is -2/3 that of the MILCT band (Figure 2.23) which is 2/3 of 
what would be expected for two such terpy groups. 70 The most likely explanation for 
this is that the tail of the z-polarised band below 300 nm is cancelling some of the 
expected signal. The x/y polarised anth signal at -250 nm is similarly overlaid by z- 
polarised transitions. The LD of anth with GC DNA is in fact very similar to that with 
ct-DNA except in the DNA region where the 250 nm positive band is rnissing. 
However, this is probably due simply to the DNA signal being larger in comparison 
than with ct-DNA. 
The phen and pyr LD r (Figure 2.23(ii) and (iii)) are similar to those of anth 
except for the fact that the 340 - 400 nm negative phen signal is smaller in magnitude 
compared with the MLCT signal than others. 
For the anth, phen and pyr complexes, all transitions which the film LD showed 
to be z-polarised have negative LD" of similar magnitude indicating they are polarised 
approximately perpendicular to the DNA helix axis. Thus these spectra are consistent 
with an intercalative orierftation. For the biphen complex (Figure 2.24), the positive 
MELCT LD and LD'signals mean that the z axis of complex is not parallel to the bases 
(and probably lies along a groove), suggesting that the binding mode is non- 
intercalative for all sequences. 
2.4 Discussion 
Using the polarisations determined for the transitions in the film LD experiments 
it is possible to interpret the absorbance, CD and LD data to give clues as to the binding 
modes of the five complexes on DNA. The clear geometric deductions to be made from 
the spectroscopic data are as follows: 
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(i) All the complexes bind to DNA. 
(ii) Pyr and anth bind in a mode where the pyrene and anthracene tail spectroscopy 
is reduced in magnitude suggesting these groups are in a iz-stacked mode even at 
low metal complex load on the DNA. The same may or may not be true of the 
other tails. 
(iii) Anth, pyr and phen probably adopt the same binding mode that involves isolated 
binding to the DNA until the mixing ratio is -4: 1 DNA base: metal complex for 
pyr and phen and -7: 1 for anth. At higher mixing ratios, a new mode switches 
into play where the metal complexes stack close together but are oriented in the 
same way as in the isolated binding mode. 
(iv) The napth complex exhibits a similar binding mode to anth, pyr and phen at low 
metal complex loading, but a second non-intercalative 7r-7r self-stacking mode is 
favoured from slightly higher metal complex loadings. The orientation of this 
mode is different from the first,. with the z-axis of the complex being closer to 
parallel to the helix axis than parallel to the bases, presumably lying along a 
groove. 
(v) The complexes, except for the biphen complex, all have their z-axis 
approximately parallel to the DNA bases. This is necessary, though not 
sufficient, for intercalation of the tails. The similarity in flow LD shape of each 
of the complexes indicates similar binding modes. 
(vi) The biphen z-polarised transitions are oriented in a manner consistent with the z- 
axis lying more perpendicular than parallel to the bases. This is consistent with a 
groove bound molecule and not intercalation. The orientation with ct-DNA, GC 
and AT is very similar. The biphen long axis transition at 350-400 nrn has no 
induced CD signal with GC whereas this band dominates the AT spectra and to a 
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much lesser extent the ct-DNA spectra. The AT CD signals are opposite from 
those for GC and ct-DNA suggesting its binding mode is different (binding 
mode seems to have more effect on induced CD signs than does sequence). 
However, the LD suggests that the MLCT and terpy parts of the molecule are 
oriented in the same manner on ct-DNA, GC and AT. 
(Vii) At low metal complex load (20: 1), methylene blue experiments (MB) indicate a 
lengthening/stiffening of ct-DNA with each complex. 
The data is consistent with anth, phen, pyr and napth tails all intercalating as 
their most stable (low metal complex load) binding mode: their z-axis is perpendicular 
to the DNA helix, they stiffen the DNA helix, their transitions (where identifiable) are 
red shifted and hypochromic upon DNA binding. At higher metal complex loads, the 
metal complexes n-stack together. This involves terpy-terpy and presumably also tail- 
tail couplings (thus giving rise to the exciton CD signals). Since the orientations of the 
metal complexes in the new mode is the same as in the intercalated mode, we presume 
that the intercalators are being used as the starting point for a crystal structure type 
packing. This leads to the'question of whether there is an extended stack or simply 
dimers. 
The data suggests that napth occupies the two modes of anth, phenan and pyr 
simultaneously even at low metal complex concentrations. The inter-metal complex 
interactions are more prominent at higher metal complex concentrations. 
The biphen complex by way of contrast does not occupy an intercalative binding 
mode at any stage nor does it show evidence of n-Tc self-stacking interactions with ct- 
DNA and GC DNA. The biphen does however exhibit a dominant 7z-n self-stacking 
mode with AT DNA at higher metal complex loads. The crystal structure of biphen is a 
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long stacked polymer that together makes a 'beads on a string' sort of structure. One can 
envisage this gaining a helical twist and fitting snugly up the major groove of the DNA. 
In this case, the z-axis of the metal complex would lie at -4511 to the DNA helix axis. 
The 310 nm terpy groups would also be expected to have a net positive LD (due to the 
factor of two from the rotational average about the DNA helix). There is no evidence for 
GC or ct-DNA facilitating such a structure, as there is no exciton CD signal in these 
cases. AT DNA, however, exhibits a biphen CD signal at 350 nm that increases rapidly 
in accord with ones' expectations for an exciton interaction. Biphen-terpy stacking, if it 
is reasonably cooperative, could be taking place even at quite low metal complex 
loadings. 
The opposite signs for ct-DNA and AT DNA suggest that the twist of the biphen 
groups is opposite in each case. The fact that the AT coupling in largest suggests that it 
is running along the minor groove with one terpy propeller being slotted in and the 
biphen running along the groove. This would stiffen the DNA as with a spine of 
hydration. For GC this mode is not as attractive due to the steric effect of the G amino 
group in the minor groove, so the option for biphen-terpy coupling is lost. The LD and 
CD combined would be comistent with an isolated biphen molecule GC major groove 
binding mode with the z-axis lying Along this groove. 
The data suggests that with biphen, GC and ct-DNA individual molecules bind 
along the groove, probably in the major groove, whereas with AT (where the minor 
groove is less sterically hindered) the molecules are stacked along the groove. 
2.5 Conclusion 
Spectroscopically, all five ruthenium complexes have been shown to interact 
non-covalently with DNA. At low concentrations, three of the complexes, phen, anth 
95 
and pyr intercalate their aryl tail groups between DNA bases. The biphen complex 
predominately exhibits groove binding with no significant aryl tail intercalation. The 
napth complex exhibits intercalation of its aryl tail groups and a non-intercalative mode. 
At high metal concentrations, the complexes exhibit a non-intercalative binding mode, 
i. e. 7r-7r self-stacking interactions on DNA. 
Resonance light scattering (RLS) studies have since been conducted using ct- 
DNA in collaboration with M. Darwish of Dr Alison Rodger's group at the University 
of Warwick. RLS studies can be used to differentiate between extended stacks (long 
range 7r-7c electronic couplings give large signals) or simple monomer/dimer formations 
(small n stacks give small signaIS)65 at higher metal complex concentrations. At low 
complex loads, all five complexes were found to show a small decrease in the light 
scattering compared with ct-DNA free solutions. At higher loads, all complexes show 
some evidence of Tc stacking in solution, though the effect is small. In the case of anth, 
the DNA facilitates a 7E-7c self-stacking of the tail that does not take place in free 
solution. With the other complexes, the DNA if anything reduces the stacking compared 
with free solution. So CD confirms a ir stacking interaction compared with free solution, 
and the RLS studies indicate only short stacks are present. 
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Novel platinum complexes and their 
interactions with DNA 
3.1 Introduction 
Metals and metal complexes have been used in medicines for years in the 
treatment of ailments and diseases. 1,2 Probably one of the best known metal complexes 
to have been used in the treatment against cancer is cisplatin (Figure 3.1). 3-6 The 
discovery of cisplatin and its variety of uses as an anticancer agent have led to an 
increase in interest in platinum coordination chemistry, and generally into interactions 
between metal ions and living matter. 
1-3,7-11 
H3N\ /Cl 
HP / 
Pt 
cl 
Figure 3.1 Cis-diamminedichloroplatinum(li) i. e. cis-Pt(NH3)2CIz more commonly known as cisplatin 
The work described in this chapter relates to novel acylthiourea platinum 
complexes that have been 'developed by Sacht et al. 12 , 13 with a view to their DNA 
binding chemotherapeutic activity. In the introduction this work is put in context by a 
brief historical review of platinum drugs. 
Cisplatin was first sYnthesised in 1845 .3 Its profile however was raised 
unexpectedly in 1964 by Rosenberg. Whilst investigating the effect of electric current 
and electric fields on Escherichia coli (E-coli), Rosenberg found that although cell 
growth was not, cell division of the bacterium was inhibited. It eventually became 
apparent that this effect - the inhibition - was due to the formation of trace amounts 
(-10 ppm) of platinum complexes. 7 Studies of cell division conducted on these 
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complexes, specifically the cis isomers of cisplatin and platinum(IV) tetrachlorodiamine 
Pt(NH3)2CI4 found them to be effective against a number of animal tumours cell lines, 
hence their eventual use in combating cancer in humans. 4 These platinum complexes 
were ultimately found to be very effective against testicular and ovarian cancers, and 
active against a variety of cancers e. g. head, neck and cervical cancers and useful 
against melanomas. 
3-5 
Some metal compounds e. g. those of gold, target proteins, ' however, the target for 
cisplatin is DNA. Cisplatin has the ability to bind to DNA and block DNA replication 
i. e. it inhibits DNA synthesis. Cisplatin, and its analogues such as Pt(en)C12 (en denotes 
ethylenediamine) (Figure 3.2), are more active than their trans counterparts. 8 
H2 
N,, 
Pt ZCI 
N' 'Cl 
H2 
Figure 3.2 Pt(en)C12 exhibits good anticancer activity 
The activation process of cisplatin occurs via stepwise hydrolysis of the chloride 
ligands. The complex can then react in a number of different ways producing platinated 
DNA adducts. Cisplatin can apparently interact monofunctionally (i. e. forming one 
platinum-nucleotide bond), or bifunctionally either intrastrand, interstrand, or even 
intermolecularly with DNA (Figure 3.3). 4,6 There is a strong indication that the various 
species/adducts that can be formed and or possible condensation products display 
differing degrees of toxicity. For example, an aqueous solution of cisplatin becomes 
more toxic on ageing. 3-5 A certain number of these platinated adducts can trigger DNA 
degradation and apoptosis - programmed cell death; these are fundamentally 
responsible for the effectiveness of cisplatin as a drug. 4 
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Pý 
t 
MONOFUNCTIONAL INTRASTRAND 
peý Glutathlone 
Pt 
Protein 
INTERSTRAND INTERMOLECULAR 
Figure 3.3 Structures of the various adducts produced in DNA by cisplatin. Diagram reproduced from reference 4. 
To understand the differences in the biological activity of the different adducts 
formed by cisplatin, the mechanism of action of hydrolysis needs to be understood. 1-5 
The labile chloride ion is not replaced by the water extracellularly, as high chloride 
concentration (104 MM) 3,4 in this region suppresses this action. The chloride 
concentration inside the cell (5 MM)3,4 is, however, much less, therefore exchange of the 
chloride by water does occur intracellularly, and it is this aquated complex that is very 
active. Figure 3.4 shows the mechanism of action. 
NIH131 
G 
5' 3' 
": k cl li-, N,, , 
Cll* G 
H cl cl- H/ 
\OH2 +G 
TG5 
H3 
NH3 
H3 xG 
H3 
Figure 3.4 Mechanism of action of activation of cisplatin. Cisplatin is hydroiysed to give mono aqua and dlaqua 
species which are much more reactive, for example towards substitution by G residues on DNA. Diagram taken from 
reference 1. 
103 
Products such as [Pt(NH3)2(OH2)2]2+ and [Pt(NH3)2(OH)2] are generated. The Pt- 
OH2 bond is very reactive, and is believed to be the active species towards DNA. This 
can interact with the nitrogen atoms, N7 of the guanine bases and to a lesser extent with 
the N atoms of the adenine bases to produce either inter- or intrastrand cis-Pt(NH3)2+ 
35 bridges. The major adduct is formed by covalent intrastrand crosslinkage and occurs 
when the platinum complex uses two of its ligand binding sites to bind adjacent 
guanines on the same strand (intrastrand crosslink) .4 Transplatin, the trans- 
[PtC12(NH3)21 complex cannot produce intrastrand bridging due to steric hinderance, 
hence its inactivity. 2,6,10 
Takahara. and Lippard have deten-nined binding sites of cisplatin using X-ray 
crystallography. Using a double stranded synthetic dodecamer d(CCTCTG*G*TCTCC/ 
14,15 d(GGAGACCAGAGG) they found that the *G bases are platinated at N7 . 
A$B 
4,14.1S 
Figure 3.5 X-ray crystal structure of intrastrand binding interaction on DNA . (A) shows the major groove of normal 
B-DNA and (6) DNA bend caused by cisplatin adduct. (C) shows the minor groove of normal B-DNA and (D) widening 
of minor groove by cisplatin adduct. Diagram taken from reference 4 
Strong bonds are formed with DNA which disrupts base-base stacking interactions 
in the DNA helix and leads to a kink in the DNA. The degree of distortion of DNA 
depends on the sequence (Figure 3.5). 4,14 The separation of strands for replication 
cannot occur. The interaction of cisplatin with DNA interferes with these normal 
processes (i. e. DNA replication) and it is this perturbation of the DNA structure that 
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perhaps lies at the centre of its anticancer activity. In addition for activity, the normal 
cell repair mechanisms need to be confused. 
Proteins known as HMG (high mobility group) proteins exist, whose function is to 
detect/repair or remove DNA which has been kinked or is distorted in any way such as 
G or A platination. 3 '5 However, rather than being repaired by the HMG Proteins, the 
5,16 
cisplatin adducts are wrapped up and protected. These proteins ensure that the DNA 
is not repaired, thus this process leads to apoptosis. Apoptosis can be defined as a 
consequence of the mechanism of action of cisplatin and a failure of the mechanisms of 
cell resistance to foreign drugs. 3,4 
Although cisplatin exhibits activity against a number of tumour cell lines, it is also 
toxic towards some normal cells. It also has a limited spectrum of activity in that it is 
not active enough against several types of cancer, this and the unfortunate development 
of resistance towards it after continued treatment has led to further research being 
carried out. Perhaps its biggest problem is that the drug delivery is very inefficient as it 
can bind to biological molecules other than DNA e. g. proteins. 17 A wide range of 
analogues have been developed, some of which are illustrated in Figure 3.6. 
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Figure 3.6 (a) carboplatin, (b) 2-picoline and (c) 3-picoline 
The key structural features of effective cytostatic platinum drugs were found to 
be: 3 the complex must have a square planar disposition of the four ligands around 
platinum(H) with two cis-primary or secondary amine ligands and two (relatively easily 
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hydrolysed) chloride or carboxylate groups and good water solubility. 3 These criteria 
have been used as a guideline for further research on structurally similar first generation 
'classical' compounds. 
Hundreds of compounds have been tested for antiturnour activity, eventually the 
lack of progress in overcoming any acquired resistance to cisplatin combined with the 
ever present need to increase the spectrum of activity of these platinum complexes 
towards a wider range of types of cancer, and the continuous emphasis on reducing the 
toxicity of platinum anticancer agents towards normal cells led to second generation 
compounds such as carboplatin (Figure 3.6(a)) being developed. Carboplatin is less 
toxic than cisplatin and is active against cisplatin resistant turnours, more or less the 
required characteristics of a new anticancer agent. Carboplatin's activity towards 
cisplatin resistant tumours could be related to the differences in their DNA binding 
characteristics since carboplatin binds preferentially in an interstrand crosslinking 
manner and does not bend DNA. Other compounds currently being investigated include 
2-picoline and 3-picoline (Figure 3.6 (b) and (c)). 
2-picoline platinum has been found to be active against cisplatin resistant tumour 
strains. The cellular half-life of cisplatin is - two hours whereas the picoline analogues 
last longer (2-picoline - ten hours, 3-picoline ?: two hours). 2-picoline is less reactive 
than cisplatin, as it is sterically hindered by the 2-methyl group which lies over the top 
of the platinum centred square plane, 18 hence the hydrolysis rate is two to three times 
slower than cisplatin resulting in the linkage in cells and binding to plasma proteins to 
proceed more slowly, I so more survives to reach the ultimate target: DNA, though its 
DNA binding reactivity is similarly reduced. 18 
Research is now extending from 'classical' to 'non-classical' platinum complexes 
with structurally unique features that apparently contravene the structure-relationship 
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rules originally set up. 3,19 For cis-platin activity, Farrell et al. 20 have provided the first 
examples of cationic anticancer species containing sulphur leaving ligands. The general 
formula is [PtCl(RR-SO)(diamine)]NO3 where diamine denotes a bidentate amine 
such as 1,2-diaminocyclohexane (dach) and RR-SO denotes substituted sulfoxides 
such as dimethyl (Me2SO) and methyl phenyl (MePhSO) (Figure 3.7). 
0 
Hr\ CH, 
Pt CH,, 
\Cl 
meso MePhSo 
Figure 3.7 Structure of [PtCI(R'R" SO)(dach)]* where dach is 1,2-diaminocyclohexane and e. g. R'R"SO = Me2SO or 
MePhSO. Structures taken from reference 20. 
These complexes have shown enhanced cytotoxicity in cisplatin resistant cell 
lines. The complexes act by binding covalently to DNA through the displacement and 
hydrolysis of the chloride ion followed by the subsequent loss of a sulfoxide ligand to 
complete the intrastrand link. 
20,21 
3.2 The complexes of this study 
Novel platinum complexes (non-classical in design) containing acylthiourea 
ligand systems have been prepared by Sacht et al. 13 Their potential use as 
chernotheraputic agents are the focus of this chapter. 12,13 These acylthiourea ligand 
systems are extremely versatile in that small structural changes can be easily made that 
can lead to very different chemical and physical properties. Sacht has suggested that, by 
specifically changing the ligand structure, the biological activity of this novel series of 
complexes could be systematically modified to provide optimum antitumour response. 13 
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The work in this chapter describes an investigation into the binding interaction 
of a series of these novel platinum(H) complexes with ct-DNA, AT and GC DNA. A 
preliminary screen of a series of eighteen platinum complexes with ct-DNA by UV- 
Visible absorbance and CD is followed by an in depth spectroscopic study on six 
complexes, structurally similar but with subtle ligand variations, with 5'- nucleotides, ct- 
DNA, AT and GC DNA. To provide a more comprehensive picture of any structure- 
activity relationship, a brief mass spectrometric study on three complexes of one . 
particular subset with 9-methyl guanine (MG) and 5'-guanosine monophosphate (GMP) 
is also presented. 
3.2.1 Platinum(II) complexes 
Eighteen novel non-classical platinum complexes 12,13 were investigated with a 
view to their potential long-term use as anticancer agents. The general formula of these 
square planar platinum(H) complexes is [Pt(L)CI(DMSO)l where L refers to an 
acylthiourea ligand system R'C(O)NHC(S)NR2, R'= aryl and R= amine, (0) and (S) 
denote points of attachment of the ligand to platinum(H), and DMSO denotes 
dimethylsulfoxide or a derivative of it. Figure 3.8 shows the general structure of the 
complexes. 
1NY 
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Figure 3.8 General structure of (PtX) 
In the context of this thesis, each platinum complex is denoted (PtX) where X= 
I- 18. Their structures are shown in Figure 3.9. The purity of these complexes has been 
confirmed using NTvM and CHN analysis. ' 2,13 
108 
1 CH. CH 
3 
J: 
D 
N N, 
R! 
Ay 
CH2 CH3 y 
0%, 
Pt Zs 
Clz Z 
CH3 
0 CH 3 
N., N 
R'/o 
0\ 
'es 
cl 
t 11-1 s , 
CH3 
11 -CH 3 
0 
1 
CH 2CH2OH 
CH2CH2OH 
N 
0s 
_CH 3 ci s' CH3 
, CH 2 CH 3 N N, 
O-YAY 
CH. CH 
3 
0/s 
Pt 
0s 
-ICH2C'-ý 
>1-" 
1 CH2CH3 
R! =H (Pti) 
R! = N02 (Pt4) 
W=0C H3 08) 
R! H (M) 
W N02 (Pt5) 
R! OCH3 (Pt7) 
R! H (M) 
W N02 (PtB) 
R! OCH3 (Pt9) 
(Ptl 0) 
Figure 3.9 Structures of platinum(fl) complexes (PtIl - RIB). (PtI 1- 13) are chiral complexes, (PtI 1) is the (-) isomer, 
no (+) isomer was provided. (Pt12)/(PH3) are the (+/-) isomers respectively, ýýt: 14 - PtI8) are intercalators. (PtI4), 
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(Ptl - Pt9) are similar in structure in that each complex contains a chloride and a 
DMSO group cis to one another other and only differ in substituents attached to the 
basic acylthiourea ligand. The variations of the amine attached to the thiocarbonyl 
functionality (R), are diethylamine (CH2CH3)2; diethanolamine (CH2CH20H)2; or 
morpholine (N(CH2CH2)20). The substituents on the aryl ring (R) are denoted H for 
hydrogen (Ptl - Pt3); N02 for nitro (Pt4 - Pt6); and CH30- for methoxy (Pt7 - Pt9). 
The two latter substituents have electron withdrawing or electron donating properties 
respectively. The (PtX) complexes are grouped in subsets according to the electron 
withdrawing or electron donating substituents on the aryl moiety. 
(PtIO - Ptl8) differ slightly in substituent structure as can be seen in Figure 3.9 
(PtI I- Pt13) are chiral, and (Pt14 - Pt18) have been shown to unwind supercoiled 
DNA and so are thought to be DNA unwinders. 1 2,13 Sacht et al. have reported that (Pt4), 
(Pt5), (M) and (Pt14) exhibit biologically activity against HeLa and MCF-7 cell 
lines. 13 
Of the eighteen complexes, (PtIO) is significant as it contains only the 
acylthiourea ligand system (L) (Figure 3.10), that is common to all the (PtX) complexes. 
(PtIO) can therefore be used as a model compound to see how the bulky acylthiourea 
ligand (L) itself can interact with DNA and act as a standard for comparison with other 
complexes of similar basic structure. 
I/R 
N 
Figure 3.10 The structure of the basic acylthiourea ligand system R'C(O)NHC(S)NR2, denoted L where R' = H, N02, 
OMe and R= diethylamine, morpholine, diethanolamine 
III 
Variation of the substituent (nitro or methoxy group) on the aryl moiety has been 
found to influence the electronic properties of the molecule. 13 Sacht et al. noted the 
sensitivity of the 195pt NMR signal to changes in the aryl substituent, with N02 causing 
a downfield shift relative to H, Cl or OCH3. The chloro-platinum ligand (Pt-Cl) bond 
(which is cis rather than trans to the aryl group) has the rate of substitution as a function 
of the aryl susbstituent being N02 > Cl > OCH3 =H ;z CH3 in accord with the 19'Pt 
NMR, though it is not obvious this effect is a through bond one. 13 Interestingly, Sacht 
and Datt found no evidence of DMSO substitution. 
3.2.2 (PtX) spectroscopy 
There is no spectroscopic literature for these novel complexes. The basic expected 
MLCT transitions for the (PtX) complexes are (i) the Pt-acylthiourea Hgand system 
(made up of the Pt-benzoyl and Pt-thiocarbonyl amine portions of the ligand) denoted 
Pt-L, (ii) Pt-Cl band or (iii) Pt-DMSO bands. In a water: methanol n-ýx, the methoxy and 
nitro substituted aryl rings are expected to exhibit transitions at 217 nm and 269 nm 
respectively. 22 These data'suggest that these substituted aryl rings do not effect 
transitions outside the DNA region of the spectrum. 
The lability of substituents on square planar platinum complexes have been 
extensively explored in terms of their DNA binding interactions, with for example, 
cisplatin and [Pt(terpy)Xl' complexes where terpy is 2,2': 6', 2"-terpyridine and X= 
20,23-29 
chloride (CI), hydroxy (OH), or methoxy (OMe). In the majority of the cases, 
these groups have been found to undergo partial solvolysis in water (e. g. Cl to OH or 
OH2 and OMe to OH etc. ) and in organic solvents. 26.27 For example, the platinum terpy 
complex, [Pt(terpy)OHI+ has been found to be stable in aqueous solution for a number 
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of days but only exhibits limited stability in MeCN or DMSO for a few hours, after 
which a decrease in the long wavelength CT absorption band of the original complex is 
seen. It was suggested that this was due to the loss of the hydroxide ligand. 26 The 
spectra of the [Pt(terpy)0111' complex in the different solvents are similar, but in the 
300 -3 10 nm region the complex exhibits a larger shoulder in DMSO, a distinct band is 
seen in MeCN and a much smaller absorbance shoulder is seen in aqueous solution. 26,27 
On interaction with random sequence DNA, after a few hours the [Pt(terpy)DH]' 
spectrum was found to show a decrease in in-ligand (EL) absorbance. at 332 nm (this was 
attributed to the loss of the OH bond), a corresponding increase in absorbance at 360 nm 
and a bathochromic shift of the centre of the charge transfer (CT) band from - 385 nm 
to 410 nm (atuibuted to the subsequent covalent binding of the complex to DNA). 26 
Thus, the data suggests that the terpy Pt-OH band in aqueous solution exhibits transtion 
bands at - 332 nm. 
26 
In general, charge transfer bands in the 300 - 350 nm region have been found to 
depend on the identity of the ligand, Pt-L in [Pt(terpy)L]n+. 28 Using the literature on 
similarly assigned terpy Pt -Cl or OH, OMe transitions in aqueous and organic media 
23 
-29 the expected wavelengtfi assignments are surnmarised in Table 3.1. 
Table 3.1 Summary of absorption literature assignments on selected platinum terpy complex transitions 
Transition Wavelength assignments / nm 
terpy pt - ci 23,2/, 28 (300 - 350); '8 (328); 23 (303,317,330,347); 
*27 (327,343)25, (342) 29 ; (306, 
318,334,350)24'l 
terpy pt _ 0H26,27 (332) ; 
26 (308,325,339) *27 
terpy Pt - OCH3 (310,327,339) *27 
*= in MeCN #=5: 5: 1 ethanol: methanol: DMF mix 
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3.2.3 Materials and Methods 
(Ptx) complexes 
The synthesis and characterisation of the (PtX) complexes have been published 
by Sacht et al. 12,13 The (PtX) complexes have been provided by C. Sacht and confirmed 
to be pure by CHN analysis. 
Polynucleotide samples 
Duplex ct-DNA, sodium salt, 'highly polymerised' Type I was purchased from 
Sigma, synthetic DNAs, poly[d(A-T)12 and poly[d(G-C])2 (AT and GC DNA 
respectively) for in vitro use were obtained from Pharmacia Biotech. DNA 
concentrations were determined spectroscopically using F254 = 8400 mol-' dM3CM-1 for 
poly[d(G-C)12,6262 = 6600 mol-1 dM3CM-1 for poly[d(A-T)12 and P-258 = 6600 mol-1 
dm 3 cm71 for ct-DNA. 9-methylguanine (MG) and the di-sodiurn salts of the 5'- 
monophosphates were purchased from Sigma and Aldrich and used without further 
purification. 
For the reasons discussed in Section 1.7, ct-DNA was initially dissolved in 
water, rather than a buffer. Its double stranded behaviour in all solvent systems used 
was verified by performing melting curves and basic spectroscopic studies. Sodium 
chloride salt and a constant concentration of sodium cacodylate buffer (I mM) were 
used to maintain AT and GC DNA structure. AT DNA was used with a minimum of 30 
mM NaCl, 1 mM sodium cacodylate buffer, pH 6.92, GC-DNA was used with a 
minimum of 10 mM NaCl, 1 mM sodium cacodylate buffer, pH 6.92. These 
concentrations were shown to be sufficient to retain their duplex structures. The 
minimum salt concentration required to ensure AT and GC DNA duplex formation was 
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also dependent on the percentage organic solvent present. Therefore, for AT DNA, 30 
mM NaCl was required for !ý 40% MeCN and 40 mM NaCl was required at > 40% 
MeCN. For GC DNA, 10 mM NaCl was required for < 40% MeCN and 20 mM NaCl 
was required for ýý 40% MeCN. 
Other Materials 
Polyvinyl alcohol (PVA) (Type III low molecular weight (hot water soluble)) 
was purchased from Sigma Chemical Co. to make the film for film LD. BPLC grade 
solvents acetonitrile, DMSO and DW were used initially to dissolve the compounds, 
followed by addition of high purity water 18.2 M12. 
Instrumentation and Methods 
The spectroscopic techniques used to determine whether interactions are taking 
place in these (PtX): DNA systems were: LTV-Visible absorbance spectroscopy, circular 
dichroism (CD), flow linear dichroism (LD) and fi1M LD. These techniques are 
discussed in some detail in Chapter 1. UV-Visible absorbance spectra were run on either 
a Jasco V-550 or Cary IE spectrometer, the CD and LD spectra were run on a Jasco J- 
715 spectropolarimeter. CD and UV-Visible absorbance spectroscopy was performed in 
aI cm pathlength quartz cuvette. Flow LD measurements were made using a1 mm, 
pathlength quartz couette flow cell . 
30 For film LD, both absorbance and film LD 
measurements were taken both before and after stretching to x2 film length (using a 
mechanically stretching device and heat) on the Jasco V-550 and Jasco J-715 
spectropolarimeter respectively. 
Fresh samples of (PtX) complexes were prepared and used immediately unless 
otherwise stated. Titrations were set up where the DNA concentration was kept 
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constant as the (PtX) concentration was varied. Mixing ratios, R, are stated in order 
DNA base: (PtX). 
3.3 Results 
3.3.1 Preliminary spectroscopic study of the eighteen complexes 
The platinum complexes exhibit poor water solubility, so the solutions were made 
as follows: the addition of a minimum amount of organic solvent required to dissolve 
the platinum complex followed by water, buffer, then DNA solution. Order and speed of 
addition was found to be important. Acetonitrile (MeCN) was the organic solvent of 
choice as it gives a nice spectroscopic window and allowed for sample recovery, 
however, not all the platinum complexes dissolved in it. DNW and DMSO were used in 
some cases. Although it was very difficult to achieve, in general, the platinum 
complexes (PtX) stayed in solution upon the addition of water and DNA. The 
percentage (%) organic solvent used is stated on the spectra. 
All compounds were initially dissolved in the minimum amount of acetonitiile, if 
this was not successful then DMIF or DMSO, or even a mix of DNM and DMSO was 
used. Structures of all the complexes are given in Figure 3.9. 
In order to determine whether there was any interactions with ct-DNA, 
preliminary UV-Visible absorbance and CD studies were conducted on (Ptl) - (Ptl8) 
using (PtX) solution concentrations of between 20 - 60 ýM (PtX) complex and a 
constant 125 [tM ct-DNA solution to give an approximate ct-DNA: (PtX) mixing ratio of 
between 6: 1 and 2: 1. 
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Preliminary absorbance studies 
The platinum complexes examined are yellow in solution and exhibit transitions 
in both the UV and visible region of the spectra. If there is an interaction of some sort 
between (PtX) and ct-DNA a change in the absorbance signal should develop. With 
absorbance spectroscopy a difference between the (PtX)-DNA solution and the sum of 
(PtX) and DNA spectra indicates an interaction. In this case it may be difficult to 
distinguish between the induced signal and the sum of the two spectra as they may 
overlap or appear in the same region of the spectra and the change may be small. 
In these preliminary studies, the addition of ct-DNA to a known concentration of 
(PtX) results in a slight dilution of (PtX) concentration, which has not been 
compensated for. Any induced interactions will therefore be more distinguishable in the 
CD spectra. The effect on the (PtX) absorbance spectroscopy when ct-DNA is added is 
illustrated for each of the eighteen (PtX) complexes in Figure 3.11. The spectra of 
(Ptl3), (Ptl4) in DMF and (Ptl7) in DMSO denoted (Ptl3ii), (Ptl4ii) and (Ptl7ii) 
respectively are also included. The (PtX) complex concentrations used are stated in the 
Figure 3.11 caption and the % organic solvent used to dissolve the (PtX) complexes is 
stated on each spectrum. Spectral recordings were taken immediately upon dissolution 
of the (PtX) complex in solvent and'On mixing with DNA. 
Where the mixture signal exceeds the (PtX) signal above 300 nm, we know there 
is an interaction (any dilution effect would cause a decrease). Further if there is an 
obvious change in the shape of the spectrum it is clear there is an interaction. 
On addition of DNA, (Pt10), the complex with the two bulky acylthiourea ligands, 
L, shows no change in absorbance (except the small dilution effect). The chiral 
complexes (PtIl. - Ptl3) and (Pt5) show small changes in absorbance. All the other 
complexes do exhibit a slight change in shape and intensity. 
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Figure 3.11 UV-Visible absorbance spectra of the eighteen (PtX) complexes (i) alone and (ii) with ct-DNA (125 gM). The 
(PtX) concentrations are listed below. The spectra of (Pt13), (Pt14) in DMF and (Pt17) in DMSO denoted (Ptl3ii), 
(Ptl4ii) and (Ptl7ii) respectively are also included. The % organic solvent used to dissolve the (PtX) complexes is stated 
on each spectrum. The spectrum of ct-DNA alone in solution (125 [LM) has been included for reference. 
(PtX) complex concentrations used: (PtI) 33 gM; (Pt2) 51 gM; (Pt3) 50 gM: (Pt4) 30 pM; (Pt5) 36 gM; (M) 50 IM; (Pt7) 
57 pM; (P18) 61 pM; (1319) 50 pM; (Pt1O) 40 pM; (PtI 1) 31 pM; (Pt12) 51 gM; (PtI3) 33 gM; (Ptl3ii) 32 IM; (Pt14) 38 gM 
(Ptl Q) 32 ýN; (Ptl 5) 40 jiM; (Ptl 6) 30 pM; (PtI 7) 18 gM; (Ptl 7ii) 25 gM; (Ptl 8) 34 pM. 
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On addition of ct-DNA, (PtI) and (Pt4) show a small increase in absorbance 
intensity (hyperchromic effect) in 300 nm - 350 nm region, but no significant 
wavelength shift. (Pt2 - Pt3) and (Pt5 - Pt9) all show a decrease in absorbance 
intensity (hypochromic effect) between 300 - 350 nm, more significant than that due to 
the dilution effect. The potential intercalators (Pt14 - Pt18) also show a decrease in their 
transition intensities above 300 nm on addition of DNA, but all the spectra show no 
wavelength shift. Attempts to use DW and DMSO as alternative solvents were not 
encouraging. (Pt17) almost certainly does not bind to DNA when dissolved in DMSO. 
The spectra of (Ptl3) and (Pt14) when dissolved in DNW are so different from that in 
MeCN to suggest a different chemical species. These experiments were therefore not 
pursued. 
Preliminary CD studies 
CD was expected to be a better tool than absorbance for probing any interactions, 
as the isolated achiral platinum complexes (PtX) do not have a CD signal and ct-DNA 
only exhibits transitions- below 300 nm. Thus the interaction of an individual (PtX) 
complex with ct-DNA would be clearly shown by an ICD signal above 300 nm. In the 
case of the chiral compounds (Ptl 1) - (Pt13), the intrinsic (PtX) spectroscopy must be 
subtracted to give the induced CD (ICD) signal due to the interaction. The effect on the 
(PtX) CD spectroscopy when DNA is added is illustrated for each complex in Figure 
3.12. The (PtX) complex concentrations used are stated in the Figure 3.12 caption and 
the % organic solvent used to dissolve the (PtX) complexes is stated on each spectrum. 
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Figure 3.12 CD spectra of the eighteen (PtX) complexes (i) alone and (ii) with ct-DNA (125 [U). The (PtX) 
concentrations are listed below. The spectra of (Ptl 3), (Pit 4) in DMF and (Ptl 7) in DMSO denoted (Ptl 35), (Ptl 4ii) and 
(Ptl 7ii) respectively are also included. In the case of the chiral compounds (Pit 1) - (Ptl 3), the chiral (M) complex CD 
and DNA CD has been subtracted from the DNA + complex spectrum to give the 1CD signal that has been plotted. The 
% organic solvent used to dissolve the (PtX) complexes is stated on each spectrum. The spectrum of ct-DNA alone in 
solution (125 gM) has been included for reference. 
(PtX) complex concentrations used: (Ptl) 33 [LM; (Pt2) 51 jtM; (M) 50 pM: (Pt4) 30 IM; (Pt5) 36 gM; (Pt6) 50 VIVI; (Pt7) 
57 VM; (PtB) 61 pM; (Pt9) 50 pM; (POO) 40 pM; (Ptl 1) 31 pM; (Pt12) 51 pM; (Pt13) 33 pM; (Ptl3ii) 32 gM; (Pt14) 38 pM 
(Pit 4ii) 32 pM; (Ptl 5) 40 gM; (Ptl 6) 30 pM; (Pill 7) 18 pM; (Pit 7ii) 25 pM; (Ptl 8) 34 ItM. 
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In summary, all the CD spectra of the DNA-(PtX) complexes except (PtlO) 
(and the DMSO spectrum of (Pt17)) show the (PtX) complexes interact with ct-DNA 
(see Figure 3.12). The developments of induced CDs (ICDs) at wavelengths/energies 
that correspond to platinum complex transitions (above 300 nm) confirm an interaction 
between the platinum complexes and DNA. 
(Ptl - PIO), (Ptl4 - Ptl8) are achiral and therefore exhibit no intrinsic CD 
signal. Addition of ct-DNA to (Ptl- Pt9), (Pt14 - Pt18) induces chirality into the 
achiral (PtX) complexes. These (PtX) complexes may therefore be concluded to interact 
with DNA. 
(Ptl- Pt3), (Pt7 - Pt9) (sets of complexes diffeiing by addition of a methoxy 
group to the phenyl group) exhibit two similar ICD signals of varying magnitude above 
300 nm (outside the DNA region): the first a positive shoulder (which becomes a more 
pronounced band for the methoxy groups) decreasing in magnitude from 300 nm to 
-340 nm and a small negative signal centred at - 375 nm. 
In contrast, complexes (Pt4 - Pt6) do not exhibit much CD intensity at 300 nm, 
rather a positive CD band centred at -325 nm, is observed with an even smaller 
negative CD transition barid of varying magnitude centred at 375 nm. These data 
immediately suggest that (Ptl - Pt3) and (Pt7 - Pt9) have similar binding interactions 
whereas (Pt6 - Pt9) are similar to each other and somewhat different from the other sets. 
In the case of the chiral compounds (Pt II- Ptl 3), the chiral (PtX) complex CD 
and DNA CD has been subtracted from the DNA + complex spectrum to give the ICD 
signal that has been plotted. (Ptl 1) shows a small clear negative ICD signal below 300 
nm, a positive ICD at 325 nm and a very small negative ICD at 375 nm were observed. 
The DNA region change may be due to a change in the DNA spectroscopy or (Ptl 1) 
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spectroscopy or both. (Ptl2) shows an ICD signal below 300 nm, and a very small 
shoulder above 300 nm. 
(Pt13) gave solubility problems in each of the organic solvents (MeCN, DNIF 
and DMSO). The spectrum of (Ptl3) in 33 % MeCN shows a minute positive ICD 
signal below 300 nm indicating a small (PtX): DNA interaction, the same complex in 
6% DMF (denoted (Ptl3ii)) shows a small positive ICD below 300 nm as well as a very 
small positive ICD at 325 mn. The ICD of (Pt13) is different in signal size from the 
ICDs of (Pt 11) and (Pt 12) in MeCN. 
Of the hexafluorophosphate salt intercalator complexes, (Pt15 -16) were found 
to dissolve well in MeCN (very low % MeCN necessary). The remaining intercalators, 
in particular (Pt14) and (PtI8), exhibited poor acetonitrile solubility with high % MeCN 
required, as well as poor water solubility as shown by the large decrease in their 
absorbance signals. (Pt14 - Ptl7) exhibit similar negative signals in CD with a negative 
shoulder extending from 300 - 440 nm, (Ptl8) only exhibits a small band at 300 - 350 
nm. The intercalators exhibit large changes in their DNA signature, in order of 
decreasing magnitude (Pt15) > (Ptl6) > (Ptl4) > (Pt17) > (Ptl8), the latter showing 
only a small decrease in DNA signal. It should be noted that the long wavelength flat 
region of the spectra show that this is not due to scattering by undissolved compounds. 
Interestingly, the spectrum of (Ptl4) in DMF i. e. (Ptl4ii) shows a much smaller 
negative ICD interactions between 300 - 400nm and no real deviation in the DNA 
chiral signature compared to its MeCN equivalent (see spectra (Pt14)); similarly the 
spectral interactions of (Pt17) in DMSO i. e. (Ptl7ii) show no interaction above 300 nm 
in the (PtX) region, compared to its MeCN equivalent spectrum (Pt17). This suggests 
that the choice of solvent plays a key role in any interaction of (PtX) with DNA, perhaps 
by changing the identity of the compound as discussed above. 
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(Ptlo) 
Upon addition of ct-DNA to an acetonitrilic solution of (Pt1O), the 
absorbance spectrum shows no change in the DNA CD signal or ICD signal. Figure 
3.13 shows the absorbance spectra of (PtlO) on addition of DNA (data taken from 
Figure 3.11). Figure 3.13 includes the expected theoretical spectrum on addition of ct- 
DNA to (PtIO) (it has been modified to account for the dilution effect on the (PtIO) 
solution upon DNA addition). 
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Figure 3.13 UV-Visible spectrum of (PtIO) with ct-DNA (the data has been modified to account for the dilution effect on 
(PtIO) (-40 pM) on addition of the ct-DNA (125, uM) in a 3.1: 1 DNA base: (PtIO) ratio 
No significant wavelength shift, hypo- or hyperchromic effect is seen, 
importantly, the CD spectrum shows no interaction between (PtIO) and ct-DNA - the 
ct-DNA: (PtlO) spectrum is indistinguishable from that of ct-DNA alone. A further 
absorbance and CD titration of (PtIO) with a constant DNA concentration was 
undertaken over a range of mixing ratios, this also showed no interaction. Thus it can be 
concluded that (PtIO) does not interact with DNA. Flow oriented studies were therefore 
not pursued. 
It is almost certainly the presence of two bulky acylthiourea ligands that is 
responsible for this lack of interaction with DNA. The other complexes only have one 
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acylthiourea ligand system. The (PtIO) results lead us to conclude that it is the less 
bulky side of the other complexes that interacts with DNA. Our investigations show that 
the basic acylthiourea ligand (L) system (specifically for (PtIO), the diethylamine 
system) has no interaction with DNA. This implies that the chloride and the DMSO 
groups (present on the majority of the other (PtX) complexes (Figure 3.9) investigated 
must play a pivotal role in any DNA interaction of this group of novel (PtX) complexes. 
This (PtlO) complex system can therefore be used as a standard for comparison with 
other complexes of similar basic structure. 
The data provided by this preliminary study enabled the selection of a set of six 
complexes for closer analysis in this thesis. (Pt4 - Pt9) were chosen in part due to their 
clear large spectroscopic interactions on interaction with DNA, reasonable solubility in 
MeCN: water mixtures and ability to remain in solution on subsequent adoitions. (Pt4), 
(Pt5) and (M) are similar in structure, each has a nitro (NOD substituent and differ only 
in the amine groups attached to the thiocarbonyl functionality, however Sacht et al. 
have suggested that of these only (Pt4) and (M) are biologically active, ' 3 whereas (M) 
is not. (Pt4), (Pt5) and (M) (forming a subset denoted 'nitro') were therefore ideal to 
study in much greater detail. 
The remaining three complekes (M), (Pt9) and (M), of which Sacht et A 
suggest (M) is biologically active, 13 have a methoxy (OCH3) substituent in common, 
and again differ only in their amine groups and similarly to those of the 'nitro' subset 
(Pt4 - M), make up a subset is denoted 'methoxy'. The main difference between the 
'nitro' and 'methoxy' subsets is the nitro-electron withdrawing and the methoxy- 
electron donating groups respectively as well as different sizes and shapes. In terms of 
the electronic properties of the (PtX) complexes, these substituents may be important 
and affect DMSO or chloride group lability as well as steric aspects. 
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As the subsets differ in the group (methoxy- or nitro-) attached to the aryl ring, a 
direct comparison of the effect of these groups on interaction of (PtX) with DNA can be 
made. (Pt4) and (M); (M) and (Pt7); and (M) and (M) contain the same amine 
group i. e. each (PtX) complex within one subset has an amine equivalent (PtX) complex 
(denoted diethylarnine, morpholine and diethanolarnine) in the second subset. The effect 
of the variation of the amine ligands can be examined and compared between (inter) 
subsets as well as within (intra) each subset. 
(Ptl5), an intercalating complex, does not contain the DMSO and CI ligands but 
has the most similar structure to those being studied. It was therefore also investigated 
in order to provide a spectroscopic comparison to (Pt4 - Pt9). 
There was not enough material to initiate a thorough investigation into chiral 
(PtI 1) and (Pt12); chiral (Pt13) had solubility problems. The intercalators (Pt14), (Pt17) 
and (Pt18) were not investigated because of their solubility issues. (Pt16) was excluded 
as it is structurally different from the subsets chosen but would be an ideal choice for a 
new study. 4,20 The hydrogen subset complexes (Ptl-Pt3) were not investigated since 
they showed similar spectroscopy in the preliminary studies to the methoxy subset of 
complexes. 
3.3.2 (PtX) transition polarisation deter"nation 
In order to understand the effect DNA has on the spectroscopy of these platinum 
complexes, the assignments including transition polarisations need to be considered. 
Figure 3.14 shows the molecular axis system for the (PtX) complexes. 
127 
short aAs / x, y 
R 
long aAs /z 
where R'= H, NO, OMe 
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Figure 3.14 General structure and molecular axis system for the platinum complexes (PtX). The complex long and 
short axes and x, y and z axes are indicated in the figure. 
When a molecule is absorbed into a stretched film, it is assumed that the long axis 
of the molecule will orient along the direction of orientation (stretch) (long axis) whilst 
the short axis would resist the stretch and lie at right angles to the stretch direction. We 
define the z axis of the molecule to lie along its long axis, and the x/y axis along the 
short axis. From Figure 3.14, one can deduce likely MELCT transition polarisations. 
MLCT bands into the sulfoxide n-systern will be short axis polarised for example. 
However, given the overlap of different bands it was important for the flow LD 
experiments to have good psignments of dominant transitions. Table 3.2 contains a 
summary of the expected MLCT trapsitions. 
Table 3.2 Summary of expected MLCT transitions 
Short axis (x1y) long axis (z) 
Pt-Cl, Pt-DMSO Pt-DMSO 
Pt-L (Pt-thiocarbonyl amine) Pt-L (Pt-benzoyl) 
The use of organic solvents in the preparation of films for LD is not straight 
forward and is covered briefly in Section 1.7. (Pt4) was used as a model compound for 
the whole series since the basic platinum chromophore is the same for all complexes 
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(i. e. all (PtX) complexes will exhibit similar transition polarisations). The film 
absorbance (A) and film LD of (Pt4) were measured and film LD' (i. e. LD divided by A) 
calculated and plotted to enable transition polarisation moments to be qualitatively 
assigned. Section 2.2.2.1 provides an explanation for film LD. Figure 3.15 shows the 
film absorbance (A), film LD and LD' spectra of (Pt4) using MeCN as its solvent. 
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Figure 3.15 Film absorbance, LD and LDr of (Pt4) oriented in PVA film. The noise (due to a hardware problem on the 
V-550) in the absorbance spectrum is translated into the calculated LYspectrum. 
The film absorbance spectrum of (Pt4) consists of a large broad sloping band 
extending from the far UV to the visible region of the spectrum (200 nm - 550 nm). The 
long wavelength part of this is much larger than that seen for the absorbance spectra of 
Figure 3.11 is due to scattering. The LD' spectrum consists of a positive LDmaxima 
centred at 250 nm and positive LD' signals above 400 nm in the MELCT region 
(suggesting predominately z-polarised transitions) with negative LD* maxima bands at 
210 nm, 290 (with a less negative signal at 310 nm) and -330 - 340 nm and a sloping 
LD" signal from 350 - 400 nm. 
We assume that most positive LD'belongs to a long axis (z) polarised transition 
and any negative (or positive minima at places of large absorbance intensity) correspond 
to short axis (x/y) polarised transitions. The negative maxima at 210 nm, - 290 nm, and 
-330 - 340 nm may therefore be assigned as short axis polarised transitions. The 
positive bands at 250 nm, and less negative signal at 310 nm and transitions above 400 
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nm are assigned to long axis polarised transitions. The sloping LD* signal from 
negative to positive 350 - 400 nm is assumed to be due to an overlap of short and long 
axis polarised transitions. 
The transitions above 300 nm can be due to MLCT or in-ligand (IL) transition 
bands of either (i) the Pt-acythiourea ligand system (L) (made up of the Pt-benzoyl 
and Pt-thiocarbonyl amine), (ii) Pt-Cl band, or (iii) Pt-DMSO bands. In order to 
help with transition assignments, we look at the. absorbance spectrum of (Pt1O) (Figure 
3.13). This complex is composed of two acythioureau ligand systems, and contains no 
chloride or DMSO groups unlike other complexes (Ptl - Pt9). Its absorbance spectrum 
shows a larger absorbance band between 350 - 400 nm compared to other complex 
spectra. We therefore conclude that the 350 - 400 nm. wavelength region is mainly 
composed of Pt-acylthiourea ligand (Pt-L) MLCT transitions. This same region in the 
film LD consisted of a sloping LD* signal from negative to positive indicative of an 
overlap of short and long axis transitions. 
The absorption band between 300 - 350 nm is not as significant for (PtlO) as for 
the other complexes, therefore is assumed to predominately be pt_C128 and Pt-DMSO 
transitions probably also with some underlying Pt-L transitions. This assumption 
correlates with the film LD finding of two short axis assigned transition bands at - 290 
nm and at -330 nm. Using a number of assumptions and the literature on sin-fflarly 
assigned Pt-Cl or OH, OMe transitions (from Table 3.1), 23-29 the following transition 
assignments have been made and are surnmarised in Table 3.3. 
Table 3.3 Summary of MLOT transitions of (PtX) compfoxes using Table 3.1 
Transition short axis (x, y)/nm long axis (z)/nm 
Pt -L 
22.2d 210 (s), 300 - 400 (s) 250 (1), 350 - 400 (mix), > 400 (1) 
pt - c123,25,27-29 330-340(s) 
Pt - DMSO? 
6,27 290(s) - 31 O(s) (mix) 
(s) = short axis, (1) = long axis 
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3.3.3 Stability studies 
3-5 The binding interactions of cisplatin are known to change over time. Studies 
were undertaken in order to determine whether, like cisplatin the binding interactions of 
the (PtX) complexes change over time. Comparison of spectra of similar experiments 
using the same sample freshly prepared (day 1) then on day 3, day 14 or day 28 were 
found to show (slow) kinetic effects. 
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Figure 3.16 (i) LD spectrum of (Pt5)-ct-DNA interactions using a 14 day old solution, (ij) CD spectrum of (Pt6)-ct-DNA 
interactions using a 28 day old solution. 
For example, Figure 3.16(i), shows the LD spectrum (see sections 3.2.3 and 
3.3.5.3 for protocols used) of (Pt5) using a 14 day old sample of (Pt5). If this is 
compared to its equivalent from Figure 3.25, the spectra are different. Whereas the fresh 
(Pt5) spectrum shows a large decrease in signal at low mixing ratio, the spectrum using 
the 14 day old sample shows little change at the same and higher R. Figure 3.16(ii) 
shows the CD titration spectrum of a 28 day old sample of (M) with ct DNA. In 
contrast to the prelin-ýnary studies (Figure 3.12), this suggests (M) does not interact 
with DNA. 
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These studies show that (PtX) changes as a function of time and the 'product' 
interacts less effectively with DNA. Thus it is important to use fresh solutions. 
3.3.4 Interactions with nucleotides; 
In order to clarify the preferential mode of action of the (PtX) complexes with 
DNA, the 5-chiral di-sodium salts of the mono-nucleotides: guanosine 5'- 
monophosphate (GMP) (Figure 3.17), adenosine 5-monophosphate (AMP), thymidine 
5'-monophosphate (TMP) and cytidine 5-monophosphate (CMP) were mixed 
individually with the (PtX) complexes of the nitro and methoxy subsets (Pt4 -Pt6) and 
(Pt7 - Pt9) and the products probed using CD and mass spectrometry. 5'-nucleotides 
were used as they represent a portion of DNA. 
Figure 3.17 Structure of the disodium salt of 5'-guanosine monophosphate (GMP) 
3.3.4.1 Circular dichroism studies 
The UV-Visible absorbance and CD spectrum of each chiral nucleotide alone 
and with (PtX) working in a 1: 5 (20: 100 gM) (PtX): nucleotide ratio were recorded. 
Table 3.4 surnmarises the transition wavelengths associated with each mono-nucleotide. 
Table 3.4 Transition bands associated with 5'mononucleotides below 300 nm 
5ý-nucfeotide Transition bands / nm 
AMP 220 (-), 260 
GMP 220 (+), 250 
CMP 220 (-), 275 
TMP 220 (-), 240 (-), 275 
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On addition of a nucleotide to (PtX) complex, minute induced signals are seen. 
Figure 3.18 shows the CD spectra of the nucleotides alone and on interaction with (M). 
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Figure 3.18 CD spectra of each nucleotide alone and on interaction with (M). 
Table 3.5 summarises all the nucleotide transition interactions with the (PtX) 
complexes. The (PtX) complexes show the largest (PtX) ICDs between 300 - 350 nm 
with GMP and AMP and also interact with CNT but show very little interaction with 
TMP. The common covalent bonding metal binding sites on the nucleotides are GN7, 
AN7 and CN3, but only GN7 and AN7 are accessible from solvent in double stranded 
3 DNA. 
Table 3.5 Summary of CD wavelength (X) interactions of (Pt4 - Pt9) complexes with 5'-nucleotides 
(Ptx) AMP GMP CMP TMP 
W /nm (-)/nm (+ /nm (-)/nm (+)/nm (-)/nm (+)/nm (-)/nm 
(Pt4) 300-310(s) 340-360 300-350 - 
300-310 
325 
(Pt5) 3OG-340 - 295-340 - 
300-310 
* - (sh) 
(M) 350-360 310-340 - - 310(s) 
(M) 295-310 330-360 290-340 - 
300-310 
* (sh) 
(PI7) 295-330 350-360 300-330 - 
300-310 
(S) (sh)* 
r 
wp o) 295-330 330-370 300-330 - 
300-310 
-1 _ - 
1 (sh) 
(sh) = shoulder, (s) small, *= wavelength shift 
AMP 
(pt8) + AMP 
GMP 
(Pt8) + GMP 
-- 0-- CMP 
---- (pt8) + CMP 
--EI - TMP 
-- (Pt8) + TMP 
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3.3.4.2 Mass spectroscopic studies 
Attempts were made to understand the nucleotide results using electrospray 
mass spectrometry. The aim of these mass spectroscopic studies was two-fold: (i) to 
determine what (PtX) adducts are formed/are to be found in solution, (ii) to look for 
evidence of which of the chloride or DMSO ligand is preferentially replaced on binding. 
The (PtX) complexes of the nitro subset, 5'-guanosine monophosphate (5GMP) and 9- 
methyl guanine (MG), 8 were used in these studies. Data were recorded on the ESI-MS 
Bruker BioTOF mass spectrometer in positive ion mode at the University of Warwick in 
collaboration with an ESI-MS operator, Dr. Karen Etherington. The nitro subset 
complexes were prepared using 50% MeCN and 2% formic acid solution. We 
anticipated that one or more of the following would take place: (1) DMSO or Cl loss or 
both, (2) addition of one or more GMP or MG (3) replacement of the labile chloride and 
DMSO with either MeCN or OH2 or -OH, (4) no interaction. Mass spectra were 
recorded immediately on mixing unless stated othenvise. 
Results 
The mass spectra of each of the (PtX) complexes alone in solution show peaks 
corresponding to the presence of adducts that indicate the preferential loss of the 
chloride ion and replacement by the solvent, acetonitrile. If the DMSO group is lost 
preferentially, MeCN may also replace it, however, there was no evidence of this, as the 
complex must be charged to be observed, when a Cl is still attached it is neutral. 
(Pt4), (Pt5)and (M) showed major peaks corresponding to PtL(MeCN)(DMSO)' 
and PtL(MeCN)2' adducts. Nfinor peaks common to all three complexes included: 
PtL(MeCN)+; PtL(DMSO)+ and PtL(MeCN)(H20)+, (M) also showed peaks 
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corresponding to PtL'. This indicates that the nitro subset complexes can lose both their 
labile Cl and DMSO groups. 21 
These studies also show that after the loss of either the chloride ion or DMSO 
group or both, MeCN when used as solvent can and does coordinate to the (PtX) 
complexes, and lead to the formation of a number of additional adducts. 
Initial studies on the interaction of guanosine monophosphate (GUIP) with the 
(PtX) complexes of the nitro subset (Pt4 - PQ confirmed an interaction in the form of a 
peak corresponding to [PtL(DMSO)(GM[P)]'. However, the use of GM[P led to the 
complications of additional adducts due to interactions with the sodium or the phosphate 
or the sugar of the nucleotide so the simpler guanine N7 binding model of 
methylguanine (MG) was used. 
On addition of MG to (Pt4 - Pt6), a major peak corresponding to 
[PtL(MG)DMSOI+ was observed with all three complexes, the major and minor adduct 
peaks observed in free solution decreasing in magnitude. After the mass spectra of the 
(Pt5): MG mixture was recorded on mixing, the remaining mixture was left to stand for a 
40 minute period, before a second mass spectra was recorded. A five fold increase in 
the [PtL(MG)DMSO]+ peak size was seen with significant decreases in the 'free' adduct 
peak sizes. Similar interactions were seen with (Pt4) and (Pt6). 
Thus, it is clear that MG can displace Cl. Although there was no evidence of 
DMSO displacement, it should be noted that if MG displaces the DMSO, a neutral 
adduct would result which would not be seen in MS unless it acquired another cation. 
3.3.5 Spectroscopic titration studies to investigate (PtX) interactions with DNA 
On the basis of the preliminary results, the (PtX) complexes that make up the 
nitro and methoxy subsets i. e. (Pt4 - PQ and (Pt7 - Pt9) respectively were investigated 
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in depth. (Pt4/Pt8), (Pt5/Pt7) and (Pt6/Pt9) are identical pairs except for the 
nitro/methoxy groups. 
The spectroscopic interactions of the (PtX) complexes were investigated with ct- 
DNA, AT and GC DNA using the spectroscopic techniques of absorbance, CD and flow 
LD. (PtI5) was also included in some parts to provide an intercalator for comparison. 
With ct-DNA, a constant 100 gM DNA concentration was used to investigate 
interactions over a mixing ratio, R, of [20: 1-1: 1] DNA base: (PtX). With GC and AT 
DNA, a constant 200 gM DNA concentration was used (unless otherwise stated) and 
interactions over R= [40: 1-2: 1] DNA base: (PtX) investigated. Where appropriate (see 
section 3.2.3 and 1.7), the salt concentrations used (with a constant 1 mM sodium 
cacodylate buffer) to maintain GC and AT DNA duplex structure are stated on the 
spectra. 
Titrations were set up where the DNA concentration was kept constant (by 
adding increments of concentrated DNA at each step) as increasing amounts of (PtX) 
complex was added so that DNA perturbations on (PtX) addition as well as ICDs could 
be monitored. The binding constants for (PtX) with DNA are such that mixing ratio 
does not equal binding ratio. 
For case of comparison, each of the following figures have been laid out with the 
(PtX) complexes of the nitro subset in the left column and those of the methoxy subset 
in the right column with otherwise identical complexes side by side. This allows a direct 
comparison of the effect of the non-leaving groups (methoxy and nitro) attached to the 
aryl ring. The individual (PtX) complexes have been divided into three rows, a row for a 
complex from each subset containing the same amine substituent placed in descending 
order diethylamine, morpholine, diethanolamine, thus allowing for comparisons between 
subsets. 
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Solubility 
Platinum complexes (M), (Pt8) and (Pt9) are more soluble in aqueous: MeCN 
solvent than (Pt4), (Pt5) and (M). (Pt4) dissolves in 50% MeCN, (Pt5) dissolves in 
59% MeCN, (M) in 15% MeCN, (Pt7) in 30% MeCN, (M) in 35% MeCN, (M) in 
40% MeCN and (Ptl5) in 7.5 - 10 % MeCN. The % MeCN used for each experiment 
are indicated in the Figures. 
3.3.5.1 U-V-Visible absorbance titration spectra 
The UV-Visible absorbance titrations for each complex, i. e. (Pt4 - Pt6) of the 
nitro subset and (P7 - Pt9) of the methoxy subset with ct-DNA (100 pM), GC DNA 
(200 [tM) and AT DNA (200 ftM) are shown in Figures 3.19,3.20 and 3.21 
respectively. The general trend of all eighteen absorption spectra is as expected: an 
increase in absorbance intensity as the metal complex concentration is increased. 
The ct-DNA spectral data are entirely consistent with the snapshot spectra of the 
preliminary studies. The spectra are a combination of that due to free and bound (PtX). 
The effect of changing the DNA sequence is not really apparent in the absorbance 
spectra if one assumes the higher salt concentration of the AT and GC sets reduces the 
binding constants. 
Within each of the nitro and methoxy series, the absorbance data look very 
similar, though the nitro (Pt4) and to a lesser extent the methoxy (M) have significantly 
larger absorbances spectra in the DNA region. When one compares across the series, the 
260 nm region of the nitro series is larger than the methoxy series giving a more 
distinctive maximum. 
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3.3.5.2 Circular dichroism titration spectra 
Figures 3.22,3.23 and 3.24 show the CD data for the two subsets with ct-DNA, 
GC and AT DNA respectively. If we look at Figure 3.22 of the CD spectra of the 
interaction of each of the six complexes with ct-DNA, our arrangement of the (PtX) 
complex subsets in columns and their respective amine groups in rows, allows us to 
immediately note differences in the spectroscopy of each subset due to the nitro or 
methoxy susbstituent. Some inu-nediate conclusions may be drawn. 
(i) All six complexes interact with DNA as evidenced by their induced (PtX) chiral 
signature above 300 nm. 
(ii) Each complex interacts with DNA producing a positively induced CD band 
(ICD) from 300 nm - 350 nm and a much smaller negative ICD band above 350 
nm. 
(iii) All six complexes exhibit an isosbestic point of zero CD. For the nitro subset the 
wavelengths are: (Pt4) (370 nm), (Pt5) (365 nm), (M) (-365 nm). For the 
methoxy subset the wavelengths are: (M) (- 340 nm), (M) (350 nm), (Pt9) 
(350 nm). 
(iv) The spectra of the nitro subset (left hand column) exhibit a distinct positive band 
between 300 - 360 nm centred at -330 nm for the short axis assigned Pt-Cl band 
and a small 380 - 400 nm negative band for the predominatly long axis polarised 
Pt-L NMCT bands. The 290 - 310 nm Pt-DMSO MELCT band at first sight 
appears to be absent but is more likely a negative band dominated by the 
positive DNA tail and the Pt-Cl band. 
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(V) In contrast, the methoxy subset (right hand column) does not exhibit a distinct 
band at 330 nm rather a broad positive shoulder extending from 300 - -340 nm. 
They also have a long wavelength negative band at slightly shorter wavelengths. 
The distinctiveness of this band increases (M) < (M) < (M). 
(vi) Figures 3.23 and 3.24 with GC and AT DNA respectively also show a difference 
in spectroscopy for each subset. The GC DNA data in each case are probably 
analogous to that of ct-DNA. With AT DNA, (Pt4) and (M) show little 
interaction. (M), (M), (M) and (Pt9) show a different spectral form 
suggesting a different interaction with AT DNA from that observed with ct- 
DNA. 
Thus the substituent on the aryl ring does seem to affect the binding mode, but the 
thiocarbonyl amine groups do not. They do, however, seem to alter the intensity of the 
ICD spectra, due presumably to the different hydrophobicities of these groups. In terms 
of magnitudes of transitions for the nitro series with ct-DNA, Pt-Cl transitions: (M) 
(Pt4) > (M); Pt-L transitions: (Pt5) > (Pt6) > (Pt4); DNA transitions: (M) > (Pt5) > 
(Pt4). Overall the order is (Pt6) > (Pt5) > (Pt4). This may in part be a solvent effect. 
In light of the mass spectrometric results we might expect a binding mode where 
the Cl ion is displaced. If the CI is displaced by the G bases but not so effectively by A 
bases then the AT versus 'the other differences' could be accounted for. Pt-GNP 
binding does result in a longer wavelength - 340 nm band than does Pt-AW binding 
(refer to Table 3.5). However, the fact that the nitro and methoxy series differ in the 
300 nm region suggests there are differences between these complexes. It could be that 
the nitro facilitates Cl ion displacement (as noted by Sacht and Datt) 12,13 and gives rise 
to a dominating negative Pt-DMSO ICD. This is certainly consistent with our MS 
145 
results and the nucleotide CD studies. A further factor to be considered with polymeric 
DNA is the steric effect of covalent binding via the chloride position. This brings the 
aryl group deeper into the groove than with the other binding modes (e. g. intercalation). 
The smaller nitro group with significant H-bonding acceptor capability compared with 
the methoxy would be preferred. In this context, the resemblence between the 
unsubstituted non-H-bonding (Ptl - Pt3) and the methoxy series (see Figure 3.12) is 
probably relevant. 
The methoxy series also differs from the nitro series above 300 nm both with 
polymeric DNA and with the nucleotides. There is generally a small shift in the 300 - 
350 nm region to longer wavelength. This perhaps reflects a greater degree of DNA 
binding via DMSO displacement with (Pt8)>(Pt7)>(Pt9) which is consistent with no 
negative Pt-DMSO CD band obvious at - 300 nm. 
3.3.5.3 Flow linear dichroism titration spectra 
If (PtX) is oriented in solution it will have an LD signal for its transitions. As 
the (PtX) can only be flow oriented upon binding to DNA, the presence of an induced 
LD at wavelengths that correspond to platinum transitions confirm that an interaction 
has taken place between the unorientated platinum complex and ct-DNA. 
Here the DNA concentration was kept constant as (PtX) complex was added in 
order to keep the solution viscosity constant. 
Flow LD with organic solvents 
As discussed in Chapter 1, organic solvent flow LD is less straight-forward than 
aqueous flow LD. When working with organic solvents in flow LD studies, the 
concentration of the DNA as well as evaporation, viscosity, turbulence effects all need 
to be taken into account and adjusted accordingly. The flow LD signal of ct-DNA is 
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large enough to compensate for the effects of using MeCN. The DNA signal of the 
shorter synthetic GC duplex and AT DNA is, however, much smaller and the 
experiments were more difficult or impossible. LD studies with AT DNA were not 
undertaken. Although the AT DNA does orientate the signal is very small. The more 
rigid GC DNA proved to give small but detectable signals. 
The flow LD titration spectra of the two subsets (Pt4 - Pt9) with ct-DNA (100 
gM) and GC DNA (200 [tM) are shown in Figures 3.25 and 2.26 respectively. Each ct- 
DNA: (PtX) flow LD interaction was investigated over a mixing ratio, R, of [20: 1-1: 1] 
DNA base: (PtX) complex and GC DNA: (PtX) interaction over a [40: 1-2: 11 ratio. As a 
comparison, (Ptl5) a DNA unwinder that has previously been concluded to intercalate 
between DNA base pairs was also studied (Figure 3.27). (Pt. 15) has a phenanthroline in 
the place of the chloride and DMSO groups that are found on (Pt4 - Pt9) (see Figure 
3.9). 
The flow LD spectra of the (PtX)-DNA complexes (Figure 3.25 and 3.26) are 
characterised by large negative bands due to DNA encompassing negative n-ýnima at 
230 nm and negative maxima at 260 nm. All six complexes exhibit negative LD signals 
for (PtX) transitions with both ct-DNA and GC DNA indicating that each platinum 
complex transition is aligned more parallel to the DNA bases than to the helix axis. 
Since the film LD work showed that MELCT bands are almost certainly polarised in the 
plane of the molecule, this suggests the (PtX) complexes are oriented more parallel to 
the DNA bases than perpendicular. 
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With ct-DNA (Figure 3.25), all six spectra exhibit non-zero isosbestic points, 
and in general similar spectra, but bend DNA by different amounts. In contrast, (Pt15) 
(Figure 3.27(a)) at low (PtX) load gives an increased DNA LD signal consistent with 
lengthening and stiffening of DNA due to intercalation. At high load the effect is 
reversed. Using selected flow LD and absorbance concentrations (absorbance data not 
shown), LD' spectra (i. e. LD divided by A) were plotted (see Figure 3.27(b)) from 
which (x (the angle between a transition polarisation and the orientation axis ) '2: 70' 
±10' was determined for (Pt15) relative to the DNA helix, (cc is - 86' for DNA bases). 30 
Section 1.3.3.2 contains an explanation, method and the equation (1.7) used to 
detern-ýine (x. This data suggest that (Pt15) unwinds and lengthens ct-DNA by 
intercalation between the DNA bases. 
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Figure 3.27 (a) The flow LD spectra of (Pt15) with ct-DNA, the legend states the gM (Pt15) concentration added to a 
constant ct-DNA concentration and (b) the LDýspectra of (PI115) with ct-DNA at selected concentrations. 
(Pt4 - Pt9) differ in their effect on the degree of orientation of the DNA. At low 
R, metal complex loads, (Pt4) (0 - 18 AM) and (Pt7) (0 - 13 AM) both show an increase 
Flow LD' 
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in DNA LD magnitude (this is similar to the effect observed for (Pt15)); both complexes 
then gradually bend the DNA. The induced (PtX) transitions of (Pt4) and (M) above 
300 nm follow these trends also increasing in size as R is increased. Both (Pt4) and 
(M) show an increase in magnitude at low R (0 - 23 pM) and (0 - 35 pM) respectively 
before decreasing at higher R. The 'stiffening' effect at low loads could indicate an 
intercalative interaction followed by another mode. 
The flow oriented LD spectra of (M), (M), (M) and (Pt9) show decreases in 
DNA LD magnitude as the (PtX) concentration is increased. (M) and (Pt9) shows a 
large decrease even at low complex loads R [20: 1]. Above 300 nm the flow LD spectra 
for all four complexes are characterised by a negative LD shoulder due to the (PtX) 
band between 300-400 nm. The signal increases with (PtX) concentration but decreases 
with the DNA bending. The latter eventually dominates. The LD spectra give no 
indication of big differences between the (Pt4 -Pt9) complexes upon binding to DNA 
except for the big orientation differences. Their spectral shape differences follow that of 
the nonnal absorbance. It is interesting to note that the orientation differences are less 
dramatic in the GC DNA 
-titration series 
(Figure 3.26) where 10 - 20 mM NaCl was 
included. In any case it seems bending takes over before any intercalative binding mode 
might be saturated. Further, the (PtX) LD signal is significantly smaller compared with 
the DNA signal than is the case for (Pt15) (Figure 3.27), suggesting a sloped orientation 
of the plane of the molecule for (Pt4 - Pt9). Without significantly more data on the 
interplay of ionic strength and the organic solvents in LD spectroscopy it is difficult to 
make conclusions from this effect. 
With the GC data, the nitro series has larger (PtX) LD signals relative to the 
DNA suggesting an orientation more parallel to the bases than is the case with the 
methoxy series. Given our previous hypothesis of a different preference for chloride or 
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DMSO displacement, this may be a steric factor of the binding mode that could be 
readily investigated by a molecular modelling study. 
3.4 Conclusion 
Under the conditions stated in this chapter the complexes exhibit concentration 
dependent interactions. We propose that complexes (Pt4), (Pt5), (M), (M), (M) and 
(M) covalently bind to DNA via the loss of the Cl or possibly the DMSO groups on the 
platinum. (Pt15) is an intercalator. Mass spectroscopic studies on the nitro subset have 
shown the preferential removal of the chloride ion and the formation of the major 
product of (PtL(DMSO)(MG)]'. 
Sacht et al. found that (Pt4), (Pt5) and (M) exhibit biological actiVitY12,13 
whereas the others do not. However, the spectroscopic studies reveal no significant 
differences in interaction with duplex DNA between those complexes that are 
biologically active and their structural analogues that are not. A possible conclusion 
may be that duplex DNA is not the primary target for these antiturnour species, the 
complexes could target other DNA structures such as tetraplexes or e. g. proteins. 
The major conclusion of this work therefore is that DNA binding does not equal 
biological activity. Molecular structure is related to biological activity, but all aspects 
of biological activity must be considered i. e. one must consider not only the activity of 
the complex when it gets to the target but also how it gets to the target and what else it 
may interact with. For example, organic solvent or ionic strength may affect (PtX) 
interactions. We propose therefore that the difference in activity for (M), (M) and 
(M) (not'biologically active) must be related to the delivery of the drug into the cell 
(this is consistent with the differences in solubility between the six complexes). 
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This novel class of (PtX) complexes, like cisplatin have a number of factors that 
can affect their interactions but they can bind to DNA and have the potential to be used 
as chemotherapeutic agents. 
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4 Supramolecular metal lo-cyclop hanes and 
their interactions with small molecules in 
organic solvents 
4.1 Introduction 
The work in this chapter reports an investigation into the molecular sensor 
potential of novel self-assembling supramolecular metallo-cyclophanes formed using an 
inexpensive imine based approach. ' A range of organic soluble supramolecular 
copper(l) and silver(l) metallo-cyclophanes were designed with their neurotransmitter 
binding being possible long term applications. In this thesis, the potential of these 
cyclophanes have been investigated in terms of their interactions with small neutral 
molecules e. g. aromatic di- and tri-methoxybenzenes (dmb, tmb) and chiral anionic 
compounds (sodium antimonyl-L-tartrate). The subsequent design and synthesis of a 
novel longer ligand capable of a facile one pot self-assembly into a supramolecular 
cyclophane structure with a larger cavity is also reported. Spectroscopic studies using 
UV-Visible absorbance and fluorescence as well as NMR studies and X-ray 
crystallography were used and are reported here. 
Cyclophanes: and their interactions in organic solvents 
Molecules containing a bridged aromatic ring are termed 'cyclophanes'. 2-4 A 
variety of synthetic cavity containing cyclophane, complexes (receptors/hosts) have been 
designed to bind organic molecules (substrates/guests) in aqueous and non-aqueous 
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media2 A and as such represent the main class of synthetic receptors in molecular 
recognition. 2 
The complexation of numerous synthetic cyclophane hosts 2 with a range of 
aromatic guests have been extensively studied in both water and organic solvents. A 
comprehensive review of these cyclophanes and their interactions with substrates has 
been compiled by Diederich. 2,4 
One of the first examples of neutral substrate complexation in organic solvent 
was reported by Siegel and Breslow in 1975. It involved the inclusion of neutral 
aromatics, toluene and anisole, by cyclodextrins in DMIF and DMSO. 2,4 Many other 
similar investigations using other cyclophanes have been reported since and have been 
reviewed elsewhere. 2 
Connor states that the solvent itself is a molecular system rather than a 
continuous medium and the solvent molecules are subject to the same intermolecular 
forces as the interactants (solutes). 4,5 Solvents can therefore compete with the guest for 
the binding site. As solvent molecules are present in very large excess, their affinity for 
the cavity does not need to be very strong for them to displace the intended substrate or 
'guest'. The extent to which a solvent molecule can act as an efficient competitor of the 
guest in the cavity binding site is also dependent on the affinity of the substrate for the 
solvent 
Organic solvent can affect binding interaction as reported by Diederich et al. 2,4 
An investigation into the solvent's effect on binding interactions with a neutral 
macrobicyclic cyclophane host molecule 2,4 (Figure 4.1(a)) and its interactions with the 
arenes: pyrene and naphthalene was undertaken by Diederich et al. The cyclophane 
used was found to be soluble in most of a range of organic solvents from methanol to 
carbon disulfide. 
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(a) 
-Et 
X- 2H 
-Et 
(b) 
Figure 4.1 (a) Macrobicyclic neutral molecule host (b) schematic of the geometry of the pyrene compfex in methanol 
supported by'H NMR spectroscopy. (The diagrams were taken from p364 and p 370 of reference 4). 
Proton NMR was used to show that similar geometric complexation of host 
molecule with pyrene (Figure 4.1(b)) occurred in a number of different solvents. The 
appropriate binding constant/association constants (K) values, however, were different. 
As the geometry of all the inclusion complexes is similar in all solvents, then the 
difference in the K values could not be due to any significant change in structural 
interactions, rather to the difference in non-covalent host-guest size or solvent-guest 
interaction, thus suggesting that any differences in K is due to a solvation effect. The 
binding constants for the pyrene inclusion complex were found to be strongest with 
polar solvents (the alcohols methanol and ethanol; K- 104 M-1) and then dipolar aprotic 
solvents acetone, DMSO, DMIF, THF (K - 103 _ 102 M-1) and weakest binding with 
chloroform, benzene and carbon disulfide (K - 43,12 and 9 M-1 respectively). This led 
to the conclusion that the latter non-polar solvents can compete with the guest for the 
binding sites and also have a strong affinity for the pyrene itself. 
This aptly demonstrates that solvent can effect the host-guest interactions, in 
turn effecting the magnitude of binding constants, K. 2 In general, for any type of 
complexation, geometrical complementarity between host and guest is crucial in 
detennining the strength of complexation but the solvent plays a significant role too. 
Binding strengths for this type of host-guest complex decreases from water to polar 
protic solvents to dipolar aprotic and apolar solvents. 
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Electron donor-acceptor interactions have also been found to help stabilise the 
inclusion complexes of aromatic guests e. g. cyclobis (Figure 4.2) and Fujita's square 
(Figure 4.3). 6 - IS 
Binding constant determination 
A comprehensive review of binding constant determination is provided by 
Connors. 5 A few of the methods that can be used to determine binding constants include 
UV-Visible spectroscopy, 
16 fluorescence, 17 circular dichroism'8 and pqjýM. 
4,19 
Table 4.1 Sensitivity of the various techniques in determining K 
Technique KI 
NMR K< 10' 
Absorbance 102 < K< 106 
Fluorescence 105 < K< 10" 
The concentration ranges required for different experiments dictate the 
magnitude of the binding constants that can be measured. Table 4.1 summarises the 
sensitivity of the techniques mentioned. K values of ,ý 104 M-1 are measurable by NMR; 
UV-Visible absorbance is appropriate in the range 10ý _106 M-1. As fluorescence is 
more sensitive than absorbance, binding constants in the region of 105 - 108 can be 
determined using this technique. Whether data from a particular technique will lead to a 
value for K rather than just an upper or lower limit can be seen by plotting signal change 
(chemical shift, change in absorbance etc. ) versus added ligand or substrate 
concentration. If the plot is curved rather than linear, a binding constant value may be 
cletennined. If it is linear, then we are seeing all added substrates binding, rather than 
an equilibrium operating. 
158 
Several types of experimental methods are used to determine binding constants. 5 
The main method that can be employed for both optical spectroscopy (UV-Visible 
absorbance and fluorescence) and 'H-NMR, and which is used in this thesis, involves a 
titration of one analyte while keeping the concentration of the other constant. 4 Here a 
titration can be set up where the change of a guest property X is monitored as a function 
of increasing receptor concentration, while the total guest concentration is held constant. 
The property of X with UV-Visible absorbance is the intensity of an electronic 
absorption, or the fluorescence change of the guest. It can equally well be the chernical 
shift of a guest proton resonance. With absorbance (and fluorescence), a detection 
wavelength is usually chosen so as to give the largest possible values of AX, in order to 
provide the most accurate results. Ideally the detection wavelength is chosen to be in a 
region where the host property shows no effect under normal circumstances, so that 
changes in X as increasing amounts of host are added are a record of the interaction and 
not complicated by increasing host conqentration. The plot of the change of the guest 
I property (AX) as a function of increasing host concentration is ten-ned a binding 
isotherm or more commonly a binding curve. 
The presence of isosbestic points (points of constant absorbance) in the guest 
spectral region with constant guest concentration and varying host can be used to 
determine the number of species in a solution. 5 Generally, but not always consistently, 
one can establish whether the system includes one species (no complexes, just one 
species in solution with all spectra of exactly the same shape and magnitude), two states 
(two species, one bound and the other free with one isosbestic point), or more than two 
states (multiple equilibria indicated by changing spectral shapes and no isosbestic 
points. ) This method is not entirely reliable and any other information regarding 
stoichiornetry available must be taken into account. 
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NMR methods have an advantage over absorbance and fluorescence methods 
because NMR is not subject to misinterpretations caused by minor impurities etc. NMR 
data can also reveal more detailed structural information than UV-Vis data. Proton 
shifts for example, would be indicative of interaction. NMR or X-ray crystallography 
can be used to better define the binding interaction, provide proof of the actual shape, 
and the former to calculate binding constants. NNM observations of binding phenomena 
are usually in the so-called fast exchange limit - 10-2 seconds-19 
The experimental methods that utilise NMR to calculate K and their binding 
isotherms are similar (as mentioned earlier) to spectrophotometric techniques, but there 
is a difference due to the different physical quantities being measured. In optical 
spectroscopy, an intensity - absorbance or fluorescence - is measured, and this is 
proportional to concentration, but in NMR spectroscopy a frequency (chemical shift, b) 
is measured. Substrate concentration is therefore an experimental variable with which 
to manipulate the analytical signal in optical spectroscopy, but this is not viable in 
NMR, instead one determines relative percentages of each species present in the 
solution and calculates K directly. 
In summary there are numerous methods that can be utilised to determine 
binding constants, and numerous effects that can affect the results. In the context of this 
chapter only the spectroscopic methods are of interest. 
Receptor requirements 
An understanding of the nature of non-covalent bonding interactions is 
necessary in the successful design, synthesis and stabilisation of self-assembling 
supramolecular synthetic structures. Modelling of biological interactions and processes 
represents an important target of supramolecular chemistry and as such most host-guest 
interactions have been investigated in water due to their specific and possible use in 
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biological interactions and reactions. The molecular interactions involved in host-guest 
molecular recognition (i. e. the forces that hold supramolecular complexes of 
cyclophanes together with neutral and charged molecules (substrates)) are covered in 
Chapter 1. 
An effective receptor needs to meet certain criteria; three clear requirements 
have emerged for the design of an effective supramolecular receptor for a specific target 
molecule. These have been summarised by Hunter: 20 (i) the receptor should be 
polymacrocyclic and contain a cavity in which the interactions with bound substrate can 
be maximised; i. e. interactions are in the cavity rather than on the exterior of the cavity, 
(ii) the receptor should have the ability to establish non-covalent binding interactions 
with the substrate and to aid stability, this can be maximised by matching 
(complementing) substrate molecular size, shape and architecture, and (iii) the receptor 
should be relatively rigid, and binding/recognition should be favourable i. e. not involve 
the loss of shape. In order to achieve selectivity, a host molecule must be rigid so as to 
allow a pre-organised binding site which is complementary in size and polarity to a 
particular guest. 
4,21 
Besides covalent pre-organised hosts, there are also hosts reported in the 
literature that do not form until guests are present, at which time the guests help to 
rigidify the cavity of the host, 22 or the host changes conformation and forms a rigid 
structure/cavity by encapsulating the guest. 23 
Synthesis of suitable rigid polymacrocyclic structures can be extremely difficult. 
The use of high dilution reactions is one way to encourage macrocyclisation and to 
reduce polymer formation but the yields can be low. 3 Template synthesis has also 
proved to be a very successful method, for generating macrocycles. 24 Other methods 
include cyclisation and normal covalent synthesis. A more promising (and more facile) 
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approach that has emerged in the last few years has been the application of self- 
assembly to generate compounds with large rigid molecular sized cavities. 23 , 25 , 26 
Two typical examples of cavity-containing cyclophane structures are the 
rectangular cyclobis formed by the template assisted assembly (Figure 4.2) and Fujita's 
square formed by self-assembly (Figure 4.4). The methods used in the formation of 
these cyclophane structures are briefly discussed below. 
Template directed synthesis approach 
The rigid cyclophane structure developed by Stoddart et al. 8-15 termed cyclobis 
(Figure. 4.2), is a good example of a macrocyclic box structure. It can be formed using 
template directed synthesis from a bis (pyridinium) salt, A, with 1,4 bis-bromomethyl 
benzene, B, in acetonitrile for a few hours. 
2PF6- 
MeCN 
heat, 48hrs 
13 r 
AB Cyclobis 
Figure. 4.2 Schematic synthesis of the totracationic rigid cyclophane box structure 
-.. I 
Cyclobis has a well-defined rigid cavity lined by two 1,4-dipyridinium acceptor 
units. These are electron deficient, and therefore make the cavity ideally designed for 
the inclusion of electron rich aromatic substrates, e. g. di-and tri-methoxybenzenes. The 
inclusion complex is also ideal for promotion of strong 7r-Tc stacking interactions 
between two electron deficient 2-dipyridinium units. The solubility of the tetracationic 
box can be controlled through the selection of appropriate counter ions. CYclobis has 
been found to form stable complexes with a wide number of substrates including di- 
methoxybenzcnes (dmb) and catecholarnines. 2 These have been detected using UV- 
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Visible spectroscopy an I NMR. 2 Cyclobis forms intensely coloured complexes with 
neutral electron rich benzene derivatives (i. e. isomers of di-methoxybenzene (dmb)) in 
acetonitrile. In solution, K values for 1,2-dimethoxybenzene (12dmb) and 1,3- 
dimethoxybenzene (13dmb) are K-8 M-1 and 17 M-1 for 1,4-dimethoxybenzene 
(14dmb). 2,8 
Self-assembling approach 
The alternative approach to the design of receptors is the self-assembly 
approach. Chemical self-assembly methods draw inspiration from natural self-assembly 
e. g. that of DNA (see section 1.6). Maverick et al 27 first described the preparation of 
inorganic self-assembled macrocyclic hoStS28 obtained in high yield by simply mixing 
suitable ligands and metal ions (Figure. 4.3). These offer advantages over the 
I 
macrocyclic covalent analogues that require multistep synthesis and are generally 
produced in low yield. Since then a range of metals with various coordination 
geometries (e. g. linear, trigonal, square planar, tetrahedral and octahedral etc. ) have 
been used for metal directed self-assembly of supramolecular host architectures. 20,29 
Figure. 4.3 Maverick's self-assembling macrocyclic; host 
Metal directed selr-assembly 
Metal ions that fon-n four-coordinate square planar complexes are particularly 
well suited to act as the right-angled comers of square suprarnolecular structures. For 
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instance platinum(H) and palladium(H) complexes are known to form four coordinate, 
square planar species with approximately 90' bond angles at the metal centre. 
The idea of supramolecular self assembly of square macrocycles (Figure 4.4(b)) 
using a protected, square planar transition metal (Figure 4.4(a)) in combination with a 
polydentate ligand was originally developed by Fujita et al. 29 
NH 
12 
NHF- I- a -UIN U2 1 
ONO 2 
8. 
(NO, -), 
M= Pd or Pt 
cN 
1-ýN NHý 
Figure 4.4 (a) cis-protected palladium(fl) ethylenedianýine, (b) Fujita's tetracationic box structure 
Fujita and co-workers were the first to report on the spontaneous assembly of a 
tetranuclear palladium(H) square, using cis-protected palladium(III) ethylenediamine 
(where ethylenediamine is denoted 'en') (see Figure. 4.4) with one equivalent of 4,4'- 
bipyridine (4,4'-bipy) in water or watcr/methanol solution to form a tetranuclear 
palladium(H) complex, f(en)Pd(4,4-biPY)14(NO3)8, where the square planar palladium 
atoms were bridged by 4,4'-bipy. This unique tetranuclear structure in its solid state, 
was found to be a square, with 90' comers and an 8A cavity length. The central cavity 
is surrounded by 4,4'-dipyridinium units 2 and, like Stoddart's cyclobis, was found to be 
ideal for aromatic substrate (di-methoxybenzene) inclusion. In water, the hydrophobic 
cavity recognises small aromatic compounds. The binding of 1,3,5 tri-methoxybenzene, 
for example, was detected in deuterated water, (D20) using 1H NMR. Complexation 
arises in part due to a charge transfer interaction, hydrophobic interactions between 
electron deficient pyridine ligands and the rich aromatic guests. 7u-stacking interactions 
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between aromatic portions of the substrates inside the box cavitY was determined using 
proton 
Extension of the box cavity can be achieved simply by the incorporation of 
spacer groups e. g. C6114, between the pyridine donor sites of the 4,4'-bipy walls of the 
cavity. Various difunctional ligands such as these have since been used to extend the 
box cavity. 30 Extensions of this type, can lead to the formation of mixtures of expanded 
molecular squares and triangles 
30,31 
and catenanes. 
32 
For example, Fujita et A31 showed that not only are molecular squares formed 
by self assembly, but that their molecular square (Figure 4.4) was found to exist in 
equilibrium with another discrete structure, a molecular triangle as assigned in the solid 
state (see Figure 4.5). 
iNOA 
x=-COH4- -x--CH-O+. 
X- -c-r-; X. -c-r-, C-C- 
Figure 4.5 Fujita's molecular square and molecular triangle structures 
JN03)s 
When Fujita et A 30 investigated replacing the ethylenediamine on the metal of 
the square (see Figure 4.4) with 2,2' bipyridine (bipy), a mixture of squares and 
triangles were found to form in solution, this was thought to be due to steric repulsion of 
the bipy groups on the metal. 
Interestingly, it has also been reported that when transition metals such as 
palladium(II) and certain organic ligands were combined in water in a 2: 1: 1 
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stoichiometry, they were found to bind so well that they self-assembled into a single 
product i. e., rectangular molecular box catenanes (see Figure 4. . 
32 
Pd 
\0"02 
HZO 
. 
Figure 4.6 The ligands shown are combined in a 2: 11: 11 ratio to form catenanes 
-1 S+ 
03N 
Stang et al. 33 have extended the approach, designing and characterising cationic 
and neutral homo and heterometallic Pt-Pt and Pt-Pd molecular squares with extremely 
high yields of 90-99%. Optically active chiral tetranuclear molecular squares, readily 
constructed by self assembly and coordination between the chiral square planar 
palladium(II) and platinum(H) bisphosphine triflate complexes and appropriate achiral 
building blocks have also been reported by this group (see Figure 4.7). 34 - 37 
--Is. 
8 'OSO. CF$ 
M= Pd, Pt 
Figure 4.7 General structure of the chiral square planar palladium or platinum bisphosphine triflate complex 
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Hupp et al. extended this now growing area of self-assembling tetranuclear 
structures by incorporating octahedral metal centres such as rhenium into the structures 
(Figure 4.8). 37,38 Molecular squares derived from rhenium pentacarbony1chloride 
(Re(CO)5CI) '39 
have been found to be fluorescent. The introduction of photo- 
luminescent characteristics is useful as an alternative to 1H NMR spectroscopy for 
detection of guest binding. Hupp introduced heterobimetallic molecular squares, with 
Re(CO)5CI incorporated in two opposite comers, and Pd(phosphane) at the other two 
within a square assembly 37 (see Figure 4.8(a)). 
14+ 
co 
cl C3 
TI [Re(00)3Cq +L 
THF[Toluene, Heat LL I 
'co 
I 
/, 
- 
C3 - 60 q-A Cb 
L44 -b4yyricM L 1: 2 E(4-,,, idylWh 
L py- 
(a) (b) 
Figure 4.8 Using octahedral metal centres (a) Hupp's heterobimetallic molecular square 37 (b) neutral molecular square 
with rhenium in all four comers. 33 
A large number of such homo- and hetero-metallic molecular squares which 
have been shown to recognise and encapsulate other molecules in their cavities, have 
now been reported incorporating metals such as platinum(H), palladium(H), 
cadmiUM(jj), 
28 
rheniUM(j)'38 osmium(VI), iron(, I)40 and colbalt(II) . 
41 Lippert et al., 
have shown in principle that it is possible to reverse the situation where the metal unit 
provides the right-angled comer with four bifunctional ligands forming the sides, by 
42 
placing the organic ligands at the comers and the metal units along the edges. These 
structures can also be termed squares in the strict sense. Lippert and others have 
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reported on the formation of molecular boxes, rectangles and hexagons made up of 
nucleobases and other heterocycles. 43 
The concepts used to construct self assembling molecular boxes have been 
extended by Fujita 28 and others to include the construction of multimetallic arrays such 
44,45 46 47 
as molecular networks, ladders and grids cages, grids44 and channels. 
Having used pyridyl ligands with two coordination sites and square planar 
metals complexes as comer templates, two-dimensional squares have been synthesised. 
Three-dimensional architectures result when the ligands with higher numbers of 
coordination sites or metal ions with tetrahedral or octahedral coordination geometries 
are used in the self-assembly process. A nice example has been demonstrated by Jim 
Thomas and colleagues where in one step, eight octahedral metal comers and twelve 
4,4'-bipy ligand edges, some twenty individual pieces, come together to form a 
supramolecular cube (Figure 4.9). 
48,49 
-111, 
N 
cl 
Nome 
R/ 4w. 
'eks 
U-SOINIC2 + 12 
cl V= MlancSýRul 
Figure 4.9 Twenty piece self-assembling supramolecular cube [[Ru([9]aneS3))8(4,4'-bipy)12](PF6)16 (Diagram 
reproduced from reference 49) 
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Supramolecular self-assembling approach 
Self-assembly (of polymacrocyclic structures) can be simply controlled by 
designing relatively rigid ligands, where the arrangement of ligand binding sites dictates 
the outcome, thus reducing the need for a protected metal. For example, Lehn and 
coworkers have explored the use of metal coordination for the construction of molecular 
racks, ladders and grids. 4445 They recently reported on the synthesis and the structural 
characterisation of a self assembling symmetric [2x2] tetracopper grid box (see Figure 
4.10), which was found to be electrochemically active and even more promisingly to 
exhibit guest inclusion in the solid state. 50,51 This approach is significantly different 
from that of metal directed self-assembly as it does not require the use of blocking 
ligands or metals. 
Ph Ph 
Ph 
! 
(ý, Ph 
N' 'N N' 
Ph 
N'4'N N- -N 
Ph 
PP 
Figure. 4.10 Self-assembling tetracopper grid box 
Hannon et al. have developed an inexpensive, simple self-assembling approach 
(where a protected metal is not needed) to the generation of self-assembling 
supramolecular architecture. This approach is based on imine ligandsi and provides a 
facile one pot route to construction of supramolecular helical arrays, 52 cageS46 (see 
Figure 4.11) and grids, in high yield from inexpensive commercial reagents. 
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t4 
Figure 4.11 A ligand developed by Hannon et aL using an inexpensive approach. The triple helical structure is formed 
by simply warming a stoichiometric combination of 3 equiv. ligand and 2 equiv. nickel (11) salts in methanol. 
Lehn et al. 53 have also reported on an equilibrating mixture of double helical (1), 
triangular (2) and square [2 X 2] grid (3) complexes that self assemble in solution in a 
6: 4: 3 ratio respectively from a 1: 1 ratio of ligand (L) and copper(I) salt in nitromethane 
(Figure 4.12) and convert to a single species (1) in the solid state. 
o 
o 
N 
+Cu+ 
--l 
Figure 4.12 The double helical (1), triangular (2) and square (3) supramolecular structures form on reaction of ligand (L) 
with copper ions in a 1: 1 ratio (taken from reference 53) 
Using their inexpensive method, Hannon et A have since reported using self- 
assembly to control the directionality of a supramolecular helical structure formed using 
an asymmetric ligand (L) (Figure 4.12). 54 
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Figure 4.12 Asymmetric ligand (L) and the crystal structure of the cation [Ag2L 212. (taken from reference 54) 
As the design and synthesis of symmetric and asymmetric ligands for self- 
assembly of box structures can be controlled, so too can the aggregation of 
supramolecular boxes as reported by Hannon et al. 52 Firstly, by designing ligands' that 
incorporate nitrogen atoms as the metal binding sites (which can self assemble into 
cage-like structures) Hannon removed the need for the protected metal. Secondly, the 
deliberate incorporation of an additional ligating site (e. g. a thiomethyl substituent) on 
the outside of the structure, in such a position that would not be involved in the inital 
self assembly process of the box enabled aggregation of the boxes in a controlled 
fashion (see Figure. 4.13). This work has subsequently been extended to produce 
polymer arrays in a controlled fashion. 
sme 
bpy-4-py 
Figure 4.13 The ligand and the crystal structure of the agggregation of boxes 
Hannon's development of supramolecular arrays in a few steps compared to 
multistep synthesis of polymacrocyclic structures is clearly an advantageous 
171 
development; it could lead to a significant increase in the potential usage of 
supramolecular self-assembling architecture in molecular sensing applications. 
The development of new innovative, inexpensive approaches in the construction 
of large self-assembling cavities containing cyclophanes, together with (i) the ease with 
which such structures can be designed and synthesised to self assemble, (ii) the fact that 
cavity size, shape and properties can be altered by using different ligands and metals 
with different oxidation states has lead to metals now being a key feature in the 
formation of supramolecular structures and all seems to advocate the use of self 
assembling supramolecular structures in receptor-substrate chemistry. Thus, self- 
assembly is an extremely promising method for the construction of polymacrocyclic 
structures for use in molecular recognition. 
4.2 The complexes of this study 
The long-term aim of this research is to develop a solution sensor for dopamine 
and other neurotransmitters (Figure 4.14). To achieve this, suitable hosts need to be 
developed that can selectively bind these compounds. It is the molecular recognition 
properties of novel supramolecular metallo-cyclophanes formed following Hannon's 
inexpensive imine based approach' that have been investigated in this chapter, as a first 
step to a possible route to such a sensor. 
HO 
CH, NH, 
HO D: 
Dopamine 
Figure 4.14 Structure of the neurotransmitter dopamine 
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Figure 4.15 Ligand L' 
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The imine ligand (L') (Figure 4.15) is fon-ned by mixing two equivalents of 6- 
methylpyridine 2-carboxaldehyde with one equivalent of 4,4'-methylenedianiline in 
ethanol with stirring for 24 hrs. The yellow solid that precipitates out is isolated by 
filtration. The reaction of this ligand (L') with tetrahedral metal ions such as copper(I) 
and silver(l) leads to dimeric [M2L2][X]2 supramolecular metallo-cyclophanes 
complexes' (where X= anion) (see Figure 4.16). The nitrogen atoms bind to the 
tetrahedral metal centres giving a supramolecular cyclophane structure. 
Figure 4.16 Crystal structure of [Ag2. L' 212. CoMplex formed (BF4 salt) (taken from C. L. Painting, PhD Thesis, University 
of Warwick, 2000). 
[CU2LI212+ý the copper cyclophane complex, was synthesised following the 
synthesis laid out by Hannon et al. ': simply mixing a [Cu(MeCN)41[XI salt (where X= 
tetrafluoroborate (BF4) or hexafluorophosphate (PF6)) with the imine ligand (L') in 
acetonitrile solution under N2 for two hours. The red product that precipitated from 
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solution was left to cool in ice before being isolated by filtration. Recrystalisation was 
not necessary as 1H NMR and CHN data indicated good complex purity! This 
cyclophane complex is soluble in either acetonitrile or methanol. A range of similar 
organic soluble copper(l) and silver(I) metallo-cyclophanes using different salts were 
also prepared! 
Xý/- 
helix box 
Figure 4.17 Schematic illustration of the conformations of [Cu2L2][BF4]2 cyclophane complex "54 
The [CU2LI2 ]2+ [BF412, copper(l) tetrafluoroborate, cyclophane complex can adopt 
two conformations in solution: a helical (helix) structure or bridging non-helical (box) 
structure, 1' 54 as shown in Figure 4.17. Similar conformations have been found with 
other dimeric metallo-cyclophanes. 55,56 The two conformations are attributed to the 
apparent flexibility of the ligand (L'). Proton NMR of the complex in deuterated 
acetonitrile, CD3CN, at low temperature confirms the presence of both species in a 2: 1 
ratio of helix: box. 1 The proton NMR of [Cu2L2]2+ complex in deuterated methanol (d 
3 
MeOH) at room temperature shows the presence of two species in solution, whereas the 
proton NMR using deuterated acetonitrile (d 3 MeCN) indicates only one specieS2 (see 
Figure 4.18) presumably due to fast exchange. 
in dMeCN 
in dMeOH 
9.5 9.0 &5 &0 7.5 zo 6.5 
rigure 4.18 Room temperature proton NMR of the copper cyclophane in deuterated MeCN and MeOH (d 3 MeCN and d 
MeOH) 
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Important features of these supramolecular metallo-cyclophane structures are (i) 
that they contain large enough cavities for small aromatic molecules to be bound and (ii) 
the metal centres (copper(l) or silver(l)) are incorporated into the cavity framework to 
hold the metal lo-cyclophanes together. 
If a binding event occurs in a host cavity, spectral changes in both the guest and 
host molecules may occur. For instance, metal-to-ligand charge transfer transitions may 
change upon substrate binding. The binding of a guest should also result in a change in 
the redox properties of the metal centre. It is these responses and others that can 
potentially be used to detect the presence of the aromatic substrate. 
This chapter reports the investigation into the binding ability of these novel self- 
assembling cavity containing supramolecular metal to-cyclophane structures with a view 
to their possible eventual use as specific sensors. Here, investigations with a range of 
neutral molecules e. g. aromatic di- and tri-methoxybenzenes (dmb, tmb) and chiral 
anionic compounds (sodium antimonyl tartrate) are described. The synthesis of a new 
ligand capable of assembling into a larger metallo-cyclophane structure is also 
presented. 
4.2.1 Electronic absorbance spectra of the ligand, L', and its metallo-complexes 
in methanol 
The copper(I) complex ([CU2LI21[BF4]2) is a dark red coloured solid; in 
methanolic solution it is red-pink. Its silver(l) equivalent ([Ag2L121[BF4]2) is a bright 
yellow, light sensitive solid which is pale yellow in methanol solution. Methanol has a 
large spectroscopic window with a cut-off point at 210 nm. Absorbance spectra were 
therefore run from 210 nm - 750 nm. The absorbance spectra of both the copper and 
silver cyclophanes as well as that of the ligand used to form them are shown in Figure 
4.19 
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Figure 4.19 Absorbance spectra of copper cyclophane [Cu2L2]2' (20 gM), the equivalent silver complex (15 gM) 
[M2. L2][BF4]2 and Ligand L' (39 pM) in methanol. 
The spectra are characterised by a number of bands in the UV and visible region. 
Table 4.2 summarises their absorption maxima and F- values. 
Table 4.2 UV-visible absorbance assignments 
Absorption maxima X,,,,, /nm (F, = mol-1 dM3 CM-1) 
Ligand 210 (54,000), 240 (25,000), 255sh (24,500), 290 (26,000), 335 (24,500) taii up 
to 410 run 
Copper cyclophane 210 (62,500), 240 (40,000), 249 (45,000), 262 (37,500), 335 (65,000), as above 
with 386 sh (15,000), 510 (12,500), 560'(5000) 
Silver cyclophane 210 (93,300), 240 (57,000), 330 (83,000) with tail extending to -450 nm 
sh = shoulder, t=tail, IL-- in-ligand, MLCT= metal-to-ligand charge transfer band. 
To help interpret any interactions, the following assignment assumptions have 
been made. The ligand transitions centred at 210,240,290,335 up to 410 nm, which 
have high F- values characteristic of 7r-7r* transitions are assumed to be almost 
unchanged upon complexation and are as assigned in-ligand (EL) transitions in the 
complexes. The copper cyclophane has additional bands at 249 nm, 262 nm and a 
shoulder at 386 nm. These are most likely charge transfer (CT) bands as they are quite 
intense. The band at 510 nm is assigned a metal (Tim) to ligand (TEM charge transfer 
band (MLCT) with a long tail to -560 nm. The silver cyclophane spectrum has bands at 
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240 and 330 nm assigned as IIL, 7E-7r* transitions with a long shoulder extending to - 
450 nm that is probably a metal-to-ligand CT, (MLCT) band. 
4.3 Interactions with neutral molecules: Methoxybenzene 
metal I o-cycl ophane interactions 
LJV-Visible absorbance and fluorescene binding studies into the interactions of 
the host/receptor [CU2LI21[BF4]2, the copper cyclophane, with substrates neutral 
aromatic methoxybenzene molecules: 1,2-dimethoxybenzene (12dmb), 1,3- 
dimethoxybenzene (13dmb), 1,4-dimethoxybenzene (14dmb); 1,2,3-trimethoxybenzene 
(123tmb); and 1,3,5- trimethoxybenzene (135tmb) (Figure 4.19) were undertaken in dry 
methanol. 
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Figure 4.19 Di- and tri- methoxybenzenes used in this work 
The di- and tfi-methoxybenzenes were chosen for this study as they have been 
shown to bind well in organic solvent in other similar box structures such as Stoddarts' 
cyclobis and Fujita's tetranuclear square. These substrates may bind by (i) interactions 
in the cavity; (ii) electrostatic and charge transfer interactions; (iii) pi stacking. 
Aromatic compounds are held in box cavities by some combination of hydrophobic, 
electrostatic and charge transfer and 7r-stacking interactions. If substrates bind 
externally onto the supramolecular lattice they may self-aggregate in solution. 
The di- and tri-methoxYbenzene substrates are colourless in methanolic solution, 
absorbing in the UV region below 310 nm (Figure 4.20). 
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Figure 4.20 Absorbance spectra of substrates in methanol 
4.3.1 Materials and Methods 
1,3,5-tri-methoxybenzene was purchased from Aldrich, the other di- and tri- 
methoxybenzenes were purchased from Lancaster. Organic solvents were obtained as 
follows: Hi-dry MeOH (anhydrous solvent) from Romil; deuterated acetonitrile 
(CD3CN) (99.8%), and methanol (CD30D) from GOSS. Molecular sieves (3A, 1.66 
mm. pellets) used in the NMR experiments were obtained from Aldrich. 
Titration experiments to determine binding constants were conducted using 
UV-Visible spectroscopY and fluorescence. Both experiments required that either the 
metallo-cyclophane or substrate concentrations be kept constant; titration sequences 
were set up to this effect. In general, methanolic stock solutions of the cyclophanes and 
substrates were made up in the following ranges: 300 - 500 ptM substrates, 20 - 40 gM 
metallo-cyclophanes. 
For UV-Visible absorbance studies, titration sequences were employed with the 
cyclophane concentration being kept constant as successive amounts of substrate 
concentration were added. The metal I o-cyc lophanes do not fluoresce whereas the 
substrates do. For fluorescence studies, therefore the substrate concentration was kept 
constant as the cyclophane concentration was varied. 
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Absorbance spectra were measured using a1 cm pathlength quartz cuvette on a 
Jasco V550 UV-Visible spectropol ari meter. Fluorescence spectra were measured using 
aI cm pathlength, four-sided clear quartz cuvette on a Perkin Elmer LS50b. Each 
titration experiment was repeated three times or until consistent results were achieved. 
The error ranges quoted in the tables reflect the variation from experiment to 
experiment. 
Stoichiometric ratios will be expressed in the order [substrate: receptorl where 
the receptor is the metal complex, or will be stated otherwise. 
4.3.2 Equilibrium Binding Constant determination 
Binding studies were undertaken using UV-Visible absorbance spectroscopy and 
fluorescence. The absorbance of the cyclophane in regions where the substrate has no 
spectroscopy and the fluorescence of the fluorescent substrate change upon mixing 
cyclophane and substrate solutions, so both have been used to probe the binding. In the 
absorbance experiments, the concentration of the cyclophane the receptor, was kept 
constant as the concentration of the methoxybenzene, the substrate was varied. Any 
change in absorbance signal of the metal complex would therefore be due to interactions 
with the substrate. Conversely, in the fluorescence experiments the substrate 
concentration was kept constant. This method can be used to determine the binding 
constant, K, of two species, if a single binding mode (or constant ratio of multiple 
binding modes) is in operation over a chosen concentration range. 
Induced spectroscopy method (ISM) to determine K 
ABSORBANCE BINDNG CONSTANT DETERMINATION: The induced spectroscopy method 
(ISM) as developed by Rodger 18 in combination with a Scatchard. plot can be used to 
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deten-nine the K value of the interaction of the copper cyclophane and di- and tri- 
methoxybenzenes. This method can be used when the higher limits of binding, i. e. the 
absorbance at full binding cannot be examined, if instead for example, a subsequent 
weaker binding mode begins to be occupied as the receptor sites are filled. 
For comprehensive details on the ISM of determining binding constants please 
refer to reference 18. 
The interaction between a receptor (R) and a substrate (S) with binding 
properties for the receptor can be described by the equation: 
k, 
R+S RS 
k2 
(kl, rate of association; k2 rate of dissociation). 
The simplest measure of the binding strength between two molecules, can be described 
by a binding association constant (K) where: 
[RSI k, 
K= -= 
[RI[S] k2 (4.1) 
From above, in general terms: 
R+S RS 
where R is the receptor (cyclophane), S is the substrate and RS is the bound species. 
More specifically, 
Rf + Sf --;:: t RS 
i. e. free receptor + free substrate = bound species. As the total receptor concentration 
R,,, equals the free receptor concentration plus the concentration of the bound receptor, 
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Rt, t = Rf + Rb and, the total substrate concentration equals the free substrate 
concentration plus the concentration of the bound substrate St, t = Sf + Sb. Therefore Rb 
is equivalent to RS which is equivalent to Sb. The equilibiium binding constant 
(equation 4.1) can therefore be defined as: 
Sb 
SfR f 
(4.2) 
The total receptor site concentration, (the total binding site concentration of the 
C. 
cyclophane) R,,, t is equal to where C. is the macromolecule concentration (the total 
constant cyclophane concentration) and, n is the number of cyclophane binding sites per 
substrate. If the experimental data show that the binding mode is constant, then, using 
spectroscopic data the starting point is equation 4.3: 
Sb = aP (4.3) 
where a (a function of wavelength) is a constant over the range of binding ratios being 
considered and p is the absorbance signal at a chosen wavelength, in this case AA (the 
change in absorbance due to the interactions of substrate with the box). 
The induced spectrospopy method simply involves the rewrite of equation 4.2 to 
give an expression: 
ap (4.4) 
(Rtot - ap) (Stt - ap) 
which when rearranged to give S,, t, for two different substrate concentrations Sil, t and 
at the same macromolecule concentration On, Rjtot -.: Rk tot gives equation 4.5. 
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S, tot -S Jtot 
Sktot Si 
tot _ 
Rt., pk -pi 
kik+a (4.5) 
Skt"t _ Sitot 
A plot of y=Sk 
101-S jtOI 
versus xPkP should give a straight line plot 
Pk_PiPkP 
with slope equal to 
C. 
and intercept a, from which Rto/Cin (the amount of box that is 
11 Cr 
binding box) and it can also be determined. 
The a value calculated and the changes in signal value p can be used to 
determine Sf, which in turn can be used in a Scatchard plot of 
r 
vs r, where r= 
Sb 
is Sf CM 
the ratio of bound substrate over the total constant box concentration and S the free f 
substrate concentration. The plot should have a negative slope of K, with the intercept 
equal to K divided by n, the x intercept occurs where r equals n. 
FLUORESCENCE BINDING CONSTANT DETERMINATION: A method to calculate K can be 
developed from the basic principles of fluorescence. 
Fluorescence is made up of F= Fb + Ff where F is the total fluorescence 
reading, Fb is the fluorescence reading of bound substrate and Ff is the fluorescence 
reading of free substrate. Similarly, if Sta equals the total fluorescent substrate 
concentration (on the assumption that the substrate alone fluoresces), we can say that at 
any one time that, Sl, t = Sf + Sb.. Both equations combined and rearranged give: 
F= 
sb 
Fb + 
Sf 
Ff (4.6) 
Slot Stof 
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If Sf is replaced in equation 4.6 and we can rearrange it to give 
Sb 
Stot (F - Ff (4.7) 
Fb - Ff 
where Sb is the bound substrate concentration. A Scatchard, plot of 
r 
vs r where Sf 
Sb 
r=- can be used to determine K. The binding curve should yield Ff and Fb, and the C. 
change in fluorescence AF i. e. (F - Ff) on addition of cyclophane increments to 
substrate. Sb can be determined using the data available from equation 4.7. The 
negative slope of the Scatchard plot should yield K. 
4.3.3 UV-Visible absorbance study 
UV-Visible absorbance data was collected over a substrate: cYclophane 
concentration mixing ratio, R, of [0: 1] - [6: 1]. Figure 4.21 shows the absorbance 
spectra of the copper cyclophane complex and its spectroscopic interactions with 14dmb 
in methanolic solution. The absorbance spectral data of the complete titration sequences 
for all five methoxybenzene substrates with the copper cyclophane (working with a 
constant cyclophane conceiltration of 15 [tM) are given in Appendix 4.1. 
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Figure. 4.21 Absorbance titration spectrum of copper cyclophane with 14dmb in methanol. Working with a constant 
cyclophane concentration of 15 pM. The arrows in the legend indicate whether the absorbance increases or decreases 
on addition of substrate. 
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In general, the absorbance intensity of the complex spectrum (Figure 4.21) 
initially increases on addition of substrate up to mixing ratios of -1: 1 - 2: 1 with each 
substrate, after which two isosbestic points at 240 nm and 304 nm appear. Isosbestic 
points below 310 nm can be ignored, as they are manifestations of substrate additions. 
The absorbance intensity then gradually decreases at higher ratios. This decrease in 
absorbance intensity is termed a hypochromic shift and usually indicative of n-stacking. 
The development of isosbestic points on successive additions from 2: 1, and the 
decrease in absorbance intensity on successive additions from 2: 1 to 6: 1 (the last 
addition made) of substrate: cyclophane, seem to indicate that the system may possess 
more than two states, possibly one free, and two different bound species. The 
absorbance spectrum of the cyclophane with 14dmb shows isosbestic points at 240 nm 
and 304 nm. after [2: 1] substrate: cyclophane mixing ratio, indicating one binding mode; 
below -[2: 1] ratio there is an additional binding mode. Changes in absorbance intensity 
at 335 nm and at 509 nm (charge transfer band magnified x1O) are clearly 
distinguishable. 
As the substrates all absorb below 310 nm, the change in absorbance (AA) at 
335 nm (assigned to an IL n-n* transition) and the MLCT band at = 509 nm over 
the length of each titration were followed (See Tables 1 and 2 in Appendix 4.1). 
For each substrate, at 335 nm and -510 nm, AA versus subs trate: cyclophane 
concentration plots yielded smooth, positively increasing binding curves, up to ratios of 
approximately 1: 1 or 2: 1 substrate: cyclophane after which the absorbance intensity 
begins to decrease and the curve begins to slope downwards. Figure 4.22 illustrates the 
AA values for 14dmb in the form of a binding curve of AA as a function of 
substrate/cyclophane concentration. 
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Figure 4.22 The binding curve of the interaction of the cyclophane with 14 dmb, a graphical version of its spectrum from 
Figure 4.21 
As the early data points up to 2: 1 probably correspond to a single binding 
regime, an induced spectroscopy method (ISM) analysis was attempted. The largest 
possible area on the binding curve was examined, in most cases [0.6: 1]-[2: 1]. (As K is 
constant in uniform binding modes, the same portion of each binding curve was 
examined for each substrate). 
The appropriate spectra, and their K values deductions i. e. ISM and Scatchard 
plots for each substrate can be found in the Appendix 4.1. K values are surnmarised in 
Table 4.3. 
12dmb, 13dmb, and 135tmb all have binding constants of - 106 M-1, with 
12dmb having the largest value of K suggesting its geometry is most suited to the 
binding site. The 14dmb substrate, which might have been expected to slot neatly 
through either the helix or box confonnation of the cyclophane has a binding constant 
an order of magnitude weaker - 105 M-1 as does 123tmb. 
4.3.4 Fluorescence study 
Fluorescence experiments were set up to monitor the substrate fluorescence 
while the metal complex concentration was varied; here metal complex increments were 
added to constant substrate concentration in order to monitor quenching of substrate. 
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Fluorescence spectra were run from just before the excitation wavelength up to 700 nm 
(the presence of Rayleigh scattering was also noted). Xex and Xem refer to the 
excitation and emission wavelengths and ex. /em refers to the size of the excitation and 
emission slits used on the fluorimeter. Once the excitation and emission slits were set to 
provide a reasonable intensity of substrate, they were not changed. 
Preliminary investigations show that whilst the substrates were highly 
fluorescent, the cyclophane itself exhibited a fluorescence of less than 10 fluorescence 
units. When both were placed in solution the presence of the box seemed to produce a 
quenching effect on the fluorescent spectra of the substrate. Therefore fluorescence 
titration experiments were set up to monitor the substrate fluorescence while the 
cyclophane concentration was varied. The changes in fluorescence were a larger 
percentage of the total fluorescence signal than is the case with the absorbance 
experiments and so consistent data sets were easier to achieve. The [1: 1 - 1: 2.4] 
(substrate: cyclophane) binding region was examined in these experiments which 
corresponds to a similar portion of the LTV-Visible titrations. 
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Figure 4.23 Fluorescence spectrum of the cyclophane with 13dmb. Working with a constant substrate concentration of 
10 pM, ratios are indicated within the figure as are experimental parameters. 
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Figure 4.23 illustrates the fluorescence spectrum of a titration of the copper 
cyclophane with 13dmb. The substrate solution was excited at 273 nm (an IIL substrate 
transition) and the change in emission recorded at 298 nm. A large quenching of the 
substrate (13dmb) fluorescence to a relatively small fluorescence intensity can be seen 
on the initial addition of cyclophane complex, this is followed by much smaller 
decreases in fluorescence on addition of cyclophane increments up to the [1: 2] 
substrate: cyclophane mixing ratio. The fluorescence at X. for all the titration 
experiments is summarised in Table I Appendix 4.2 as are the AF values (where AF 
equals F the fluorescence of the box and substrate minus the free fluorescence Ff ). 
For each substrate, AF (the change in signal) versus box: substrate concentration 
plots were found to be smooth negatively decreasing binding curves (not shown). As the 
data produces a curve, these changes can be used to calculate the extent of binding. 
Appendix 4.2 holds the fluorescence spectra for all five substrates and their K values 
deductions. 
The substrates Were found upon ISM and Scatchard analysis to bind with 
106 (106WI binding constants of 105 - M-1. K values were largest for 14dmb ), and 
weakest for 123 and 135 tmb (105M-1) as summarised in Table 4.3. 
4.3.5 Summary of binding studies 
The binding constants determined for the interactions of the copper cyclophane 
complex with di- and tri- methoxy benzenes are unusually high when compared to 
reported values for similar structures of this type (for 14dmb: K value of lX104 M-1 with 
Fujita's square (Figure 4.5) in deuterated water, 7 K= 340 M-1 in deuterated methanol 
and water Mix 2,7 and K= 17M-1 with cyclobis (Figure 4.4) in acetonitrile solution) .2 
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Table 4.3 Summary of binding constants determined using absorbance and fluorescence spectroscopy. The detailed K 
tables including error calculations for absorbance and fluorescence studies can be found in Appendix 4.1 and 4.2 
respectively 
Substrate Absorbance K values / M*' Fluorescence K values / 1W 
12dmb 4-5x 106 -Ix 10, 
13dmb -3x 106 _IX 106 
14dmb 2-8x 105 3 -5 x 
106 
123tmb 4x 105_ 1X 106 7x 105- 1X 106 
135tmb 1-2x 106 7x 105_ 1X 106 
Comparison of the binding constants deten-nined using absorbance with those of 
fluorescence, do show agreement within acceptable limits of experimental error. The 
exception is the value for 14dmb. 14dmb's binding constant was found to be an order 
of magnitude weaker than other substrates when probed using UV (-105M-1) and 
significantly larger when probed using fluorescence. 
The absorbance studies seem to indicate the existence of at least two modes of 
binding to the metal complex, the first mode starts from [0: 1-2: 1] substrate: cyclophane, 
with the second switching on below R of [2: 1]. The latter may perhaps involve 
substrates stacking in solution (as shown by the spectra and the binding curves). There 
was no indication of different binding modes from the fluorescence, but then a similar 
binding region to that for absorbance was not explored due to the non-fluorescence of 
the metal complex. 
Absorbance experiments were set up to look at [0: 1-6: 1] substrate: cyclophane 
region of the binding curve by probing the box. K values were calculated in the [0.6: 1- 
2: 1] region, so the values reflect the earlier binding mode of the two exhibited by 
absorbance. The second mode can also be probed using absorbance, but calculations 
were only made on the first mode due to the overlay of signals. The fluorescence 
188 
experiments explored the [1: 1-1: 2.41 substrate: cyclophane binding region by probing 
the substrate. 
4.3.6 Specific interaction investigations 
Although the binding constant determinations gave real data and allow a 
determination of K, it remained possible that the process being probed was not the 
insertion of the dmb into the metal lo-cyclophane cavity. In order to determine whether it 
is the inserted cyclophane complex associated with its ligand or the metal ion (copper(l) 
or silver(l)) or a salt effect (tetrafluoroborate) or a combination of these that we were 
observing, the interaction of each with 13dmb was investigated using fluorescence. 
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Figure 4.24 Fluorescence of ligand L' with 13dmb. Working with a constant substrate concentration of 10 pM, ratios are 
indicated within the figure as are experimental parameters. 
The ligand itself does not fluoresce in these experiments. However, Figure 4.24 
shows the fluorescence quenching of the substrate when ligand Ll is added (see 
individual spectra for conditions, NB: ratios are [cyclophane: substrate] in contrast to the 
copper data). The quenching observed is similar to that observed when copper 
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cyclophane is added to substrate but not as large. A binding constant of K=105 M-1 - 
an order of magnitude weaker than that with the cyclophane complex was calculated. 
This is still a large binding constant, which suggests ligand-dmb interactions are a 
significant part of the cyclophane-dmb complexation. This result positively suggests the 
ligand takes part or has an effect on the substrate in some way, but also that the 
cyclophane structure enhances the binding interaction in some way. It is possible that 
the metal complex dissociates to metal plus ligand or metal plus ligands on substrate 
addition. This would account for the increase in absorbance as substrate concentration is 
increased up to a [2: 1] substrate: cyclophane addition with the substrate reacting either 
with free ligand or a part of the metal complex. 
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Figure 4.25 The fluorescence spectrum of 13dmb with the silver BF4 cyclophane. Working with a constant substrate 
concentration of 10 pM, ratios are indicated within the figure as are experimental parameters. 
To detennine if the metal used in the complexation of the cyclophane affects the 
interaction between the substrate and the cyclophane, two experiments were set up. 
The silver equivalent cyclophane and its interaction with 13dmb was investigated, (see 
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Figure 4.25). On comparison with Figure 4.23, changing the metal ion was found to 
have little or no effect on the interaction between the substrate and the cyclophane. (ii) 
The interaction of 13dmb with [Cu(MeCN)41[BF4] was investigated. Figure 4.26 shows 
the fluorescence interactions of the substrate with the copper salt [Cu(MeCN)41[BF4]. 
Very little quenching of the substrate fluorescene is seen when the BF4 salt is added to 
13dmb. When the [Cu(MeCN)41[PF6] salt was used (not shown) again only minor 
quenching was seen. Thus it was concluded that the metal centre itself was not playing a 
role in metallo-cyclophane/dmb interactions. 
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Figure 4.26 Fluorescence interactions of 13 dmb with (Cu(MeCN)41[BF4] salt. Working with a constant substrate 
concentration of 10 IM 
Stability Studies 
Proton NMR, UV-Visible absorbance spectroscopy and mass spectrometry were 
used to investigate cyclophane stability over a range of concentrations 10-3,10-4,10-5 M 
and over time in methanolic solution. Proton NNIR and absorbance studies show the 
same species to be present in solution at all of these concentrations. NMR and 
absorbance studies on comparable concentrations of the [CU21,2] 
2+ 
complex in CD30D 
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were undertaken. No evidence of aggregation at high concentration and/or of 
dissociation at lower concentrations was found (data not included). 
Fourier transform - ion cyclotron resonance (FT-ICR) on the Bruker Apex 11 at 
Warwick (in collaboration with FT-ICR operators X. Feng and H. Fielding) and 
electrospray ionisation (ESI) mass spectrometry studies showed that the copper 
cyclophane of the formula [M2L2][BF4]2 has the same species in solution at 1 0-3 , 10 -4 
and 10-5 M. It also shows evidence of self association at higher concentrations i. e. a 
peak corresponding to [MýL41[BF413+ was seen. When used to see if binding interaction 
is taking place, no peak corresponding to [cyclophane + substrate] was seen. However, 
this is not proof of lack of formation of such non-covalent complexes. 
Interestingly, in absorbance studies, a defined increase in absorbance is seen as 
substrate concentration increases before decreasing at higher concentrations. A similar 
increase in the number and size of cyclophane peaks was also seen as substrate 
concentration was increased via mass spectrometry. 
NMR studies to investigate interactions 
NMR studies were tonducted in deuterated methanol using dry molecular sieves 
(3A 1.6 mm pellets). The NMR sample preparation and titration method employed was 
to weigh and mix directly in the NMR tube. Titrations similar to those employed for the 
spectroscopic methods were used. Concentrations were in the 1 mM concentration range 
as is necessary for NMR. 
NMR studies were undertaken in order to confirra the spectroscopic data to 
provide reasonable explanations for the strength of binding and to determine if the 
ligand L' or the metallo-cyclophane complex affects interaction. The chemical shifts 
were compared and the formation of new species was sought. A comprehensive study 
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using low temperature 1H NMR, 19F and 11B with 14dmb in deuterated methanol was 
undertaken. 
Briefly, the following proton NMR were investigated at low temperature in 
cleuterated methanol (CD30D): (i) ligand (L) alone; (ii) 1: 1 ratio of L1: 14dmb; (iii) L1+ 
[Cu(MeCN)4BF4]; (iv) 1: 1: 1 ratio of L' + 14dmb + [Cu(MeCN)4BF4] salt; and (v)l: l 
ratio Of [CU2L2]2+ cyclophane complex: 14dmb. 19F and 1 1B NMR of (iii) and (iv) at 
room temperature were also undertaken. The results are not included. 
The results of (i) and (ii) suggested that the ligand has no interaction with the 
substrate alone. The results of (iii), (iv) and (v) were inconclusive in that no noticeable 
changes in NMR (>O. 1 ppm shift) were observed. Initial studies had seemed to indicate 
that the substrate was interacting with the complex, with (a) the imine proton on the 
complex shifted upfield; (b) the CH2 group in the middle of L' shifted upfield; and (c) 
the CH3 groups at the tail end of the ligand exhibiting a downfield shift. These data 
initially suggested that 14dmb sits on the box but not in it. However, similar shifts were 
found to occur with Ll+[Cu(MeCN)4BF4], Ll+[Cu(MeCN)4BF4] + dmb over a 
temperature range so these results are inconclusive as any chemical shifts seen could be 
a result of temperature decrease. 
Summary of methoxybenzene metallo-cyclophane interactions 
Interactions between the metal lo-cYClophane structure and neutral molecules (di- 
and trimethoxybenzenes) have resulted in unusually high binding constants of K _105 _ 
106 M-1 being determined using both absorbance and fluorescence spectroscopy. 
Investigations into the specific interactions in solution, suggested that metallo- 
cyclophane binds unselectively but strongly with all the aromatic electron-rich 
substrates investigated. The copper and silver metal ions and their salts are not involved 
directly in complexation between the substrate and the metal] o-cycl ophane (studies 
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using a different metal centre (a silver cyclophane) showed similar interactions) but they 
do play a role since the presence of the metal gives a binding constant xIO higher than 
with the ligand alone. 
NMR studies were inconclusive, after preliminary results seemed to indicate that 
the substrate may interact/sit on the box rather than in it. NMR and absorbance studies 
indicate that the metallo-cyclophane does not dissociate in solution. Both the complex 
and the substrate are perturbed in some way but it is still unclear as to where the 
substrate is binding. 
It may be that the metallo-cyclophanes are not large enough to accommodate the 
substrate in the cavity but the ligand or ligands and substrate interact in some way. This 
is addressed in section 4.6. Solvent molecules have been found inside the cyclophane 
cavity in the solid state, ' but no larger molecules to date. 
Further work 
Although the cavity of the cyclophane should be large enough for single 
aromatic systems, this does not seem to be the binding mode adopted. Further work to 
design sensors for neurotransmitters will require the synthesis and analysis of a larger 
metal I o-cycl ophane. Molecular modelling studies on this and any new systems would 
aid in determining if and how the substrates sit in the box cavity, and to help account for 
the range of binding constants. 
4.4 Interactions with anionic compounds 
The interaction of the copper cyclophane with chiral anionic compounds was 
investigated and resulted in a method whereby the copper tetrafluorobarate cyclophane, 
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[Cu2L12]2' helix-box mixture (and other cyclophanes with similar ligands) can be 
resolved into its helical enantiorners. 
4.4.1 Resolution Of [CU2L12 ]2+ copper cyclophane helix-box mixture 
Sodium antimony] tartrate, NaSbtat, (Figure 4.27) is a member of a family of chiral 
molecules that are well known for their use in the resolution of racemic (rac) tris chelate 
complexes due to the different binding of NaSbtat to their A and A-enantiomers. 57,58 For 
example, [Ru(1,10-phen)3]2+ where 1,10-phen = 1,10-phenanthroline, [M(biPY)31 2+ 
where bipy = 2,2'-bipyridine (see chapter 2) can be resolved by these compounds. 59 
2- NaSbtat exists in a dianionic form, (C406H2Sb)2 , in solution (Figure 4.27). 
2. 
11 
(a) (b) 
Figure 4.27 (a) The 2-D and (b) 3-D stick and ball structure of the chiral dianion, sodium antimony[ tartrate 
Sodium antimonyl-L-tartrate (98%) was purchased from Avocado, the sodium 
antimony]-D-tartrate is not commercially available and was synthesised using a 
modified version of the preparation described by Coggan et al. 59 An aqueous slurry of 
Sb203 + NaOH + D-tartaric acid ( in a molar ratio 1: 1: 2) was heated under reflux for 2- 
A. The white precipitate formed on cooling, NaSb-D-tat, was collected under vacuum, 
and used without further purification. The NaSb-D-tat is only sparingly soluble in 
water. 
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Spectroscopic investigation 
The L isomer of NaSbtat, NaSb-L-tat, is chiral but colourless in solution, 
therefore exhibiting a CD signal in the far UV region only. A CD spectrum of the 
[Cu2L2] 2+ helix-box mixture exhibits no signal due to the racemic mix of the helices. On 
addition of NaSb-L-tat to a methanolic solution of the box: helix mixture, a CD signal is 
induced in the LTV-visible region of spectra. The magnitude of the signal is reasonably 
large so it corresponds to a Pfeiffer effect shift (shift of A and A equilibrium) of the 
helix: box mixture to having an excess of one helical enantiomer (see Figure 4.28). 
Both the D and L fonn of NaSbtat induce bands in copper cyclophane at 255 
nm, 310 nm (IL transitions), 350 nm and 500 nm. The signals are equal in magnitude 
but opposite in sign. 
4 
2 
P. A 
--------- copper cyclophane alone 
......... Na Sb-L-tat 
- cyclophane + Na Sb-L-tat 
A cyclophane + Na Sb-D-tat 
300 400 500 600 700 
wavelength/ nm 
Figure. 4.28 CD spectra of the interaction of the D- and L- enantiomers of sodium antimonyl tartrate with a 
methanolic solution of the [Cu2L12 ]2+ metal complex. The synthesised D-enantiomero is not as soluble as the L- 
enantiamer in MeOH hence it exhibits a smaller signal. 
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Proton NMR investigations 
Preliminary proton NMR studies confirmed that NaSb-L-tat interacts with the 
helix of the box: helix, through the splitting of its phenyl helix signals and an increase in 
the ratio of the helix: box. 
A proton NMR study over [1: 0-1: 4] copper cyclophane: NaSb-L-tat mixing ratios 
was set up. A known concentration and volume of the copper cyclophane was placed in 
an NMR tube and its NMR run; additions of NaSb-L-tat were then added directly into 
the NMR tube to give [1: 0.5]; [1: 1); [1: 2]; [1: 3] and [1: 4] cyclophane: NaSb-L-tat 
mixing ratios. Figure 4.29 shows the proton NMR interactions that occur on increasing 
the anionic tartrate concentration. Figure 4.29(b) shows the aromatic portion of the 
NMR spectra of the copper metallo-cyclophane complex alone in deuterated methanol 
(CD30D). Figure 4.29(c) shows the effect of addition of the chiral NaSb-L-tat in a [1: 1] 
cyclophane: NaSb-L-tat mixing ratio. Peak splittings suggest that the anion initially 
perturbs the helix of the box: helix n-dx. As the concentration of the anion is increased up 
to a [1: 4] cyclophane: NaSb-L-tat ratio, an interaction with the box imine peaks is also 
seen (Figure 4.29(d)). 
Thus, the helix: box Metallo-cyclophane is in equilibrium between helix and box 
under normal circumstances and the A and A helices also exchange. Addition of the 
chiral anion shifts the equilibria to favour one enantiorner of the helix over the other 
enantiomer and the box. The integrals suggest that the equilibrium of the copper 
cyclophane, which is initially -[2: 1] helix: box is pushed to [3: 1] in the presence of the 
tartrate 
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Figure 4.29. (a) NMR assignment s of L' of the copper cyclophane; (b)The aromatic portion of the copper cyclophane 
(box-helix) spectra mix alone [1: 0] in deuterated methanol (d 3 MeOH); (c) At [1: 1] cyclophane: NaSb-L-tat, see splitting 
of the H phenyl helix assigned peaks and the H imine helix peak, (d) At (1: 4] see the splitting of the Himine box and 
helix peaks, broad H4 and H3/5 and the separation of H phenyls of the different helices and the box. NMR spectra were 
recorded on a 300 MHz Bruker FT-NMR with 128 scans 
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The splittings observed are most dramatic for the phenyl and imine resonances, 
the CH2 resonances are also perturbed (Figure 4.30) whereas the methyl group 
resonances are unchanged, implying that the chiral anion interacts with the metal 
complex in the perturbed region of the structure. 
4.5, '4.0' -, 'TJ 
(b) 
4. S 4.0 3.5 
PPM 
Figure 4.30 The CH2 group resonances of the copper cyclophane box: helix mbdure in d3 MeOH (a) alone and (b) on 
interaction wih NaSb-L-tat, the CH2 resonances also show splitting. 
Proton NMR titration experiments set up to approximately determine the 
interactions of both enantiomers of antimony] tartrate with the copper cyclophane over 
time in deuterated methanol, showed that the interactions are immediate with no big 
change over the space of 24 hours (data not shown), The solutions are a deep red in 
colour. Over the period of a week, however, the deep red solution containing the L 
anion eventually becomes colourless with the precipitation of a dark red crystalline 
solid. 
Specific interaction investigation 
To determine whether the interaction was due to the replacement of the 
tetrafluoroborate salt with the tartrate anion, interactions with other chiral tartrates such 
as sodium L-lactate, potassium L-tartrate, dibenzoyl-L-tartrate were examined. For each 
of these anions, no CD signal was seen, so the isolated tartrate portion plays no part in 
resolution rather it is the antimonyl complex that does. To investigate whether the Na' 
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ions were interacting with the N atom binding sites, a proton NMR titration of sodium 
acetate CH3COONa with the copper cyclophane in CD30D was examined. This showed 
no NMR interaction. KSb-D-tat is not very soluble in methanol but also provides a CD 
signal on mixing with the copper cyclophane. The cationic metallo-cyclophane must be 
sensitive to the shape of the sodium antimonyl tartrate dianion. This is analogous to the 
fact that unsaturated tris-chelate complexes can be resolved by antimonyl tartrate, 
whereas the saturated [Co(ethylenediarnine)3]3+ can be resolved by barium tartrate, but 
not NaSb-tat. 
4.4.2 Crystal structure 
To try to examine the interaction in more detail, crystallisation was attempted. 
The copper cyclophane was mixed with NaSb-L-tat in acetonitrile and benzene diffused 
into the solution. Unfortunately the crystals obtained proved not to contain the chiral 
anion. The tetrafluoroborate salt that resulted (Figure 4.31) was similar to the previously 
characterised hexafluorophosphate salt (see Figure 4.16), although the crystal packing 
was quite different. A solvent molecule was present in the cavity. The X-ray crystal data 
can be found in Appendix 4.. 3. 
Figure 4.31 Crystal structure of the copper BF4 cyclophane formed. Two non-identical but very similar boxes were found 
in the unit cell. 
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4.4.3 Summary 
The cationic copper metallo-cyclophane has been shown to interact with chiral 
anionic sodium antimonyl tartrate showing its possible potential as a probe for certain 
types of chiral carbonyl compounds. The dianion antimonyl tartrate has been shown 
capable of resolving the box-helix mix of the cationic copper cyclophane by inducing 
helix formation. 
4.5 Conclusion 
The mechanism of action of the interaction of dmb with the copper(l) metallo- 
cyclophane complex is still not understood. Although binding occurs, the box does not 
bind dmbs in its cavity, it seems that the box cavity is not large enough to accommodate 
the substrates fully. This is addressed in section 4.6. The metallo-cyclophane, 
however, has been shown to interact with chiral anionic antimonyl tartrate leading to an 
excess of one helix over the other and the box. 
4.6 Redesign 
In this section, the design and synthesis of a novel longer asymmetric ligand (C) 
(Figure 4.32) capable of a facile one pot self-assembly into a supramolecular 
cyclophane structure is presented. 0 has been designed such that one side is longer than 
the other; this change should produce a rectangular cyclophane structure with a larger 
cavity than that formed with L'. The length of a benzene ring is 5.2 A. The original 
copper and silver cyclophanes investigated were synthesised using L, having 
dimensions approximately 7Ax7A (length x width). With L? the metallo-cyclophane 
structure should have dimensions of approximately 11 Ax7A. This metallo- 
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cyclophane should have the space to hold aromatic substrates comfortablY inside its 
cavity. The asymmetry of the ligand may also disfavour helicate formation possibly 
resulting in one species in solution. 
R 
where R=H= L2 N- 
= quinoline = L3 
= CH3 L4 
:N 6-' 
R 
Figure. 4.32 The asymmetric Ligand 2,0, and its variations: Ligand 3 (0) and Ligand 4 (L! ) 
The asymmetry of the ligand complicates the synthetic preparation of 12 
compared to that for Ll. The basic structure of L2 is composed of a biphenylene group 
attached to a phenylene group via a bridging oxygen spacer. Variations using this basic 
structure are also presented as is the attempted extension of the ligand using a- 
(OCH2)- spacer group in place of the oxygen. 
4.6.1 Novel ligand synthesis 
The asynu-netry of 12 and introduction of a bridging oxygen provide a challenge 
to ligand synthesis when compared to the simplistic synthesis of L'. Scheme 4.1 
outlines the synthetic route that has been developed to reach L2. Using commercially 
inexpensive starting materials, the synthesis reported herein is a modification of 
numerous literature synthetic preparations. 60-69 
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Scheme 4.1 Six synthetic preparation steps of Lý 
+ 
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Scheme 4.1 illustrates the five steps that are necessary (each step denoted 
precursor 1 (Pl), step 2 precursor 2 (P2) etc. ) in order to attain the diamino precusor 
ligand H2N-C6H4-C6H4-0-C6H4-NH2 (12P5). This is not commercially available but 
its synthesis is documented 
60-64 
as are those of IýP3 and IýN 
65-66 i. e. 02N-C6H4C61L- 
OH. These are discussed in more detail in section 4.6.2. 
L? P5 can be used in the sixth step to synthesise the imine ligand L2. Using 
Hannon's method, ' mixing the commercially available 2-pyridine carboxaldehyde with 
12P5 results in the formation of 0 in high yield. An advantage of this synthetic route is 
that other than recrystalisation, purification of the compound at each stage is not 
necessary. Thus time-consuming column chromatography can be avoided. 
4.6.2 Ligand precursor synthesis 
The synthesis of 0 is outlined in the following sections: 
Ligand 2, precursor 1 synthesis (L 2pl) 
0-0-OH 
+ 
Cl 
4-hydroxydiphenyl benzoyl chloride 
1.1: 1 ratio 
pyridine 
--R-ca-t 
0 
reflux 
L2PI 4 diphenylbenzoate 
Scheme 4.2 Benzoylation of starting materials to form CP1 
The first step is the formation of 4-diphenylbenzoate 61-63 through the 
nucleophilic substitution (i. e. the benzoylation) of the hydroxy group of 4- 
hydroxydiphenyl. Scheme 4.2 outlines L2PI synthesis using commercially available 4- 
hydroxydiphenyl. The proton NMR of L2P1 in CDC13 was not easily assignable but the 
expected number and pattern of resonances were found. 
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Ligand 2, precursor 2 synthesis (L2P2) 
glacial acetic acid 
fuming nitric acid 0-&O-LO 
> 02N-o-&O-LO 
VP1 4 diphenylbenzoate 
nitration L2P2 
4- nitro4 diphen)Ibenzoate, as well as the 2 isomer 
Scheme 4.3 Nitration of L! Pl to form L2P2 using the Jones and Chapman preparation34 
The second step involves the nitration of the 4-diphenylbenzoate in the 4' 
position (see scheme 4.3). There are numerous preparations for the nitration of 4- 
phenylbenzoate. 63--64 Here the Jones and Chapman method using fuming nitric acid and 
glacial acetic acid was used . 
64 The 4-diphenylbenzoate undergoes electrophilic 
substitution to form 4'-nitro-diphenyl benzoate and the 2- nitro compound with the 4'- 
the predominant species in a 4: 1 ratio. 
The benzoyl introduced in the previous step is a deactivating group, which 
reduces the activity of the OH group on the phenyl ring to which it is attached so that 
substitution does not occur on that phenyl ring. Due to the ortho/para directing effect of 
the phenyl ring containing the deactivating substituent (and its affect on the connecting 
ring), subsequent substitution takes place on the connecting phenyl ring in 
predominantly the 4'- position (as well as in the 2' position). 64 The 4'-nitro-4- 
diphenylbenzoate is the least soluble of the isomers and it precipitates out (the 2' nitro 
ester is more soluble and remains in solution). 
An advantage of this reaction is that it does not require extensive purification or 
columning. However it was found that using larger quantities of starting material leads 
to a lower yield. The proton NMR in CDC13 was not easily assignable but the integrals 
do match the expected number and pattern of resonances. 
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Ligand 2, precursor 3 synthesis WP3) 
0 KOH/H20 
02N 0 
11 /ý\ EtOH --- )10'- 02 N 0- 0 -0-a-IJ/ 
L2P2 hydrolysis potassium salt 
K+ HO 
results in the fortrotion 
L2P3 ofbenwicacid 
Scheme 4.4 Hydrolysis of OP2 to give the potassium salt of L! P3 " 
The third step involves the hydrolysis of 4-nitrodiphenylbenzoate to form IýM, 
63,64 
the potassium salt of (HOC6114C6H4N20) (see scheme 4.4). Benzoic acid is a side 
product formed in the process, however there was no need to purify 12P3. If needed the 
potassium salt of the complex can be dissolved in hot water and acidified, resulting in a 
yellow solid of HOC6H4C6114NO2. This ligand can also be formed using a range of 
different synthetic methods. 
65,66 
Ligand 2, precursor 4 synthesis (L 2 P4) 
02 N-G-&O- K' 
potassium salt 
DMSO 
2hrs heating at 550C 
F-aNO2 > 02N--ýýO"'IiýýNO 
L2P4 
L2P3 
fluoro nitro benzenc 
Scheme 4.5 Formation of the basic ligand L! P4 structure using a modified version of Wilcoxýs synthesis 67 
The fourth step involves the reaction of IýM with para-fluoronitrobenzene in 
DMSO leading to the formation of the dinitro compound, 67 via an SN2 reaction. This 
step is a modified version of Wilcox's synthesis 67 where 4-cyanophenol was reacted 
with 4-fluoro-l-nitrobenzene (under the conditions outlined in Scheme 4.5, Le. KOH, 
DMSO, 551C) resulting in the p-nitrophenyl ether in a 98% yield. 67 
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The Wilcox approach was chosen as it is synthetically simpler and results in a 
larger yield compared to a number of other methods. 60,68,69 For instance Steller et al. 
used a larger number of steps to achieve a 28% yield . 
68 Rarick et al. 69 used similar 
materials (KOH, phenol and p-fluoronitrobenzene), but a different synthetic route 
whereby the solution was heated to 160'C for 30 minutes. The mixture was then poured 
into dilute NaOH and solid 4-nitrophenylether collected by filtration affording a 92% 
yield. Other similar methods include Acordia and Scarlatta who have suggested solid- 
state fusion, heating in an autoclave at 230'C. '60 The modified Wilcox approach results 
in a 95% yield of creamy white square-like crystals of L2P4 (02N-C6H4C61_14-0-C61_14- 
N02)- 
Ligand 2, precursor 5 synthesis (L 2 P5) 
NO 
2 
L2P4 
SnCI2.2H20 in conc HCI 
1A dioxane at 650C 
50%NaOH(aq),.. H2N-O-&O,, a 
NH2 Reduction to arnine L2P5 
Scheme 4.6 Reduction of L! P4 using'the method set out by Arcordfa and Scarlata 60,70 
The fifth step (L 2 P5) involves the reduction of the nitro groups to form the di- 
amino L2 P5. Care has to be taken to ensure that the reduction is gentle enough to retain 
L2 P4 structure. Reduction of ON with stannous chloride leads to the L2P5 60,70 (see 
scheme 4.6) in 69% yield. 
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4.6.3 Ligand synthesis (L 2, L3,0 and L) 
+ 
L2P5 Nlý, 0 
stir, 21 ratio 
pyridine-2-carboxaldehye 
EtOH 
L2 
Scheme 4.7 Condensation reaction, the preparation of 1! using Hannon's self assembling method ' 
The imine ligand 12 can be formed by mixing two equivalents of pyridine-2- 
carboxaldehye with one equivalent of OP5 in ethanol and stirring under dintirogen for 
24 hours. See Scheme 4.7. A bright yellow solid, 1! was isolated by filtration under 
vacuum affording a 89% yield. The ligand is formed via a condensation reaction where 
the two molecules combine to form a third molecule with the loss of water. 
Variations of 12 can be synthesised by mixing I2P5 with appropriate aldehydes. 
Quinoline-2-carboxaldehyde ligand has been used to form I? and 6-methylpyridine-2- 
carboxaldehye to form 0 (see Figure 4.32) 
The 1H NMR of 12 in deuterated chloroform was not easily assignable, its 1H 
NMR in deuterated DMSO was also not easily assignable but the expected number and 
pattern of resonances were found. 0,0 and Lý were all found to contain traces of 
starting material (SM) of 12P5 and the aldehyde used. 
Extension of ligand L2 
The incorporation of a spacer -(CH2)- group at the bridging oxygen site was 
also attempted, the new extended ligand denoted 0. 
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1,2133 can be used in the fonnation of 0. In a similar fashion to the L2P4 
synthesis (scheme, 4.8), OP3 was reacted with commercially available 4- 
nitrobenzy1bromide to successfully form L5 P4, the nitro complex. 
02 N 
C) 
0- --&NO, 
DMSO 
>0 
2N-Gý-&O- ý -0- 
K+ 
Br/ 2hrs, heat 551C 
potassium salt 4-nitrobenzylbromide 
LSP4 
L2P3 
02 
Scheme 4.8 Preparation of Lý using L! P3 to forrn L! P4 
However, using the reduction method outlined in Scheme 4.6, results in the 
break up of the ligand (see Scheme 4.9). The reduction method is too harsh for this 
compound so the synthesis was not pursued further (see section 4.6.5). 
SnC'2,2H20 in conc HCI 
1 -1 1-1 1A dioxane at 650C 
02N-Q-0-0- 50% NaOH (aq) 
LsP4 Reduction to arnine 
N02 
Scheme 4.9 Failed reduction step to the diamino complex 
4.6.4 Metallo-cyclophane formation with L2 and L3 
NH 
20-&o- 
L5P5 
NH, 
The reaction of 12 and 12 with tetrahedral metal ions, copper(l) and silver(l) as 
described' leads to the synthetically simple formation of novel dimeric supramolecular 
metal lo-cycloph anes of the structure M2L2[X]2 (where X= anion) (see experimental 
section). 
The reactions of C and 0 with silver(l) acetate in methanol gave rise to dark 
yellow solutions, which on addition of methanolic hexafluorophosphate (PF6) or 
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tetrafluoroborate (BF4) salts precipitate dark yellow complexes. One of two methods 
can be used: refluxing for one hour, or stirriDg under N2 for a few hours before addition 
of the methanolic salt. The latter method was found to result in larger and purer yields 
and was therefore used a majority of the time. Where reactions did not proceed then 
refluxing (a harsher method) or a combination of the two methods (refluxing followed 
by stirring) was then employed. 
In order to remove impurities from the silver complexes, it was found that if the 
complex was dissolved in dichloromethane and filtered through a pasteur pipette packed 
with celite and then reduced to dryness under vacuum resulted in bright yellow silver(l) 
complexes containing little or no SM. Numerous salts of the complexes [Ag2l22][X]2 Of 
0 have been made including the BF4 salt (formed by stirring), OTf (S03CF3, 
tiifluoromethanesulfonate) and C02CF3 (trifluoracetate) (formed by stirring for 2h 
followed by refluxing for a further 2h). However, all contain traces of starting materials 
(by NMR) and were therefore not characterised. 
Figure 4.33 Proton NMR of [Ag2L! 21[PFr, 12 jý CD2CI2 solution 
The proton NMR of the silver cyclophane, [Ag2]22][PF6]2 in deuterated 
dichloromethane (CD2CI2) at room temperature (Figure 4.33), however, was sufficiently 
pure enough to allow complex characterisation (see experimental section for 
assignments). At low temperature, broadening of the peaks in the proton NMR is seen, 
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(low temperature NMR were carried out by NMR operator Dr. Adam Clarke). Low 
temperature proton NMR of complexes in CD3CN and CD2Cl2 that were synthesised 
using method 1 and not purified using dichloromethane show the presence of both 
starting materials and silver complex. Acetonitrile readily dissolves both complex and 
starting materials, hence its complicated NNR spectra. The characterisation data 
provides proof of L2 formation and characterisation using proton NTvM. The mass 
spectrum (+FAB) of [Ag202][PF6]2 confirms the presence of complex exhibiting peaks 
for M2L2PF6 and M2L2 consistent with the formation of a dimeric species. 
The proton NNR of the silver cyclophane, [Ag202][PF6]2 (the metallo- 
cyclophane complex formed using 12), in CD202 at room temperature, was also pure 
enough to allow complex characterisation (see experimental section for assignments). 
The integrals indicate one species in solution at room temperature. The I-Emine 
(denoted H, in the experimental section) proton resonances have a coupling constant (J) 
of 7.4 Hz corresponding to a Ag ---- Himine coupling interaction. Low temperature 
proton NMR shows that the size of the Ag ---- Himine coupling is unaffected by 
temperature. The proton NMR exhibits one species in solution, which shows broadening 
at low temperatures. This'with a 2D 114- 1H COSY (correlated spectroscopy) NMR 
experiment (COSY assignments can be found in the experimental section) have been 
used to confirm the structure of the ligand (L 3) and hence the PF6 salt complex. The data 
strongly suggests that there is only one complex species in solution. Synthesis of the 
equivalent BF4 salt results in broad peaks that cannot be clearly assigned. 
Reactions of L2 and 12 with [Cu(MeCN)41+ salts in methanol result in red-brown 
solutions from which red-brown hexafluorophosphate or tetrafluoroborate salts may 
precipitate. The spectra of both L2 salts exhibit broad complex peaks as well as starting 
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material; as a result the integrals are unreliable and the proton NMR spectra of both 
salts in CD3CN or CD202 are not clearly assignable. Low temperature proton NMR in 
deuterated acetonitrile of both salt complexes (from 273 K to 193 K) shows the 
development of sharper peaks with the integrals eventually suggesting one species (i. e. 
22H) as well as SM. The spectra of the L3 salts are also broad and not readily 
assignable. The copper spectra have a tendency to be broad. 
Complexation was not attempted using 0 due to its low yield. The interaction of 
1ý with octahedral iron(H) was also attempted, a dark purple complex of low solubility 
formed but was not investigated further. 
Unfortunately, all attempts to obtain X-ray quality crystals of 1ý, 12 and their 
complexes proved unsuccessful. 
4.6.5 Conclusion 
Novel asymmetric ligands (I-?, L3 and 0) capable of a facile one pot self- 
assembly into supramolecular metallo-cyclophane box structures in solution have been 
synthesised and characterised. The silver PF6 metallo-cycllophanes of L? and L? have 
also been synthesised and characterised 
An advantage of this synthetic method is the ease of complex formation in 
relatively high yields as well as the use of cheap commercially available starting 
materials. A disadvantage of the ligand synthesis is that attempts to make larger 
amounts using larger quantities of reagents resulted in lower yields than if smaller 
amounts are used. 
The main problem encountered is the presence of starting materials in some of 
the products. Although, relatively pure silver PF6 complexes of L2 and 12 can be 
synthesised, it is obvious that a revised methodology is needed to provide consistently 
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pure complexes. As acetonitrile dissolves all complex and starting materials, perhaps 
complexation should be attempted in this solvent and not methanol. 
Further work 
Further work could involve the clean up of the ligands and complexes by: (i) the 
use of acetonitrile instead of methanol in complexation as acetonitrile seems to dissolve 
both starting material and ligand and complex as evidenced by proton NMR. (ii) the use 
of a modified version of Hannon's simple self-assembling method that involves the use 
of molecular sieves 71 to provide cleaner end products. (iii) Bellamy et al. have reported 
a mild, selective, inexpensive and general method for the reduction of nitro groups to 
amines using tin chloride in alcohol or ethyl acetate. 72 A part of further work could 
include an attempt at the reduction of ON using this milder reduction method. 72 
These suggestions were not attempted due to time constraints and also as the 
complexes could be purified as described here. 
Further work in this area would also be to investigate the binding of guests to 
these species. 
4.7 Experimental Section 
lH NMR spectra were recorded on 250 MHz, 300 MHz Bruker FT-NMR 
machines. Low temperature 1H, and room and low temperature 19F and 11B NMR were 
conducted by NMR operator Dr. A. Clarke on the 400 MHz Bruker FF-NMR machine 
at the University of Warwick. Mass spectra were obtained from positive Fast Atom 
Bombardment (+ve FAB) conditions with 3-nitrobenzyl alcohol (NOBA) used as a 
matrix or Electrospray (ES) conditions using appropriate solvents. The Infra-Red (IR) 
spectra were recorded using KBr disks on a Perkin Elmer FT-IR Spectrometer (Paragon 
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1000), or alone on a Nicolet Avatar 320 FF-IR specac equipped with a Golden Gate 
accessory. NEcroanalyses (CHN) were conducted on a CHN CE440 Elemental Analyser 
by Wanvick Analytical Services. 
Ligand synthesis 
L2 Pl: 
0-01,1-0-Lo 
LIPI 4 diphenylbenzoate 
L2 P1 was Prepared following the method of Hazlet et al. 
61--63 4-hydroxydiphenyl 
(5.136 g, 0.030 mol) was dissolved with stining in a cooled solution of pyridine (100 
cm 3) (in an ice water bath). The solution was held at this cooled temperature (-IO'C) as 
3 benzoyl chloride (3.8 cm , 0.033 mol) was added in a 1: 1.1 ratio with stirring. The 
mixture was then heated at 60'C for 30 minutes, refluxed gently for further 30 minutes, 
then was left to cool before treatment with water (in excess 100 cm 3) resulting in a 
white precipitate (water added with stirring until no more precipitate) and dilute HCI 
(20 cm). The white precipitate was then filtered under vacuum. Water was added to 
filtrate until no more precipitation was seen and that precipitate also collected. The 
white solid was then washed 5x with water, before being recrystallised from methanol 
(150 CM3 per 2 g) and dried over P205 affording the fluffy white needle-like solid of 4- 
diphenylbenzoate (8.05 g, 93 %). 
lH NMR (CDC13): S 8.23 (2H, d, J=3.5 Hz); 7.63 (2H, d, J=4.4 Hz); 7.59 (2H, d, J= 
4.1 Hz); 7.54 (2H, d, J=4 Hz); 7.48 (1H, dt, J=1.7 Hz); 7.43 (2H, d, J=2.9 Hz); 7.36 
(IH, dt, J=3.6 Hz); 7.29 (2H, d, J=3.2 Hz); FAB +MS: nz1z 275 [IýPI+Hl; IR 
(KBr)(cm-1): 1732(s), 1280(s), 1234(m), 1194(m), 1169(m), 1087(m), 1064(m), 879(m); 
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818(w), 759(s), 704(s), 688(s); Found: C, 83.19; H, 5.18. Calc for I2Pl: C19H1402: Cq 
83.18; H, 5.15; mp: 149 - 150'C 
L2 P2: 
O'N 
L2P2 
4ý niuý4 diphcuylbca=cc 
L2 P2 was prepared following the Jones and Chapman method. 64 I.? PI (0.961 g, 
3.5 mmol) was mixed with glacial acetic acid (8.5 cm 3) . The suspension heated to 85'C 
- 95'C to ensure that all of L2 PI dissolved to give a clear solution. If the solution is 
allowed to cool, the starting material will precipitate out. With the temperature 
maintained above 90'C, fuming nitric acid (2.4 cm 3) was added dropwise with stirring, 
the solution turned yellow and was left to cool, leading to the formation of a yellow 
precipitate. The precipitate was filtered by vacuum filtration, washed with water then 
methanol. The 2-nitro isomer could be isolated from the filtrate solution and the mother 
solutions. 64 The light yellow solid of 4-nitro-4-diphenylbenzoate (0.905 g, 81 %) was 
dried over P205. Note: using larger quantities of starting material leads to less yield. 
1H NMR (CDC13): 13H: 158.27 (2H, d, J=4.6 Hz); 8.22 (4H, m); 7.74 (2H, d, J=4.4 
Hz); 7.68 (2H, d, J=4.4 Hz); 7.54 (IH, t); 7.36 (2H, d, J=4.3 Hz); FAB +MS: nilz 320 
[OP2 + HI; IR (KBr)(cm-1): 1734(s), 1600(m), 1514(s); 1485(m); 1450(m), 1384(s), 
1342(s), 1265(s), 1213(s), 1190(s), 1165(m), 1080(m), 1060(s), 1024(m), 1005(m), 
858(m), 810(w), 790(w), 712(s) 
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L2 P3: 
02N-0-aO - 
potassium salt 
K 
L2P3 
L2 P3 was prepared following the synthetic method laid out by Jones and Chapman. 64 
L? P2 (1.510 g, 4.7 mmol) was mixed with EtOH (40 cm 3), the yellow suspension then 
stirred to reflux before an aqueous solution of KOH (1.019 g in 7 cm 3) was added. The 
solution turning deep red immediately zshowing rapid hydrolysis - and was left to 
reflux for a further 15 minutes to ensure hydrolysis was complete before being left to 
cool in ice overnight. Dark red blue-black crystals of L2P3 formed were filtered under 
vacuum (0.828 g, 69%). 
lH NMR (CD3CN): (5 8.23 (2H, d, J=4.5 Hz); 7.79 (2H, d, J=4.5 Hz); 7.59 (2H, d, J= 
4.5 Hz); 6.89 PH, d, J=4.4 Hz); IR (KBr)(cm-1): 1652(w), 1583(s), 1519(m), 1482(s), 
1345(s), 1284(m), 1205(w), 1116(w), 836(m) 
L2P4: 
02N--ýýO,, 
J, ýýNo, 
LIN 
L2 P4 was prepared following a modified version of Wilcox's synthetic 
approach. 67 The potassium salt L2P3 (0.787 g, 3.1 mmol) was mixed in a 1: 1 ratio with 
fluoronitrobenzene (0.436 g, 3.1 nimol) before DMSO (9 cm 3) was added. The dark 
red-purple solution was stirred with heating at 55'C for two hours. Over this time, the 
solution exhibited a colour change from dark purple to orange-red as a light yellow 
precipitate formed. The solution was then left to cool and crystallise out, filtered under 
vacuum to give cream coloured square-like crystals of L2 P4 (0.995 g, 95%), which 
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require no purification. (If the precipitate has a red/orange tinge, it is still wet with 
DMSO) 
lH NMR (CDC13): (5 8.30 (2H, d, J=4.7 Hz); 8.24 (2H, d, J=4.6 Hz); 7.73 (2H, d, J= 
3.5 Hz); 7.68 (2H, d, J=4.4 Hz); 7.21 (2H, d, J=4.4 Hz); 7.09 (2H, d, J=4.6 Hz); 
FAB +MS: nz/z 336[OP4]; IR (KBr)(cm-1): 1585(s); 1508(s); 1483(s); 1343(s), 1251(s); 
1167(w); 1109(s); 1006(w); 881(m); 858(s); 840(s); 755(m) 
L 2P5: 
H2 N-C)-&O_a 
L2PS Nlý 
L? P5 was prepared following the method of Acordia and Scarlatta. 60 I-? P4 
(0.447 g, 3 mmol) was mixed with 1,4-dioxane (8.2 cm 3) and heated with stirring to 
65'C. Once all 12P4 was dissolved, (the solution turning yellow), a solution of tin 
chloride (SnC12.2H20) dissolved in concentrated HCI (2.213 g in 4.9 cm 3) (also known 
as stannous chloride) 60,70 was added dropwise over a 15 minute period, the solution was 
then left at 65'C for a further 2 hours. 
On addition of contentrated HCI (in excess) to the solution, the white acidic 
protonated amine salt (NH3') product was precipitated and collected by vacuum 
filtration. The salt was then dissolved in a little water before a chilled aqueous solution 
NaOH (50%) was added to make the solution strongly alkaline. The resulting white 
precipitate of L2P5 that formed on cooling was filtered under vacuum and washed with 
water (can recrystallise from EtOH) (0.254 g, 69% yield). 
lH NMR (CD3CN): (57.47 (2H, d, J=3.3 Hz); 7.34 (2H, d, J=4.4 Hz); 6.91 (2H, d, i= 
4.5 Hz); 6.83 (2H, d, J=4.5 Hz); 6.70 (2H, d, J=3.3 Elz); 6.66 (2H, d, J=3.5 Hz ); 
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4.15 (4H, broad d); FAB +MS; itilz 276[OP5]; 552 [L2*P5]2; IR (ICBr) (CM-1): 1612(m); 
1508(s); 1494(s); 1244(s); 822(s) 
Ligand 2 synthesis (L 2) 
N 
0-0-0, 
-0-N 
L2 
Py6dine 2-carboxaldehye (0.188 g, 1.75 mmol) was rrdxed with L2 P5 (0.243 g, 
0.88 mmol) in ethanol (10 cm 3) with stirring under N2 for 24 h. (OP5 sonicated to 
ensure dissolution). A bright yellow precipitate of 12 formed which was filtered under 
vacuum and recrystallised from EtOH (0.330 g, 83%). 
lH NMR (DMSO): (58.73 (m, IH); 8.65 (t, 1H, J=2.9 Hz, J=1.8 Hz); 8.18 (2H, t, J= 
3.5 Hz ); 7.97 (2H, m); 7.74 (2H, dd, J=1.2 Hz, J=3 Hz), 7.55 (4H, m); 7.45 (4H, t, i 
= 3.5 Hz); 7.13 (2H, d, J=4.4 Hz); 7.08 (2H, dd, J=2.8 Hz, J=2.59 Hz), 6.60 (2H, 
m); FAB +MS: m/z 455 [CHI, 259 [Cl8H4N2]; IR (solid)(cm-1): 2358(m), 1576(m, 
broad), 1489(s), 1466(w), 1433(m), 1262(s, broad), 829(s), 775-600(w) 
Ligand 3 synthesis (L) 
Quinoline 2-carboxaldehye (0.219 g, 1.39 mmol) was mixed with L2P5 (0.133 g, 
0.48 mmol) in EtOH (15 cm 3) . The solution immediately turned bfight yellow and was 
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left stirring under dinitrogen for 24h. The yellow precipitate of L3 was filtered under 
vacuum (0.194 g, 73%). 
'H NMR (CDC]3): not easily assignable, also contains starting materials (SM). FAB 
+MS: nilz 555 [L? H]; IR (KBr) (cm-'): 2359(s); 1623(m); 1594(m); 1408(s); 1262(m); 
834(s); 745(s) 
Ligand 4 synthesis (0) 
Iýc 
N 
C113 
0 was prepared following Hannon's method. 1 6-methyl pyridine 2- 
carboxaldehye (0.030 g, 0.24 mmol) was mixed with L? P5 (0.032 g, 0.12 mmol) in 
ethanol (15 cm 3) . This was left stirring under dinitrogen for 24h. The light yellow 
precipitate of 0 was collected under vacuum filtration (0.0 15 g, 26%). 
1H NMR (CD2CI2): H imine peak spliting, 2 species and SM (L2P5 and aldehyde): 
98.62 (d, 2H, J=1.3 Hz); (with secondary species at 8.62 (d)); 8.04 (t, 2H); 7.75 (td, 
2H); 7.68 (mix, 4H); 7.39 (mix, 6H); 7.28 (dd, 2H); 7.15 (q, 4H), 2.66 (s, 6H); FAB 
+MS: m1z 483 [0+ 
Ligand LS synthesis 
L5 P4 
02N-Q-&O- 
LSP4 
N03 
67 2 Using a modified version of Wilcox's approach. L P3 (0.431 g, 1.7 mmol) was 
mixed with I equiv 4-nitrobenzylbromide (0.372 g, 1.7 mmol) to which DMSO (10 
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cm 3) was added. The resulting dark purple solution was then heated to 55"C. The 
solution gradually changed colour over a 15 minutes as a yellow precipitate formed, the 
solution was left stirring for a further 1.5h before it was left to cool in ice. A bright 
yellow crystalline solid of Lý1? 4 was filtered under vacuum (0.569 g, 95%), water was 
added to the filtrate to bring out more OP4. 
1H NMR (CDC13): S 8.27 (4H, dd, J=3.7 Hz); 7.68 (2H, d, J=4.4 Hz); 7.63 (2H, d, J 
4.4 Hz); 7.59 (2H, d, J=3.4 Hz); 7.07 (2H, d, J=4.4 Hz); 5.24 (2H, s); FAB +MS: i? zlz 
355 [OP3 + 5H] 
Complexation synthesis using L 
[Ag202][PF6]2- 
IN C, 3ý N-C)-&O 1: >// ýhmine 
H5 
NI 
L2 N H4 
H2 
H3 
Method 1: The salt AgOAc (0.02 g, 0.043 mmol) and L2 (0.007 g, 0.04 mmol) 
were heated to reflux in methanol (8 cm 3) for Ih. The reaction vessel covered in foil to 
exclude light. The solution was filtered through celite and treated with methanolic 
[NI44][PF6] resulting in an immediate yellow precipitate, which was filtered under 
vacuum to yield the silver complex (0.031 g, 49%) 
Method 2: The salt AgOAc (0.015 g, 0.088 mmol) and L? (0.030 g, 0.067 
mmol) were stirred in methanol under dinitrogen for 3h. The dark orange solution was 
filtered through a pasteur pipette with cotton wool and celite, before treated with 
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methanolic [NH4][PF6] resulting in a dark yellow precipitate of [Ag202][PF6]2 which 
was collected by filtration. (0.06 g, 67%) 
lH NMR (CD2CI2) 58.87 (2H, d, Hi .. i,,,, J=6.4 Hz); 8.78 (2H, t, H2j5, J=2.6 Hz); 8.19 
(2H, m, H3/4); 7.99 (2H, t, H215, J=2.5 Hz, J=3.9 I-lz); 7.78 (2H, q, H314, J=2.9 Hz, J 
= 3.2 Hz); 7.52 (4H, t, Hphenyls J=3.5 Hz, ,J=4.4 Hz); 7.38 (4H, dd, 
Hphenyli J=3 Hz); 
7.02 (4H, dd, Hphenylg J=2.8 Hz); FAB +MS: nilz 1272 [M2L2PF6 + 3H]; 1126 [M2L2] 
IR (solid) (cm-1) 3380(w); 1684(w); 1590(w); 1489(m); 1242(m); 1170(w); 840(s); 
774(w) 
Other [Ag2L22][X]2 complexes prepared include: BF4 (67%) salt complex (using 
method 2). The AgOTf (56%) (OTf = S03CF3, the trifluoromethanesulfonate salt) and 
the C02CF3 (trifluoracetate salt) silver complexes were fon-ned by stirring for 2h. 
followed by refluxing for a further 2h. But all of these contain traces of starting 
materials. 
[CU2L 2 2][BF4]2 
The salt [Cu(MeCN)41[BF4] (0.025 g, 0.08 mmol) and L2 (0.036 g, 0.08 mmol) 
was left stirring in methanol (10 cm 3) under N2 for 24h. The resulting red solution was 
concentrated under vacuum; the resulting red precipitate was then filtered under vacuum 
(0.044 g, 47%). 
FAB+MS: mlz 577 [M2L2-3H]; 603 [MLBF4]; 870 [ML2-2H]; IR (solid) 667- 
640(w); 826(m); 1067(s); 1243(s); 1488(s); 1683-1593; 2388; lH NMR (CD3CN) and 
(CD2CI2) both unassignable, containing starting material and broad peaks, integrals 
unreliable. Low Temperature 1H NMR (CD3CN): as temperature decreases from 273K 
to 193K see the development of sharper peaks with the integrals eventually suggesting 
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one species (i. e. 22H) and SM. The proton NMR in CD2CI2 exhibits broad peaks and 
does not yield much more infonnation. 
ICU2L 2 2][PF6]2- 
The salt [Cu(MeCN)41[PF6] (0.033 g, 0.089 mmol) and L2 (0.037 g, 0.081 
mmol) were stirred in MeOH (10 cm 3) under dinitrogen for 12h. The resulting red 
solution was concentrated and left to precipitate out before being filtered under vacuum. 
(0.03 g, 20%). 
FAB +MS: nilz 577 [M2L-3H1; 419 [M2(PF6)2H]; 663 [MLPF6]1-1; IR(solid) (cm-'): 
2364(w); 1698-1592(w); 1489(m); 1244(m); 840(s); 649-600(w); Found C, 56.84; H, 
3.78; N, 8.94; Calc for [CUL2PF612: (C3oH22N40)2CU2P2FI2: C, 54.37; H, 3.35; N, 8.46; 
1H NMR (CD3CN) and (CD2CI2) both unassignable, containing starting material and 
broad peaks, integrals unreliable. Low Temperature 1H NMR (CD3CN): as temperature 
decreases from 273K to 193K see the development of sharper peaks with the integrals 
eventually suggesting one species (i. e. 22H) and starting material (SM) similarly for 
(CD2C]2), broad peaks at 223K but the integrals match 22H, but still broad, indicates 
one species. 
Complexation using L 
[A92L 3 2][PF612- 
L3 
Nab 
e 
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A suspension of the salt AgOAc (0.009 g, 0.054 mmol) and 0 (0.029 g, 0.053 
mmol) were stirred in methanol (15 cm. 3) under N2 for 2h. The resulting dark orange 
solution was filtered through a pasteur pipette with cotton wool and celite, before being 
treated with methanolic M][BF4]. The bright yellow precipitate fonned (0.063 g, 
74%) was collected by vacuum filtration. 
lH NMR (CD2CI2): 89.20 (2H, d, J=7.4 Hz, H. ); 8.76 (2H, dd, Hbic, J=2.2 Hz); 8.18 
(2H, dd, Hc/b, J=2.6 Hz); 8.09 (4H, td, Hd/. ); 7.73 (4H, quintet, Held), 7.53 (8H, 
7.02 (4H, dd, g, J=3.2 Hz). 2D COSY assignments: b is next to c, d is linked to e, f is 
next to g (where a-e refer to the quinoline portions of the complex, f refers to the 
biphenylene and g to the phenyl portion of the complex); FAB +MS: nz/z 1470 
[M2L2PF6 + 3H]; 1324 [M2L21; 1215 [ML21; 663 [ML]; 554[L]; IR (solid) (cm-'): 
1650(m); 1507(m); 844(s); 758(w). 
[A92L 3 2][BF4]2- 
A suspension of the salt AgOAc (0.009 g, 0.056 mmol) and L? (0.026 g, 0.047 mmol) 
were stirred in methanol (15 cm 3) under N2 for 2h. The solution changing from a bright 
yellow suspension to a dark orange clear solution. This dark orange solution was 
filtered through a pasteur pipette with cotton wool and celite, before treated with 
methanolic [NI14][BF4] resulting in a bright yellow precipitate which was collected by 
vacuum filtration. (0.042 g, 60%) 
1H NMR (CD2CI2): broad peaks but integrals do match the expected number and pattern 
of resonances (26H): (5 9.18 (2H, m); 8.78 (2H, m); 8.17 (6H, mix); 7.5 (12 H, broad 
mix); 7.02 (4H, m); FAB +MS: nilz 942 [ M2L(BF4)1; IR (solid) (cm-1): 1683(m); 
1582(m); 1506(m); 1240(m); 1230(m); 1062(s); 833(w); 600(w). 
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(CU2L 3 2][PF6]2- 
0 (0.028g, 0.054 mmol) was dissolved in methanol (15 cm3) before the salt 
[Cu(MeCN)41[BF4] (0.022 g, 0.06 mmol) was added. The mixture was stirred under 
dinitrogen for 48h. A dark red precipitate formed which was filtered under vacuum. 
(0.034 g, 42%) 
1H NMR (CD3CN): is not readily assignable, all the peaks are broad and there is also 
very small amount of starting material present; 9.40 (d, 2H); 8.78 (d, 2H); 8.22 (s, 2H); 
8.10 (s, 2H), 7.85 (s, 2H), 7.67 (m, 12H); 6.98 (s, 4H); ES +MS: nilz 618 [M2L2]2+; ]R 
(solid) (cm-)- 1597(w); 1542(m); 1508(s); 1488(m); 1243(m); 841(s); 754(w). 
[CU2L 3 
2][BF4]2: The method used was the same as for the 
[CU2L32][PF6]2- (71% yield) 
dark red black solid. 1H NMR (CD3CN): broad peaks and integrals do not match up; IR 
(solid)(cm-1): 1630 (m); 1510-1488(s); 1244(s); 1057(s); 832 (m); 786(w); 750(w) 
Low temperature proton NMR in CD3CN and CD202 of both copper complexes show 
the presence of one complex species and SM. The PF6 salt dissolves better in CD202 
than in CD3CN, whereas the BF4 complex NMR spectrum looks much cleaner in 
CD3CN than in CD2CI2 where the complex exhibits broad peaks. 
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5 Conclusions and further work 
This chapter contains the overall conclusions of the research presented in this 
thesis as well as suggesting further areas of work. 
The DNA binding interactions of five novel ruthenium(II) bis-terpyridine 
complexes functionalised with an aryl tail group (i) biphenylene (biphen), (ii) P-napthyl 
(napth), (iii) phenanthrene (phen), (iv) anthracene (anth) and (v) pyrene (pyr) in the 4' 
position on each terpyridine ligand were investigated with ct-DNA, AT DNA and GC 
DNA using the spectroscopic techniques of absorbance, CD and LD. Using qualitative 
spectroscopic assignments, all five ruthenium complexes have been found to bind non- 
covalently to DNA. At low complex concentrations, three of the complexes, the anth, 
phen and pyr complexes were found to intercalate their aryl tail groups between DNA 
bases. The napth complex was found to exhibit both an intercalative and a non- 
intercalative mode. The biphen complex was found to predominately exhibit groove 
binding with no significant- tail intercalation. At high metal complex concentrations, the 
complexes exhibit a non-intercalative binding mode, i. e. Tc-Tc self-stacking interactions 
(aggregation) on the DNA is observed. Resonance light scattering studies indicate 
aggregates of low nuclearity along the groove. 
The design of molecules with planar tails attached to the terpy groups has 
successfully led to intercalative binding in four out of five cases. These tails have the 
ability to act as low nuclearity aggregation agents, and can provide a useful platfonn 
from which to establish a basis for molecular designs. Further work on these complexes 
could take the form of CD and LD experiments with AT DNA to clarify any sequence 
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dependence, NMR investigations with small oligonucleotides and X-ray crystallography 
to confirm binding. Further mixed ligand complex synthesis using the substituted terpy 
tail groups may lead to novel complexes that can be finely tuned specific DNA binding 
agents or 'probes'. 
The DNA binding interactions of a novel series of eighteen platinum(H) square 
planar complexes of the formula [Pt(L)CI(DMSO)] where L= an acylthiourea ligand 
system R'C(O)NHC(S)NR2, R'= aryl and R= amine, (0) and (S) denote points of 
attachment of the ligand to platinum(H), and DMSO denotes dimethylsulfoxide or a 
derivative of it were investigated using absorbance, CD, LD and mass spectrometry. A 
preliminary screen of the eighteen platinum complexes with ct-DNA by absorbance and 
CD was followed by an in depth spectroscopic study on six complexes, structurally 
similar but with subtle ligand variations, with ct-DNA, poly [d(A-T)12, poly [d(G-C)12 
DNA and T-mononucleotides. Ligand variation was found to affect DNA binding 
interaction. Mass spectrometric studies on three complexes of one particular subset with 
9-methyl guanine and 5'-guanosine monophosphate indicate that these complexes bind 
covalently to DNA via the loss of the chloride or possibly the DMSO groups on the 
platinum. The spectroscopic studies suggest that duplex DNA may not be the primary 
target for these complexes and the use of organic solvent and ionic strength may affect 
interactions. This raising more questions that need answering. 
Further work on the six (PtX) complexes in the form of AT DNA LD studies (if 
experimentally feasible) may help to clarify further any sequence dependence. Mass 
spectrometric studies (similar to those carried out with the nitro subset), with 9- 
methylguanine and the (PtX) complexes of the methoxy subset may show which of the 
chloride or DMSO groups leaves preferentially with the methoxy subset and help 
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explain further the different spectroscopy seen between both subsets. Further mass 
spectrometfic studies on all six (PtX) complexes using dinucleotides and small 
oligonucleotides may also provide more information on the interactions. CD and mass 
spectrometry experiments on the effects of the chloride ion concentration and organic 
solvent effects may help make clearer the mechanism of action of these complexes and 
should help distinguish between the biologically active complexes and the others that 
are not. There is a very real possibility that once these questions have been answered, 
these (PtX) complexes could be systematically modified to provide optimum anti- 
tumour response. There are also twelve remaining (PtX) complexes, that have been 
examined briefly and been shown to interact with DNA, that, subject to compound 
availability could be investigated further. 
The molecular sensor potential of a range of organic soluble supramolecular 
copper(l) and silver(l) metal I o-cyclophanes and their interactions with small molecules 
e. g. the isomers of di- and tri-methoxybenzenes and chiral anionic compounds (sodium 
anti monyl-L-tartrate) were investigated using absorbance, fluorescence, NMR studies 
and X-ray crystallography. The metallo-cyclophanes can adopt two conformations, a 
helical (helix) and a bridging non-helical (box) structure. Using CD and proton NMR, 
the chiral dianion sodium antimonyl tartrate was found to be capable of resolving the 
metal complex box-helix mixture by inducing helix formation leading to an excess of 
one helix over the other and the box. Although the metallo-cyclophanes bind with the 
di- and tri methoxybenzenes, the mechanism of binding is still not understood. This has 
led to the Subsequent design, synthesis and characterisation of novel longer asynunetric 
ligands capable of assembly into supramolecular cyclophane structures with larger 
cavities. 
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Further work, in the form of improving the purity of these novel complexes (as 
outlined in section 4.6.5), addressing the 0 synthesis issue and complexation with 
octahedral metal ions could be investigated as well as the binding of 'guests' to these 
species 
The unifying theme of this thesis has been the biophysical investigations into 
novel metallo-systems and their interactions with DNA and small molecules. A variety 
of systems have been studied, the common features of which have been the spectral 
techniques used and the need to solubilise the systems in organic solvents, hence the 
development of methods to study the metallo-systern biomolecular interactions 
spectroscopically in organic solvents. 
The research presented in this thesis represents a variety of novel metallo- 
systems that have the potential to be adapted to have future biomedical applications 
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Appendix 4.1 Absorbance titration spectra, ISM and 
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Appendix 4.2 Fluorescence titration spectra and Scatchard 
plots. 
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Appendix 4.3 X-ray crystal data 
Table 1. Crystal data and structure refinement for jnat. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system, space group 
Unit cell dimensions 
Volume 
Z, Calculated density 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Limiting indices 
Reflections collected unique 
Completeness to theta 28.97 
Absorption correction 
Max. and min. transmission- 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F"2 
Final R indices (I>2sigma(I)l 
R indices (all data) 
Largest diff. peak and hole 
j nat 
C56 H51 B2 Cu2 F8 N9 
1150.76 
293(2) K 
0.71073 A 
Triclinic, P-1 
a= 11.6049(2) A alpha = 87.9650(10) 
b= 14.8366(3) A beta = 73.5870(10) 
c= 16.37190(10) A gamma = 79.6210(l 
2659.40(7) AA3 
2,1.437 Mg/mA3 
0.875 mmA-1 
1180 
0.50 x 0.40 x 0.04 mm 
1.89 to 28.97 deg. 
-15<=h<=15, -18<=k<=19, -20<=l<=21 
17G2G 12215 [R(int) = 0.03101 
86.6 
Semi-empirical from equivalents 
0.928 and O. G70 
Full-matrix least-squares on FA2 
12215 / 94 / 694 
1.017 
Rl = 0.0636, WR2 = 0.1264 
Rl = 0.1221, wR2 = 0.1561 
0.930 and -0.714 e. A A -3 
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